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ABSTRACT 
A segment of DNA can vary in the number of copies between two or 
more genomes known a copy number variation (CNV). CNVs are a common 
genomic variant that is now shown to be associated with numerous diseases. 
A large portion of the genome (approximately 12%) has shown to be 
vulnerable in producing common or rare CNVs. These genomic regions are 
often prone to rearrangement due to the underlying molecular mechanisms 
(i.e. non-allefic homologous recombination (NAHR), non homologous end 
joining (NHEJ), fork stalling and template switching (FoSTeS) and 
microhomology-mediated break-induced recombination (MMBIR)) that gives 
rise to inter-individual genetic differences through copy number changes. 
Segmental Duplication (SO) is another type of genomic variant and is 
at least 1 kb in length with >90% sequence identity with other genomic 
regions, constitutes a significant portion of the human genome. A pair of SO 
block that are homologous to each other influences the rate of NAHR events, 
often resulting in CNVs. Large portions of SDs overlap with CNVs, some of 
which are associated with disease. Although investigating SO is important to 
the study of evolution, and for inferring the underlying mechanism of nearby 
CNVs, the structural relationship of SDs and CNVs in complex disease is yet 
to be elucidated. Detecting SO is notoriously complex and genotyping single 
nucleotide polymorphism (SNP) within these regions is near impossible with 
traditional array based approaches. 
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The primary objectives of this thesis are - i) to detect CNVs arising 
from complex genomic rearrangements mediated through SDs; ii) to design a 
custom microarray, targeting rearrangement hotspot regions and iii) to identify 
novel CNVs associated with complex disease (i .e. Ankylosing Spondylitis 
(AS) and Tourette Syndrome (TS)) using the custom microarray. 
Until the advent of high throughput whole genome sequencing, the 
primary CNV detection methods included SNP genotyping arrays, 
comparative genomic hybridization (CGH) arrays, clone-PCR product arrays, 
and fluorescent in situ hybridization (FISH). Each method is reported to have 
pros and cons show no single method have the capacity to detect the entire 
CNV content in a genome. In this thesis, the use of SNP microarrays 
(primarily designed for SNP genotyping) to detect CNVs in a complex disease 
cohort was explored. This analysis shows the limited capacity of existing SNP 
arrays for the detection of CNVs. In light of this apparent complexity on the 
detection of CNVs, a hybrid model was described in the second chapter to 
detect SDs and CNVs using both whole genome sequencing and microarray 
technologies. The whole genome sequence analysis was performed to detect 
approximately 2000 rearrangement hotspots within SDs for an African 
genome (18x coverage). A high density microarray consisting of 2 X 1 million 
probes was custom designed targeting the hotspots. 
The application of the microarray leads to the detection of a large 
number of CNVs and was applied on two complex (i.e. Ankylosing Spondylitis 
(AS), and Tourette Syndrome (TS)) diseases to identify novel disease 
iii 
associated CNVS. The third chapter shows the detection of a highly stratified 
gene UGT2B17 in copy number and its association with Ankylosing 
Spondylitis. The fourth chapter of this thesis show the application of the 
custom array that leads to the detection of a novel locus at 2q21.1-q21.2 for 
Tourette syndrome. CNVs breakpoint within the locus show atypical micro-
duplications includes C2orf27A gene that segregates within multiple 
generations correlates with severe TS phenotypes. 
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Chapter 1 
INTRODUCTION 
1.1 COPY NUMBER VARIATION 
Structural variation (SV) was originally defined as insertions, deletions, 
and inversions greater than 1 kb in size (Feuk et al., 2006). With the high 
throughput sequencing of human genomes now becoming routine, the detection 
spectrum of structural variants (SVs) and copy number variation/variants (CNVs) 
has widened to include much smaller events (for example, those >50 bp in 
length) (Mills et al. , 2011). Genomic CNVs describe a unique DNA segment that 
differs in copy number between two or more genomes. The earliest evidence of 
gene CNV found to be associated with a phenotype was reported in 1936, when 
researchers discovered that the BAR duplicated in Drosophila melanogaster, 
which was shown to cause the Bar eye phenotype (Bridges, 1936). The evolving 
definition of CNV now includes a size constraint; as new technology emerges 
with high resolution detection capacity, the length of a CNV is now considered to 
be as small as 500bp (Conrad et al., 2010; Mills et al. , 2011). Depending on the 
method employed for assessment, up to about 12% of the human genome is 
thought to be comprised of CNVs. A significant portion of these regions contain 
genes that are functionally active in humans. That over 41% of all CNVs identified 
overlap with known genes suggests that CNVs may play a prominent role in 
modulating the regulation of genes. Current estimates are that more than 240 Mb 
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of the reference genome is comprised of CNVs and are present in at least 6% of 
each chromosome (Scherer SW et al. , 2007; Zogopoulos et al., 2007; McCarroll 
et al. , 2008; Perry et al. , 2008; Henrichsen et al. , 2009) . 
Over the past few years, CNVs have attracted much attention due to the 
fact that they are common in the human genome and can have dramatic 
phenotypic consequences, including the capacity to alter gene dosage, disrupt 
coding segments, and regulate functional genes (Barbara et al. , 2007). CNVs are 
now routinely analyzed to identify disease susceptible loci in the genome. Despite 
extensive studies, the total number, position, size, gene content, and population 
distribution of CNVs remain elusive. Moreover, small CNVs (i.e., 0.5-50 kb in 
size) have been under-ascertained because there has not been an accurate 
molecular method available to study these smaller rearrangements on a genome-
wide scale in different populations (Hurles et al. , 2008) . The analysis of Conrad et 
al. is, to date, the most comprehensive catalogue of CNVs; it used 42 million 
probe aCGH microarrays for three global populations. The 1,000 Genome Project 
also performed a large CNV detection analysis using high throughput sequencing 
for major global populations (Mills et al. , 2011 ; Sudmant et al. , 201 0). These 
studies used both microarray and sequence technology, providing the most 
comprehensive common and rare CNV catalogue to date. They identified a set of 
genes that are highly stratified in terms of copy number within numerous world 
populations, and they postulated that these CNVs are associated with diseases. 
CNVs may have a range of involvement in reference to diseases. In 
numerous genomic disorders, CNVs manifest with the phenotype as de novo or 
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inherited variants. Within neuropsychiatric disorders (i .e., autism spectrum 
disorder (ASD), schizophrenia , etc.), CNVs have been shown to be highly 
penetrant, primarily manifesting as de novo variants (Pinto et al. , 201 0). Genomic 
regions containing CNVs may harbor important genes and gene regulatory 
elements and, therefore, may substantially influence gene expression and, thus, 
phenotypic diversity (Barbara et al. , 2007; Aldred et al. , 2005). More importantly, 
these CNVs within putative genes and their associated pathways could be 
potential therapeutic targets in the future. At least two distinct models have been 
proposed with respect to associations between disease and structural variation . 
The first involves large variants (i.e., typically gains and losses several hundred 
kilobase pairs in length) that are individually rare in the population (<1 %); 
however, in a control population at least 11% can have large CNVs of at least 
400kb in size. A significant fraction of diseases, as seen in reference to some 
neurological and neurocognitive disorders, can be explained by the presence of 
such large variants (Stankiewicz et al. , 2002; Sebat et al. , 2007; Sharp et al. , 
2006; de Vries et al. , 2005). At least 14.2% of developmental delays have been 
associated with large CNVs (>400kb), which are rare in control populations 
(Cooper et al. , 2011). The second includes multi-copy gene families that are 
commonly copy number variables and which contribute to complex disease 
susceptibility, as frequently seen for traits related to immune gene functions 
(Fellermann et al. , 2006; Aitman et al. , 2006). It has been reported that dosage 
sensitive gen·es may have considerable influence on disease susceptibility (or, 
alternatively, disease resistance) in humans. 
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The discovery and genotyping of such small-length CNVs has been central 
to the understanding of their contribution to complex disease pathogenesis. At 
present, only the "tip of the CNV iceberg" has been explored in relation to 
complex trait genetics. In recent years, initiatives involving large-scale population 
genome analysis have revealed the structural complexity of CNVs. In reference 
to understanding the contribution of CNVs to gene expression and disease 
pathogenesis, inferring these complex structural properties is essential. The 
structure of CNVs is noticeably different from other genomic repeat variants such 
as retrotransposons (long interspersed elements (LINE) and short interspersed 
elements (SINE)) and microsatellites (for example, di- or trinucleotide 
microsatellite tandem repeats) . LINEs and SINEs (known as alu sequences in 
primate genomes) are usually short and repeated elements, whereas the 
microsatellite DNA is tandemly repeated (Bailey et al. , 2002; Bailey et al. , 2006). 
Intuitively, a CNV can overlap or contain retrotransposons as a variant (Asako et 
al. , 2011). However, the presence of repeated elements within CNVs introduces 
complexities in terms of detection technologies. 
Segmental duplication (SD) or low copy repeat (LCR) is another genomic 
variant that is conceptually similar to CNVs. Segmental duplications are blocks of 
DNA sequences that reached fixation after duplicating themselves multiple times 
within the genome through molecular mechanisms during the course of human 
evolution. Segmental duplications are at least 1 kb in length with >90% sequence 
identity and, unlike CNVs, the majority of the SDs are greater in length. 
Phylogenetically, SDs were initially unique sequences which, over time, 
6 
duplicated (often, multiple times) within the genome and reached a static state 
within the population or species. The current catalogue of SDs comprises 
approximately 5% of the human genome, encompassing 18% of genes (Bailey et 
al. , 2002; Bailey et al., 2006). Some reports show SDs can vary in copy numbers 
among individuals or populations. A significant portion of CNVs overlap with SD 
regions; quantifying copy number for these regions is very difficult. Large-scale 
studies for detecting CNVs and SDs show that approximately 25% of SD regions 
overlap with CNVs in a population (Bailey et al., 2006; Red on et al. , 2006; Alkan 
et al. , 2011). 
1.2 REARRANGEMENT HOTSPOTS AND CNVS 
Genomic rearrangement is the mechanism behind the creation of 
structural variations. Initially, genomic rearrangement was shown to take place 
within the centromeric and telomeric regions of the chromosomes. These regions, 
known as "hotspots," are susceptible to rearrangement due to their sequence 
content. Numerous cases have been identified 1n which 
translocation/insertion/deletion/inversion or complex aberrations took place due 
to genomic rearrangement within these regions. In recent years, numerous 
mechanisms of rearrangement have been proposed (e.g., non-allelic homologous 
recombination (NAHR), non-homologous end joining (NHEJ) , fork stalling and 
template switching (FoSTeS), and microhomology-mediated break-induced 
recombination (MMBIR)) which shed light on the concept of "genome-wide 
rearrangement hotspots," which are not limited to centromeric/telomeric regions 
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and provide some new insights into non-centromeric/telomeric hotspot regions 
(Hastings et al. , 2009). There is a wide range of functional consequences related 
to genomic rearrangements, including gene activation, modification of gene 
expression, and gene fusion. 
Genomic rearrangement is an important biological mechanism that can be 
used to explain some complex human diseases etiology. In recent years, such 
pathogenic rearrangements have been identified in different types of cancers and 
in neuropsychiatric diseases. Among the four mechanisms, NAHR and NHEJ are 
recombination-based methods, whereas the proposed MMBIR and FoSTeS are 
replication-mediated. Apart from NAHR, the other recombination-based 
mechanism, NHEJ, is responsible for repair of DNA double-strand breaks. In 
NHEJ, double-strand breaks are detected; after that, both broken DNA ends are 
bridged, modified, and, finally, ligated (Weterings et al. , 2004). The product of 
repair often GOntains additional nucleotides at the DNA end junction, leaving a 
"molecular scar" (Gu et al. , 2008). 
Different molecular mechanisms are thought to be responsible for 
producing genomic rearrangements with certain properties. For example, MMBIR 
has been shown to be the mechanism that produces smaller-sized SVs than 
each of the other mechanisms. Additionally, not many studies have provided 
genome scale evidence of aberrations that originated via MMBIR. In addition to 
NAHR and NHEJ, fork stalling and template switching (FoSTeS), a mechanism 
that is based on DNA replication error, has recently been shown to play an 
important role in the origin of genomic disorder-associated non-recurrent 
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rearrangements that have complex structures (e.g., deletions and/or duplications 
interrupted by either normal copy numbers or triplicated genomic segments) (Lee 
et al. , 2007; Zhang et al. , 2009). In this model , the DNA replication fork stalls; 
then the lagging strand disengages from the original template and anneals to 
another replication fork in physical proximity by virtue of microhomology at the 
3'end, "priming" or reinitiating DNA synthesis. Depending on the location of the 
new fork (i.e., upstream or downstream), a deletion or duplication, respectively, 
will occur. Whether the lagging or leading strand in the new fork is used as a 
template determines whether the erroneously incorporated fragment from the 
new replication fork will be in direct or inverted orientation with respect to its 
original position (Hastings et al., 2009). In this thesis, the NAHR is the primary 
mechanism that will be discussed and investigated. 
Emerging evidence reveals an increasing frequency of deletions and 
duplications in and around segmental duplications in comparison to the unique 
portion of the human genome. Recently, the association of SO regions with 
genomic disorders has been reported frequently, with the vast majority 
representing novel sites whose genomic architecture is susceptible to disease-
causing rearrangements (Sharp et al., 2005). Among the proposed mechanisms, 
NAHR is the well studied mechanism that produces CNVs mediated through 
SDs. Especially for NAHR; CNVs that are flanked by two SDs have been found to 
be near identical in sequence homology (see Figure 1.1 ). This recombination 
event takes place due to the presence of segmental duplications where two 
blocks of SDs that are homologous (completely or partially) to each other 
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recombine. The region between the SDs (see Figure 1.1) which is prone to copy 
number changes is known as the "critical region. " The two homologous blocks of 
SDs can reside within the same chromosome or among different chromosomes, 
creating intra-chromosomal and inter-chromosomal recombination events, 
respectively. Importantly, NAHR-mediated events occur much more frequently 
than the rate for the creation of single-nucleotide polymorphism (SNPs; 1 x1 0-4 
compared with 1 x1 0-8 per generation) (Hastings et al. , 2009; Henrichsen et al. , 
2009; Shaffer et al., 2000). This molecular mechanism has been shown to be 
responsible for the vast majority of the common-sized recurrent rearrangements, 
including reciprocal deletions and duplications, or inversions. However, the 
complexity of their structural architecture in the human genome and, more 
importantly, their role in disease pathogenesis remains largely unknown. In the 
second chapter of this thesis, a proposed solution to the problem of detecting 
complex SO regions using high throughput sequencing technology is formulated 
and executed. 
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Figure 1.1 NAHR mechanism shows two common outputs from the misalignment 
of segmental duplications. 
The proposed replication-based mechanisms (FoSTeS and MMBIR) 
have not been thoroughly studied. These mechanisms require population 
scale analysis using high throughput sequencing from researchers to better 
understand their contribution to genomic variants, especially in terms of 
CNVs. In contrast, NAHR and NHEJ have been thoroughly studied. One of 
the primary focuses of this thesis is to develop techniques to identify genomic 
regions that are NAHR-prone. The NAHR event and its resultant variant 
depend vastly on the orientation of the SOs. For example, two inverted SOs 
will produce ~n inverted SO; one inverted and one forward-oriented SO will 
produce a deletion; and two forward-oriented SOs will produce a forward-
oriented SO. This recombination mechanism is capable of producing genomic 
gains or losses through the course of evolution and acting as a mutational 
mechanism in the human genome (Hastings et al. , 2009). In recent years, 
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multiple disorders have been reported to be associated with genomic gains 
and losses that are due to NAHR. Charcot-Marie-Tooth disease type 1A, 
Smith-Magenis Syndrome, and Neurofibromatosis type 1 are the classic 
examples of SO-mediated pathogenic genomic losses/gains that occur 
through NAHR mechanisms. The presence of the proximal and distal SDs is 
indicative of a possible NAHR mechanism that caused the pathogenic 
variants. The location of the proximal and distal SDs can be within a 
chromosome or between chromosomes. NAHR is the most common 
mechanism underlying disease-associated genome rearrangements, primarily 
in reference to neuropsychiatric diseases (Shaw et al. , 2004). 
There have been very few attempts to detect on a genome-wide scale 
the total content of SDs that contribute to the formation of CNVs. Moreover, 
the characterizations of SDs and CNVs have yet to be applied in large 
complex disease cohorts. The detection of rearrangement hotspots will lead 
to better understanding of the mechanistic formation of CNVs that are 
susceptible to various complex diseases. In this thesis, I have proposed a 
technique to detect rearrangement hotspots with in SDs that are likely to 
produce CNVs, primarily through the NAHR mechanism. 
1.3 DETECTION OF COPY NUMBER VARIATIONS (CNVs) 
Initially, cytogenetic studies used microscopes to investigate gross 
chromosomal abnormalities. The first such observation involved the 
identification of an additional copy of chromosome 21 that is associated with 
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Down's syndrome. As technology utilizing high resolution detection capacity 
emerged, an explosion of submicroscopic CNVs were discovered in the 
human genome. The primary detection methods include microarray, 
comparative genomic hybridizations, clone-PCR product arrays, and 
fluorescent in situ hybridization (FISH). In recent years, high-throughput 
sequencing appears to be the most promising approach to detect genomic 
variants. This new perspective on human variation has been driven largely by 
the implementation of whole-genome scanning methods that enable 
researchers to interrogate the genome at a resolution intermediate between 
that of cytogenetic analysis using microscopy (>5-1 0 Mb) and that of DNA 
sequencing (1-700 bp) (Aikan et al., 2011 ). Below is a description of the 
primary detection methods that are commonly used in the detection of CNVs 
and segmental duplications. 
Fluorescent in situ Hybridization (FISH): 
Fluorescent in situ Hybridization (FISH), developed in the 1980s, allows 
visualization of chromosomal regions during the metaphase spread or in the 
interphase nuclei. The primary aim of this method is to detect a locus or its 
derivatives within the genome through a fluorescent signal through the use of a 
fluorescently labeled probe which hybridizes with the targeted locus and its 
derivatives. Two- and three-color FISH is primarily used to target genomic loci. 
The use of FISH in clinics is very common for the detection of large aberrations 
for patients with neuropsychological disorders. The known pathogenic large 
deletions (usually >40kb) or duplications are routinely tested for in patients with 
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genomic disorders (e.g., Down's syndrome). In recent years, a variety of FISH 
techniques have been developed with increasing resolution (i.e., fibre FISH, 
Quantitative FISH or Q-FISH, Multiplex FISH, and flow FISH). 
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Figure 1.2 The representation of the processes that involve in fluorescent in situ 
hybridization (FISH). 
Traditional approaches employ a fluorescently-labeled copy of the probe 
sequence (a fragment of DNA) that is large enough to produce a hybridized 
signal (see Figure 1.2). Prior to the hybridization process, both the target and the 
probe sequence are denatured with an appropriate amount of heat, which allows 
the formation of hydrogen bonds between the target and the probe sequences. 
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The probe and the target sequences are then mixed together, and the probe 
specifically binds to its complementary sequence on the chromosomes (Bayani 
and Squire, 2004). Probe and the target regions within chromosomes can be 
detected using a fluorescent microscope. The two major limitations of using the 
traditional FISH experiment include restrictions in terms of the number of loci as 
targets and the length of the aberrations that can be detected. The first restriction 
is due to the fact that introducing too many target loci usually allows for spurious 
signals which make it difficult to detect true signals using the fluorescent 
microscope; therefore, the common practice is to use only one or two probes 
simultaneously. The second restriction is the limitation of the use of a single 
genome per experiment. These restrictions do not allow detection of aberrations 
on large cohorts. 
Clone and PCR-product Arrays: 
The use of microarrays is the most common way of detecting genomic 
aberrations. Initially, bacterial artificial clones (BAC) were often used as 
templates to produce DNA microarrays; this method has the lowest noise 
from among all hybridization techniques. For the use of custom designing 
arrays, a catalogue of more than 30,000 overlapping clones covering the 
entire human genome is available. The length varies between 80 to 200 kb, 
which is a major limitation in reference to detecting CNVs that are less than 
50kb in length. More recently, fosmid and cosmid clones (bacterial genomic 
DNA) were commonly used for array-comparative genome hybridization 
because it provided an improved CNV detection capacity of at least 20kb in 
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length. There are examples of the use of eDNA (complementary DNA) clones 
for the construction of array-comparative genome hybridization targeting an 
entire or partial gene. Using eDNA often produces uneven distribution due to 
the lack of coverage of the genome, which, in turn, reduces the capacity to 
detect high resolution breakpoints of CNVs. 
PCR and quantitative PCR-based methods provide rapid and accurate 
cost efficient approaches to detect CNV in a large number of sample sizes. 
These approaches are limited in terms of the number of loci they can test 
simultaneously, and so, are appropriate for targeting narrow regions in the 
genome. Among these methods, multiplex ligation-dependent probe 
amplification · (MLPA) and multiplex amplicon quantification (MAQ) can 
simultaneously assay a number of loci in a large number of samples. The 
most commonly used approach is the developing technology that can utilize 
the PCR product via real-time quantitative PCR (rt-qPCR) for the efficient 
detection of CNVs located on a single DNA fragment (Schouten et al., 2002; 
Schaeffeler et al., 2003; Weksberg et al., 2005; Kumps et al., 201 0). 
Among various molecular approaches, MLPA is interesting because of 
its ability to detect multiple loci and their copy number changes in one simple 
PCR reaction , making it an attractive alternative to FISH (Abdool et al., 201 0) . 
One of the primary limitations of this method is the restricted number of loci 
involved, which falls short for genome-wide analysis of CNV detection. MAO 
is another approach that has been shown to be a low-cost and high-
throughput PCR-based technique that can accurately predict copy number 
16 
alterations (Kumps et al. , 201 0) . Currently, MAQ allows 40 targets in one 
reaction , which is sufficient for routine clinical diagnostics, but not enough for 
genome-wide scale analysis. The most prominent molecular technique is rt-
qPCR-based copy number screening, which serves as the method of choice 
for targeted screening. A large number of samples can be analyzed to detect 
CNVs for a restricted number of targeted loci. All of these approaches are 
widely used as validation methods for targeted regions after the analysis of 
whole genome CNV detection using other microarrays. CNVs that overlap 
consist of regions with common repeats and segmental duplications which 
require extra care in reference to detection and analysis. 
Genotyping Arrays: 
In the last decade, numerous disease loci have been identified using high 
throughput genotyping arrays for the investigation of single nucleotide 
polymorphisms (SNPs) associated with a disease. Subsequently, the 
development of bioinformatics approaches has allowed researchers to detect 
CNVs by re-using the probe intensity data that was initially designed for SNP 
genotyping. Two very important sources of genotyping data exists: dbGAP (The 
database of Genotypes and Phenotypes) and the HapMap project archive. The 
dbGaP project includes all of the SNP microarray data primarily for common 
complex diseases (Mailman et al. , 2007), whereas the HapMap project produced 
the catalogue of SNPs for major world populations. The current genotyping 
platforms (i .e., Affymetrix and lllumina) offer comprehensive coverage of the 
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human genome; recently, these high density data from dbGaP and HapMap have 
been used in multiple studies to produce CNV catalogues. 
The primary difference between other array-based approaches and the 
SNP genotyping array is that, when using SNP, hybridizations are not performed 
using cohybridization of two DNA samples, as in array-CGH. Instead, probe 
hybridization ·occurs for a single DNA sample. To reduce the signal-to-noise 
ratio, the DNA is first digested with a restriction enzyme and then ligated with 
adapters. To minimize the complexity of hybridization, smaller fragments are 
amplified using universal primers. To detect CNVs using SNP genotyping 
platforms, the probe signal intensities the match, and mismatch probes are 
compared with values from another individual (or a group of individuals treated as 
reference individuals); then the relative copy number per locus is determined 
(Dennise et al. , 2006). The reference individuals have to match ethnically and 
phenotypically. Although the primary aim is to genotype SNPs, the detection 
capacity is very high compared to clone-based arrays. The detection capacity is 
dependent, mostly in terms of the distribution of the probes. For example, the 
early Affymetric 500k consisted of probes targeting SNPs with a 2.5kb median 
gap (WTCCC, 2007). 
18 
a . 
> ro 
~ 
~ 
<t 
c.. b . 
z 
V) 
c. 
0 
·.o:; 
"' 0::: 
b..O 
0 
__. 
LL 
<t 
cr:l 
0 
-"' 0:::
b..O 
0 
__. 
0 Copy 
• .... =-···· . • 
• • • • • • 
• • • • 
• 
• • • 
• • 
•• • • 
• • • 
• • • • • 
• 
• M .:-.•.• • 
1 Copy 3 Copy 4 Copy 
••• -.· •.a .•. ..r ----·.· • 
... --.·· • 
. ... .......... 
----.-
. ............. 
.......... 
·-·-·-
. -- ..... 
••••••••• . ............ 
...• ..... • ... ....... _. 
- .. ···-
...r ----·.· 
••• -.· •.a ••• 
........... · .. 
Position 
Figure 1.3 Illustration of an SNP microarray and an array CGH copy number 
detection pattern. In the SNP microarray, a) the signal intensities a sample is 
analyzed with reference to a set of samples from the same population. The B-
allele frequency is another metric that b) can be calculated as the proportion of 
the total allele signal (A+ B) explained by a single allele (A). In combination with 
the log2 ratio pattern, the BAF may be used to accurately assign copy numbers 
from 0 to 4 in diploid regions of the genome. c) aCGH generates a similar 
intensity metric except for the fact that the intensities do not depend on a 
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reference set. In contrast, the signal is produced by hybridizing a test with a 
reference sample and the intensity is normalized and converted to a log2 ratio , 
which acts as a proxy for copy number. 
Recent arrays (i.e., Affymetrix 6.0 SNP and Ilium ina 1M platforms) 
incorporate b~tter SNP selection criteria for complex regions of the genome and 
non-polymorphic copy-number probes. Along with log intensity, a second metric, 
termed BAF (B allele frequency), can be utilized to determine the copy number of 
a locus (limited to 0 to 4 copies) by calculating the total allele signal (A+B, for 
allele A and B) as explained by a signal allele A (see Figure 1.3). The BAF has a 
significantly higher per-probe signal to noise ratio than the log ratio data and can 
be interpreted as follows: a BAF of 0 represents the genotype (A/A or AI-) , 
whereas 0.5 represents (AlB) and 1 represents (B/B orB/-). Different BAF values 
occur for AAB and ABB genotypes or more complex genotypes (for example, 
AAAB, AABB, and BBBA). Homozygous deletions result in a failure of the BAF to 
cluster (Cooper et al. , 2008; Peiffer et al. , 2006). Thus, the BAF may be used to 
accurately assign copy numbers from 0 to 4 in diploid regions of the genome. 
Array comparative genome hybridization (aCGH): 
Comparative genomic hybridization (CGH) was the first approach used 
to scan the entire genome comprehensively to detect variations in DNA copy 
numbers (Pinkel et al., 1998; Iafrate et al., 2004; Conrad et al. , 2010). In a 
typical CGH measurement, total genomic DNA is isolated from test and 
reference cell populations that are differentially labeled and hybridized to 
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metaphase chromosomes or, more recently, DNA microarrays. The relative 
hybridization intensity of the test and reference signals at a given location are 
then (ideally) proportional to the relative copy number of those sequences in 
the test and reference genomes. If the reference genome is normal, then 
increases and decreases in the intensity ratio directly indicates DNA copy-
number variations in the genome of the test cells. More than two genomes 
can be compared simultaneously if distinguishable labels are available. Data 
are typically normalized, so that the modal ratio for the genome is set to some 
standard value, typically 1.0 on a linear scale or 0.0 on a logarithmic scale 
(Conrad et al. , 2010) (see Figure 1.3). Additional measurements, such as 
FISH or flow cytometry, can be used to determine the copy number 
associated with a given ratio level. 
Array-comparative genome hybridization (aCGH) technology, 
developed in the last decade, affords the capacity to examine the whole 
human genome on a single chip with a level of resolution dependent only on 
size and distance between the interrogating probes, a process also known as 
microarray-based cytogenetics (Pinkel et al. , 1998). Microarray technology is 
superior to cytogenetic techniques such as conventional karyotyping and 
FISH analysis. The resolution afforded by microarray technology is at least 
1 0-fold greater than the best pro-metaphase chromosome analysis obtained 
via conventional karyotyping, rendering it the most sensitive whole-genome 
screen for genomic deletions and duplications (Lee et al., 2007). 
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Most _arrays cover a larger segment of the subtelomere and 
centromere than the existing FISH probes and , subsequently, can identify a 
greater number of rearrangements (Lee et aL , 2007; Iafrate et aL , 2004). In 
addition, they provide more information with respect to the size of the 
chromosome segment involved, which is often larger than 5Mb, and may also 
define complex rearrangements within the subtelomere, which may include 
both deletion and duplication within the same region (Antonacci et aL , 201 0). 
Microarray-based cytogenetic testing characterizes CNV size and genomic 
location, which facilitates genotype-phenotype correlations. The increased 
resolution of microarray technology over conventional cytogenetic analysis 
allows for identification of chromosomal imbalances with greater precision, 
accuracy, and technical sensitivity; it represents the technical convergence of 
molecular genetics and cytogenetics and is rapidly revolutionizing modern 
cytogenetics. The use of aCGH technology for neuropsychiatric patients has 
led to the identification of atypical duplications and deletions in a growing 
number of them (Dawson et aL, 201 0). 
Array-based comparative genome hybridization (aCGH) technology 
offers several advantages over SNP-based approaches, including: 1) 
coverage of genomic regions with low SNP incidences (i.e. , SNP deserts); 2) 
the use of intra-experimental control rather than use of a pre-established 
laboratory standard; 3) a higher signal-to-noise ratio; and 4) the availability of 
custom, high-density probe arrays (Peiffer et aL , 2006; Coe et aL , 2007). 
These notable advantages have led to their widespread adoption in clinical 
22 
diagnostics, essentially replacing karyotype analysis as the primary means of 
detecting copy-number alterations among children with developmental delays 
(Miller et al., 201 0). 
Customized aCGH can be applied to genotype the largest number of 
CNV loci, as recently demonstrated by the Wellcome Trust Case Control 
Consortium (WTCCC) (WTCCC, 201 0) . Microarray-based testing is currently 
considered to be the first-line test for most patients with neuropsychiatric 
diseases. Conrad et al. used multiple microarrays consisting of 42 million 
probes, tilling the entire genome and producing the most comprehensive CNV 
catalogue with the highest resolution to date. These identified CNVs using 
microarrays within three major global populations and are now used for 
association studies for complex disease cohorts. The application of 
microarray-based cancer cytogenetics has also led to the identification of 
putative oncogenes and tumor suppressor genes (Tagawa et al. , 2005). 
High-throughput Sequencing: 
Over the past few years, there has been a major shift away from 
automated Sanger sequencing for the analysis of the genome. The advent of 
high-throughput sequencing technologies (i.e., Roche/454, lllumina/Solexa, 
Life/APG's SOLiD, Helicos BioSciences, etc.) promises to revolutionize 
structural variation and is a potential replacement for microarrays as the 
platform for discovery and genotyping. The technology differs for each 
platform in chemistry and the employed molecular approaches used to 
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sequence the entire genome. The output sequence read length also varies 
among the commonly used platforms. For example, Roche/454, 
lllumina/Solexa, Life/APG's SOLiD, and Helicos BioSciences produce 
average sequence read lengths of 330bp, 32-1 OObp, 50bp, and 32bp, 
respectively. 
However, high-throughput sequencing approaches present substantial 
computational and bioinformatics challenges. Most of the methods used to 
detect SVs are computational algorithms that were initially designed for 
capillary sequence reads or fully sequenced large insert clones (Volik et al., 
2003; Tuzun et al. , 2005). The algorithms are now improving and can 
undertake substantially large amounts of data produced by the high 
throughput sequencer to decipher the SVs from multiple genomes. There are 
three primary strategies to investigate sequence data in the detection of 
structural variations in a genome. Each of the strategies has a unique 
capacity for detection of SVs. Below is a description of the methodologies that 
are commonly applied on genome-wide sequence data. 
Read-pair Technology: 
Read-pair technology, instead of utilizing a standard single-read DNA 
library, facilitates the reading of both the forward and reverse template 
strands during one paired-end read . Each paired read includes sequence 
information and positional information that allows for highly precise alignment 
of reads in the genome. During alignment, the read-pair method computes the 
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span and the orientation of paired-end reads and detects discordant pairs, 
where either the orientation or the span is not consistent with the reference 
genome (Tuzun et al., 2005; Kidd et al., 2008). The discordant pairs that 
indicate the mapping is too far apart infer that a deletion is present. Pairs that 
appear to map too closely together indicate an insertion, and if the 
orientations are inconsistent, then it implies a possible inversion or tandem 
duplication. Novel insertions also can be detected when only one end cluster 
is mapped. 
The unique paired-end sequencing by lllumina usually allows inserts 
that are within 200 to 500bp in length. A typical paired-end run produces 75bp 
reads each and allows up to 200 million reads. The detection capacity is in 
base pair resolution for the detection of deletions, duplications, inversions, 
and insertions. The major limitations include ambiguous mapping 
assignments within the repetitive region of the genome, producing 
inconsistent mapping positions, which may lead to high false positive rates. 
Based on the fragment size of high throughput sequencing, most of the 
detected SVs are <1 kb in length, and the majority of such SVs are deletions 
(1 000 Genomes Project, 201 0; Kidd et al. , 201 0). The first application of 
paired-end reads was demonstrated using BAC end sequences generated 
from cancer cell lines (Volik et al. , 2003). Later, this approach was applied to 
detect germline SVs using a fosmid end sequence library (Tuzun et al., 2005). 
A wide range of computational algorithms exist to compute and detect SVs 
from paired-end reads (e.g., PEMer, VariationHunter, BreakDancer, MoDIL, 
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MoGUL, HYDRA, Corona and SPANNER) (Mills et al., 2011 ; 1000 Genomes 
Project, 201 0). 
Read-depth Methods: 
Read-depth approaches utilize the mapping distribution of short read 
sequences from high throughput sequencing in comparison to the reference 
genome. The read depth is computed for a given region by counting the 
number of reads that map to that region. Theoretically, a unique region of the 
genome consists of uniform depth; regions with duplications and deletions 
show deviated read depths (Aikan et al., 2009). To identify SO blocks, it is 
crucial to know all of the possible mapping positions for each short read. 
Unlike unique regions, short reads that belong to SO blocks will return 
multiple mapping positions. Not all computational aligner algorithms return all 
mapping positions for short reads in the reference genome. The Micro-read 
Fast Alignment Search Tool (mrFAST) and the Micro-read Substitution-only 
Fast Alignment Search Tool (mrsFAST) are the most efficient tools that return 
all mapping positions for short reads (Aikan et al. , 2009; Hach et al. , 2010). 
Using the entire reference genome will return spurious mapping calls within 
the repeat-rich region of the genome; hence, the repeat masked genome 
should be used to reduce noise during mapping. Prior to computing the read 
depth, GC corrections need to be employed to eliminate the GC bias of the 
sequencing technology. For each user-defined window length, the read depth 
is computed on GC-corrected data to reduce false positives. 
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The read-depth-based method is particularly efficient in terms of 
estimating absolute copy number and detecting segmental duplications in 
base pair resolution. The detection resolution is positively correlated with the 
genome coverage, i.e., higher coverage reduces false positive results. The 
primary benefit of utilizing read depth is the detection of absolute copy 
number, which is crucial for association analysis. With adequate coverage, it 
is possible to detect genes that are high in copy number (i.e., DUX4) (Aikan et 
al. , 2009). This is a major advantage compared to microarray-based 
approaches, which are not capable of computing absolute copy numbers. 
Read-depth approach algorithms also efficiently detect duplication in a 
genome with high precision. Moreover, the read-depth approach can identify 
absolute copy numbers that are embedded or overlapped with segmental 
duplications. Recently developed tools utilizing read depth methods provide 
high resolution breakpoints in reference to the discovery of smaller deletions 
and duplications (Sebat et al. , 2004; Yoon et al. , 2009). 
Read-depth approaches using NGS data were first applied to define 
rearrangements in cancer and segmental duplication and absolute copy-
number maps in human genomes (Campbell et al. , 2008; Chiang et al. , 2009). 
Recently, 1000 Genomes data for 159 individuals with low coverage was 
analyzed for three major populations, and absolute gene CNV was inferred to 
catalogue their frequencies (Sudmant et al. , 2010). The major drawback of 
this method is the inability to detect inversions and insertions. Unlike paired-
end reads, read-depth-based approaches are able to detect only forward-
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oriented segmental duplications and CNVs, which provides an incomplete 
catalogue of SVs in the genome. 
de novo Assembly: 
The microarray and sequence-based approaches described earlier 
rely on the reference genome for mapping information. de novo assembly 
eliminates the requirement of a reference genome to construct the genome 
assembly. In practice, the de novo assembly approach is based purely on 
computational algorithms that are in their infancy. The approach first 
assembles the genome, comparing the read sequences, and produces large 
contigs that are then compared to a reference genome. Although it is a 
complex task to identify SVs from de novo assembly, this method has the 
potential to identify thousands of novel variants. Recently, a substantial 
number of tools have become available to assemble genomes without a 
reference; this includes EULER-USR, ABySS, SOAPdenovo, Cortex 
assembler, NoveiSeq framework, and ALLPATHS-LG (Chaisson et al. , 2009; 
Simpson et al., 2009; Li et al., 2009; Mills et al. , 2011 ; Gnerre et al. , 2011 ; 
Hajirasouliha et al., 201 0). de novo variant assembly can be done by 
obtaining different degrees of information from a reference. The Cortex 
assembler has the ability to assemble multiple genomes and call SVs 
simultaneously between samples without reference genome information. 
The current algorithms are not yet mature enough to provide a full 
catalogue of the structural variation of the human genome. Thus, these 
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approaches produce an assembly that is 16.2% shorter than the reference 
genome (including coding regions). A large portion of the missing genome 
consists of common repeats, and almost the entire content of segmental 
duplication is missing within these assemblies (Aikan et al., 2011 ). Although 
current technologies have substantially improved data production capabilities, 
accurate genome assembly and correct annotation methodologies remain 
under development. The common repeat regions and segmental duplication 
regions remain big challenges in reference to assembly methods. 
1.4 NEUROPSYCHIATRIC DISEASES AND COPY NUMBER VARIATIONS 
Developmental neurocognitive disorders (DNDs) involve a variety of 
signs and symptoms, including a range of cognitive impairments from learning 
disabilities to mental retardation to abnormal behaviors. Several DNDs are 
now known · to be caused by recurrent and non-recurrent genomic 
rearrangements that are mediated or stimulated by complex regional genomic 
architectures occurring throughout the human genome. Genetically, the 
picture is complicated by significant inter-individual heterogeneity, numerous 
contributing loci, and multiple gene-gene and gene-environment interactions 
(Persico et al., 2006). Different combinations of the inherited genes might 
explain the variations in severity or the manifestation of complex 
neuropsychiatric diseases among family members. However, genetic and 
phenotypic heterogeneity has made it difficult to detect the DND-associated 
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genetic mechanism(s). Many of these genomic disorders are due to altered 
gene dosages, or CNV, of one or more dosage-sensitive genes within the 
rearranged region. 
Although DND compose a group of relatively common disorders, a 
cause is unknown in as many as 60% to 70% of patients with them. 
Genetically, the picture is complex because of significant inter-individual 
heterogeneity, multiple genes, and gene-environment interactions (Persico et 
al. , 2006). The presence of different combinations of the inherited genes 
might explain the variations in severity or the manifestation of DND in siblings 
and family members. However, phenotypic and genetic heterogeneity has 
made it difficult to detect the genetic mechanism(s) underpinning DND. 
Several new genomic disorders caused by CNVs of genes whose dosage is 
critical for the physiological function of the nervous system have been recently 
identified. Patients who carry the dup(7)(q11.23) reciprocal duplication of the 
genomic region deleted in Williams-Beuren syndrome are characterized by 
prominent speech delays. The phenotypes of Potocki-Lupski syndrome and 
MECP2 duplication syndrome have been neuropsychologically examined in 
detail; this has revealed that autism is an endophenotype and a prominent 
behavioral feature of these disorders. The recent identification of the SHANK 
gene family (SHANK1, 2, and 3) has revealed extreme variability in copy 
number for autism spectrum disorder (ASD) (Durand et al. , 2006; Berkel et 
al. , 201 0; Sato et al., 2012). 
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Genome-wide studies of large cohorts of patients with mental 
retardation (MR) have led to the identification of chromosomal aberrations 
that delineate novel syndromes, some of which occur at frequencies 
comparable to known recurrent rearrangement disorders. Most notably, three 
groups (Shaw-Smith et al. , 2006; Sharp et al. , 2006; Koolen et al. , 2006) 
independently characterized a microdeletion syndrome of 17q21.31 that is 
associated with MR that arises on parental chromosomes that carry a 
common inversion of the region. On chromosome 15, three novel syndromes 
associated with mental retardation have been confirmed at 15q13.3, 15q24, 
and 15q26.2 (Poot et al. , 2007; Sharp et al. , 2007; Sharp et al. , 2008). 
Therefore, it is evident that the gene copy number of the genome disrupts 
neurogenic pathways which manifest in phenotypes with abnormal cognitive 
function (Lee et al. , 2006). In this thesis, we have examined a 
neuropsychiatric cohort of individuals with Tourette's Syndrome (TS). 
Tourette's Syndrome is a developmental neuropsychiatric disorder 
characterized by the presence of both motor and vocal tics. TS is often 
accompanied by features associated with obsessive compulsive disorder 
(OCD), attention deficit hyperactivity disorder (ADHD), and poor impulse 
control. The co-morbidity of these diseases is complex and the relationship is 
not clear. The prevalence of Tourette's Syndrome is approximately between 
0.3-1% in a population. Although it is very common in a given population, to 
date, there has not been a single locus identified that segregates within 
Tourette's-affected individuals in families (Centers for Disease Control and 
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Prevention, 2009). According to twin studies, the concordance rates are 
between 50-70% for monozygotic twins compared to 10-23% for dizygotic 
twins (Price et al., 1985; Walkup et al., 1988; Pauls et al., 1991), and the 
range is dependent on whether TS manifests alone or with other features, i.e., 
OCD or ADHD. Similar to other neuropsychiatric disorders (i .e., autism 
spectrum disorder) , TS is a male-dominant disorder (approximately 4:1) 
(Robertson, 2008). However, studies demonstrate that, within family members 
with TS, if one includes OCD as the affected status, the risk to male and 
female relatives of a TS proband approaches 1 : 1 , with female relatives more 
likely than male relatives to display obsessions and compulsions. The mode 
of inheritance was initially thought to be autosomal-dominant, but researchers 
have been unable to detect a TS locus by using the techniques for mapping 
Mendelian disorders (Pauls et al. , 1986; Eapen et al., 1993; State, 2010; 
State, 2011 ). Further segregation analysis implicated TS as a complex 
neuropsychiatric disease (State MW, 201 0). 
There have been numerous attempts to decipher the genetic cause of 
TS by linkage and association studies, although no strong common candidate 
genes have been identified. One candidate locus shows the presence of a de 
novo chromosome 13 inversion in a TS family. Further analysis revealed that 
the SLIT and TRK-Iike family member 1 (SLITRK1) gene that resides in close 
proximity to the inversions carries a frameshift deletion as well as two 
independent occurrences of the identical variant in the binding site for 
microRNA hsa-miR-189 (O'Roak et al., 2010). This gene remains elusive due 
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to the fact that subsequent analysis of different studies found no such 
mutation. The SLITRK1 gene carries a rare mutation; hence, collecting a 
large sample size to obtain proper frequency distribution might be an issue to 
replicate the mutation. Another report found that CNV breakpoints within the 
NRNX1 gene and a breakpoint within 1q21 locus had previously been 
implicated in ASD (Senthil et al., 201 0). This association is preliminary and 
requires replication due to the small sample size. The lack of strong evidence 
of a causative variant in TS provides an opportunity to search for risk-
susceptible CNVs. 
1.5 COMMON COMPLEX DISEASES AND COPY NUMBER VARIATIONS 
Most studies investigating the genetics underpinning complex diseases 
have focused primarily on SNP-based approaches. They have found that 
these autoimmune diseases exhibit strong heritability, but linkage and 
genome-wide SNP-based association studies explain little of the genetic 
variation (i .e., usually 1-15%), strongly suggesting that other genetic factors 
are at play (Stranger et al., 2011). For example, genome-wide SNP-based 
association studies have identified more than 71 genes related to Grahn's 
disease, which explains only 23.2% of the total heritability (Franke et al. , 
201 0). Hence, SNP-based association analysis identifies only a fraction of the 
entire genetic burden for complex diseases, leaving a large portion of 
heritability unresolved. Research into complex diseases is yet to resolve the 
total genetic contribution involved and it suffers from the problem of missing 
heritability. Recently, CNV is gaining popularity because of its high frequency 
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in the genome and because of substantial technological developments in 
terms of the detection of CNVs. 
The functional consequences of a CNV event which highlights the 
potential to significantly alter the expression of a gene shows the importance 
of CNV studies in complex diseases. The largest CNV association analysis 
was conducted by the Wellcome Trust Case Control Consortium (WTCCC, 
201 0). This study analyzed primarily common CNVs, a majority of which can 
be tagged with a nearby SNP. The main conclusion of that study states that 
common CNVs that can be detected with existing technology do not 
contribute to common complex disease susceptibility. Although the negative 
conclusion is very discouraging, there is a growing list of independent studies 
that show that CNVs are associated with common complex diseases. A list of 
CNVs (genic/agenic) that reports associations with complex diseases is given 
in Table 1. 
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Table 1.1 A list of CNV loci that is associated with complex diseases. 
Disease Cytoband CNV Status Reference (Gene) 
Rheumatoid 17q12 (CCL3L1) ~2 copies (McKinney 
Arthritis (RA) et al. 2008) 
1q21.3 (LCE38, Deletion. (Lu et al. 
LCE3C) 2011 ) 
Psoriasis 8p23.1 (beta- ~5 copies (Hollox et al. 
(PsV) defensin DEFB 2008) 
gene family) 
1q21.3 (LCE38, Deletion. (Cid et al. 
LCE3C) 2009) 
Psoriatic 1q21 .3 (LCE38, Deletion. (Bowes et 
Arthritis LCE3C) al. 2010) 
Inflammatory 8p23.1 (beta- ~ 2 copies (Fellermann 
Bowel defensin 2 et al. 2006) 
Disease (IBD) DEFB2) 
Systemic 1q23.3 <2 copies (Willcocks et 
Lupus (FCGR38) al. 2008) 
Erithmatosis 17q12 (CCL3L1) ~4 copies (Mamtani et 
(SLE) al. 2008) 
Crohn 5q33.1 (upstream Deletion (Brest et al. 
/RGM) 2011) 
Obesity 16p11 .2 Mirror Extreme: (Jacquemon 
Deletion with t et al. 2011) 
Obesity; 
Duplication with 
Underweight. 
Osteoporosis UGT2817 Deletion (Yang et al. 
2008) 
In this thesis, we have attempted to find novel genetic susceptible loci for 
Ankylosing Spondylitis (AS) , which is the second-most-common cause of 
inflammatory arthritis worldwide, with a prevalence of 1/1 ,000-3/1 ,000 in white 
populations (Galin , 1998). It is characterized by inflammation in the spine and 
sacroiliac joints, causing initial bone and joint erosion and subsequent ankylosis. 
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Arthritis affecting peripheral joints, particularly the hips, occurs in 40% of cases 
and inflammation may also involve extraarticular sites such as the uvea, tendon 
insertions, aorta, lungs, and kidneys. Long ago, genetic factors were implicated in 
the etiology of the disease, with the demonstration of a high degree of disease 
manifestation within families (de Blecourt et al. , 1961 ). The sibling recurrence-risk 
ratio is 82 (Brown et al. , 2000b) and heritability, assessed by twin studies, is 
>90% (Brown et al. , 1997). The recognition of the association of HLA-B27 with 
AS confirmed the importance of heritable factors in the disease (Brewerton et al. , 
1973; Schlosstein et al. , 1973) and remains one of the strongest disease 
associations of any inflammatory human disease. 
In most populations that have been studied, the prevalence of AS is 
strongly correlated with the prevalence of the main disease-susceptibility gene, 
HLA-B27 (B27). In only a few families , has it been reported that AS segregates 
independently from B27 (van der Linden et al. , 1975; Gladman et al. , 1986; 
Desha yes et al. , 1987; Woodrow, 1988; Brown et al. , 1996; Said-Nahal et al. , 
2000) and only rare cases of familial B27 -negative AS have been reported (Rubin 
et al. , 1994; Skomsvoll et al. , 1995), suggesting that B27 is almost essential for 
the inheritance of AS within families. However, only 1 %-5% of B27 -positive 
individuals develop AS, and there is increasing evidence to suggest that other 
genes must also be involved . B27 -positive relatives of AS patients have a 
recurrence risk of the disease that is 5.6-16 times greater than that of B27-
positive individuals in the population at large, implying the presence of non-B27-
shared familial risk factors (Cal in et al. , 1983; van der Linden et al., 1983). 
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Recurrence-risk modeling in AS rejects single-gene and polygenic models. 
Oligogenic models between three and nine genes operating in addition to B27 fit 
the observed pattern of recurrence risks in relatives of patients with AS (Brown et 
al. , 200Gb). A major non-B27 contribution to susceptibility to AS is suggested by 
the greater concordance rate in monozygotic twins (63%) than in B27 -positive 
dizygotic twin pairs (23%) (Brown et al., 1997). 
Ankylosing spondylitis is a type of spondyloarthropathy; the pathogenesis 
of the disease is very poorly understood. Gene expression profiling approaches 
have been used to determine the molecular mechanisms and pathways of the 
disease. Elucidating the potential role of non-HLA genes is still being done. Using 
powerful genome-wide-association study approaches, a growing list of non-HLA 
genes or intergenic loci with varying effect sizes (IL23R, RUNX3, KIF21 B, 2p15, 
IL1R2, PTGER4, ERAP1, IL12B, CARD9, TNFR11 LTBR, TBKBP1, and 21q22) 
have been reported , most of which have been subsequently validated (5) . The 
associations were primarily reported by investigating single-nucleotide 
polymorphism (SNPs) analysis. Recently, apart from single-allele associations, 
one study revealed the complex interactions between the non-HLA gene ERAP1 
with HLA-B27 (Evans et al., 2011 ). However, the genetic risk described by HLA 
or non-HLA genes suggests that other genomic variants might contribute to risk 
for AS. To date, no CNV has been reported to be associated with AS; this 
provides a unique opportunity to investigate the contribution of CNVs to the 
disease pathogenesis of AS. 
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1.6 RESEARCH HYPOTHESIS AND SPECIFIC OBJECTIVES 
In the last decade, SNP-based association studies have successfully 
identified loci that are associated with complex diseases. These studies are 
well designed for identifying common variants but are underpowered to detect 
rare variants. Although the search for common alleles was the focus during 
the last decade, there has, nonetheless, been a steady parallel effort to 
evaluate the contribution of rare variants. These have included cytogenetics, 
parametric linkages in individual pedigrees or isolated populations, targeted 
sequencing, and analysis of copy number variation. The contribution of copy 
number variation to most complex diseases is yet to be elucidated. Detection 
resolution is a key aspect that always plays a big role in the ability to detect 
disease-susceptible CNVs. There are significant differences in reference to 
the detection of CNVs in the current technologies. As technological 
advancements have been made, no single method yet has the capacity to 
detect the entire content of structural variations in the genome. In light of this 
detection complexity, identification of CNVs that are susceptible to diseases 
requires new strategies to evaluate their genetic contribution. 
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The specific objectives of this thesis are fourfold: 
1. To characterize the human genome regions that are susceptible to 
rearrangements that produce copy number variations and are mediated 
through the presence of segmental duplications. 
2. To design a custom microarray that targets the rearrangement 
hotspots that have been identified. 
3. To identify copy number variation (using the custom-designed 
microarray) that contributes to the genetic susceptibility of Tourette's 
Syndrome and Ankylosing Spondylitis. 
4. To quantify the detection sensitivity of copy number variations using 
whole genome SNP-microarray. 
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Genome-wide Signatures of 
Hotspots' within Segmental 
Humans 
'Rearrangement 
Duplications in 
Mohammed Uddin, Mitch Sturge, Lynette Peddle, Darren D O'Rielly, Proton 
Rahman 
Discipline of Genetics, Faculty of Medicine, Memorial University of 
Newfoundland, St. John's, Newfoundland, Canada. 
PREFACE 
The primary contribution of this manuscript is the detection 
rearrangement hotspots using high throughput sequencing technology. The 
first phase of the analyses includes read depth computation to detect SO and 
CNV. The next phase of the analysis includes the detection of rearrangement 
hotspots and characterization of complex genomic regions. A version of th is 
manuscript has already been published in PLoS ONE Journal. 
All co-authors worked as a team in preparation of the manuscript. The 
primary author, Mohammed Uddin, conceptualized the problem and with 
proper guidance from Dr. Proton Rahman, developed the framework of the 
study design. Mohammed Uddin conducted extensive literature review, and 
developed the computational algorithms. The application of the detected 
hotspots in this manuscript is highlighted in chapter 3 and 5. 
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ABSTRACT 
The primary objective of this study was to create a genome-wide high 
resolution map (i.e., .1 00 bp) of 'rearrangement hotspots' which can facilitate 
the identification of regions capable of mediating de novo deletions or 
duplications in humans. A hierarchical method was employed to fragment 
segmental duplications (SOs) into multiple smaller SO units. Combining an 
end space free pairwise alignment algorithm with a 'seed and extend' 
approach, we have exhaustively searched 409 million alignments to detect 
complex structural rearrangements within the reference-guided assembly of 
the NA 18507 human genome (18x coverage), including the previously 
identified novel 4.8 MBp sequence from de novo assembly within this 
genome. We have identified 1,963 rearrangement hotspots within SOs which 
encompass 166 genes and display an enrichment of duplicated gene 
nucleotide variants (ONVs). These regions are correlated with increased 
nonallelic homologous recombination (NAHR) event frequency which 
presumably represents the origin of copy number variations (CNVs) and 
pathogenic duplications/deletions. Analysis revealed that 20% of the detected 
hotspots are clustered within the proximal and distal SO breakpoints flanked 
by the pathogenic deletions/duplications that have been mapped for 24 
NAHR-mediated genomic disorders. FISH Validation of selected complex 
regions revealed 94% concordance with in silica localization of the highly 
homologous derivatives. Other results from this study indicate that intra-
chromosomal recombination is enhanced in genic compared with agenic 
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duplicated regions, and that gene desert regions comprising SDs may 
represent reservoirs for creation of novel genes. The generation of genome-
wide signatures of 'rearrangement hotspots', which likely serve as templates 
for NAHR, may provide a powerful approach towards understanding the 
underlying mutational mechanism(s) for development of constitutional and 
acquired dise~ses. 
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2.1 INTRODUCTION 
Segmental duplications (SDs) or low-copy repeats are blocks of DNA.1 
kbp in size which share a high level of sequence homology (.90%) (Bailey et 
al. 2006; Red on et al. 2006; Bailey et al. 2002; Alkan et al. 2011 ). The 
catalogue of SDs comprises approximately 5% of the human genome 
encompassing 18% of genes (Bailey et al. 2006; Redon et al. 2006; Bailey et 
al. 2002; Alkan et al. 2011 ) .. They are considered antecedents to the 
formation of copy number variants (CNVs) which comprise approximately 
12% of the human genome and are responsible for considerable human 
genetic variation (Redon et al. 2006; Sharp et al. 2005). Emerging evidence 
suggests that SD regions are frequently associated with known genomic 
disorders with the vast majority representing novel sites whose genomic 
architecture is susceptible to disease-causing rearrangements (Sharp et al. 
2005). However, the complexity of their structural architecture in the human 
genome and, more importantly, their role in disease pathogenesis remains 
largely elusive. 
There is a growing body of evidence suggesting the involvement of 
multiple events in the origin of genomic rearrangements such as non-allelic 
homologous recombination (NAHR), non-homologous end joining (NHEJ), 
fork stalling and template switching (FoSTeS), and microhomology-mediated 
break-induced replication (MMBIR) (Gu et al. 2008; Lieber et al. 2003; Zhang 
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et al. 2008). Although the origins of the aforementioned mechanisms are 
strongly associated with highly homologous regions residing outside of 
common repeat elements (e.g., transposons) (Conrad et al. 2010a), the non-
random distribution of highly homologous regions within SDs that are 
susceptible to such mechanisms remain to be fully elucidated. Moreover, 
evolutionary conservation of these mechanisms complicates the identification 
of SO breakpoints due to differing levels of sequence homology. 
Genoll)iC disorders arising from microdeletions/duplications fail to be 
adequately explained by a single underlying event. The true contribution of 
NAHR, NEHJ, MMBIR and FoSTeS events to the origin of genomic 
rearrangement remains elusive, although large-scale studies are beginning to 
implicate NAHR as one of the primary events contributing to the origin of 
these genomic copy number changes (Conrad et al. 201 Oa; Mills et al. 2011 ). 
Genomic DNA situated between distal and proximal SDs represents a critical 
region often reported to be deleted/duplicated due to misalignment of the SDs 
between homologous chromosomes (Shaikh et al. 2007). Evidence suggests 
that the breakpoint architecture of SDs (i.e. , distal and proximal) is associated 
with a higher propensity for NAHR-mediated rearrangement predisposing to 
an abnormal phenotype (Firth et al. 2009). In other words, the increased 
frequency of pathogenic rearrangements is often directly correlated with the 
structural complexity of the local genomic regions involved. This is consistent 
with numerous reports indicating that highly homologous regions within SDs 
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influence NAHR-mediated rearrangement events (Conrad et al. 201 Oa; Mills 
et al. 2011 ; Turner et al. 2007). Throughout this paper, these highly 
homologous regions will be referred to as 'rearrangement hotspots'. Classic 
examples of NAHR-mediated genomic rearrangement include genomic 
disorders such as 3q29 microdeletion/duplication syndrome, 
globozoospermia, and Williams-Beuren syndrome (Ballif et al. 2008; 
Koscinski et al. 2011 ; Bayes et al. 2003). 
In a recent report, the detection and validation of 8,599 CNVs using 
microarrays (Conrad et al. 201 Oa) and subsequent targeted sequencing on 
1067 of these CNV breakpoints (Conrad et al. 201 Ob) revealed extreme 
homologous reg ions consistent with NAHR-mediated rearrangements as the 
primary event in the origin of CNVs. In this study, we identified genome-wide 
'rearrangement hotspots' within SO regions that often predispose to genomic 
disorders in humans, mediated predominately by NAHR. We specifically 
devised a hierarchical approach to detect SO units using an all-hit mapping 
algorithm, interrogating every 100 bp (GC-corrected read depth window with a 
1 bp overlap) excluding common repeat elements. Reference-guided 
assembly was obtained from reads based on the NA 18507 human genome 
and duplicated sequences were extracted from the assembly using detected 
breakpoints (Figure. 2.1 ). The primary objective of this study was to create 
genome-wide signatures of 'rearrangement hotspots' which can facilitate the 
detection of genomic regions capable of mediating de novo deletions or 
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duplications in humans. To create a genome-wide high resolution map of 
'rearrangement hotspots', we developed an end-space free pairwise 
alignment algorithm integrating a 'seed and extend' technique which can 
accurately investigate the complex structural architecture associated with the 
technically challenging and problematic nature of segmental duplications. The 
hypothesis of this study is that highly homologous SO regions (i .e., 
rearrangement hotspots) predispose to genomic rearrangements arising from 
recombination and replication-based events. 
2.2 RESULTS AND DISCUSSION 
Detection ofSegmental Duplication (SD) Units 
Given that SOs intuitively consist of common repeat elements, SOs 
were fragmented into multiple smaller SO units which did not overlap with 
known repeat elements during the read depth-based analysis. In this study, 
20,237 non-redundant sets of SO units with at least one inter- or intra-
chromosomal rearrangement event were identified, representing 16.65 Mbp of 
SO units residing outside of common repeat elements in the human genome 
(supplementary 1, chapter 2). At first glance, this total content of SOs may 
appear small compared with that previously reported (Bailey et al. 2002) and 
that reported in the database of genomic variants (OGV) which is mainly 
attributed to methodological differences (i.e., exclusion of common repeats, 
GC-correction, shorter window length, low read depth threshold). Results from 
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this study and Perry et al (Perry et al. 2008), suggest that previously reported 
SO breakpoints are overinflated in size, further emphasizing the importance of 
creating a high-resolution map of' rearrangement hotspots'. Read depth 
distribution for duplicated and non-duplicated regions throughout the genome 
produced a distinctive distribution pattern with an approximate 7% error rate 
(supplementary 1, chapter 2). 
Considering CNVs have a tendency to overlap with nearby SO 
breakpoints, the results of this study were compared with a recent study 
which identified common CNV breakpoints in three populations (i.e. , 57 
Yoruba, 48 European and 54 Asian individuals) (Sudmant et al. 201 0). The 
detected autosomal SO units greater than 200 bp shared 82% concordance 
(i.e. , .50% overlap) with common CNV breakpoints using low coverage short-
read data (supplementary 1, chapter 2). Moreover, 79% of breakpoints 
residing within genes with .3 copies as previously reported (Aikan et al. 2009), 
were located within SO breakpoints identified in this study (supplementary 1 
chapter 2). 
Comparison with previous read depth-based reports highlights the 
advantages of our hierarchical strategy which include: 1) the use of a 100 bp 
read depth window with a 1 bp overlap to detect SO units which enabled the 
capacity to detect SO units with higher resolution; 2) the use of a lower 
threshold (i .e., mean +2 standard deviations) than previously reported 
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methods in order to detect homozygous and hemizygous duplications; 3) 
fragmentation of SDs into smaller SO units in order to separate duplicated 
regions from common repeated elements while reducing alignment bias for 
rearrangement analysis and computational time; and 4) integration of end 
space alignment algorithm with a 'seed and extend' clustering technique to 
the duplicated region of the reference guided assembly sequences to perform 
an exhaustive search (i .e., 409 million alignments) to identify rearrangement 
breakpoints (supplementary 2, chapter 2). 
Compared with copy number gains identified using microarray 
analysis, sequencing data used in this study revealed that autosomal SO unit 
breakpoints overlapped 54% with copy number gains (Conrad et al. 201 Ob), 
which increased to 67% when compared with 436 coverage (supplementary 
1, chapter 2) (Sudmant et al. 201 0). Discrepancies are attributed to 
methodical b·iases, as detection of structural variants can be specific to 
different methodical approaches and discrepancies between methods can be 
as high as 80% (Aikan et al. 2011 ). The rearrangement analysis within the 
novel sequence revealed multiple hits within the duplicated sequences (i.e., 
.90% similarity) that were previously uncharacterized (supplementary 2, 
chapter 2.). 
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Characterization of Rearrangement Hotspots Within Segmental 
Duplications 
Using 409 million pairwise alignments, we identified 1963 complex SO units or 
'rearrangement hotspots' within SOs in the human genome with significantly high 
distribution of duplicons (p < 1.0 X 1 o-6) with at least 10 duplicons per SO unit 
(Figure. 2.2a). Within these regions, an increase in copy number gain (i.e. , 
increase of 62% in copy number gains within hotspots) with at least 50% overlap 
with SO units and CNV breakpoints has been observed compared with a previous 
report (Conrad et al. 201 Ob). Importantly, 25% of these 'rearrangement hotspots' 
(i.e., 489/1963) overlapped with 166 unique genes (Figure. 2.2b) of which 77% 
(i.e., 375/489) were contained within 82 genes with increased copy number gain 
that have been previously validated using microarray analysis (Conrad et al. 
201 Ob). That 25 of these genes are highly variable in copy number within three 
populations indicates population-specific frequency of the underlying events in 
the origin of CNVs (Sudmant et al. 2010) which , in turn, implies an increase in 
frequency of genomic rearrangement events within hotspot regions. However, the 
extent of gene conversion within the NAHR hotspot is still unknown. In our 
analysis, we observed a relative increase of gene content transfer within agenic 
hotspot regions (i .e. , approximately 50%) compared with the remainder of agenic 
non-hotspot duplicated regions (i.e. , 32%) (Figure. 2.2c). The finding of elevated 
levels of gene content transfer is consistent with a previous study which 
hypothesized such a finding as an apparent feature for hotspots arising from 
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homologous recombination (Gu et al. 2008). Further analysis on duplicated gene 
variants (DNVs), which is a special type of paralogous sequence variant, was 
compared between the hotspot and non-hotspot duplicated regions (Ho et al. 
2010). We observed a 3-fold increase in DNVs located within hotspots compared 
with the remainder of the duplicated regions (p < 0.0001) which implies greater 
diversity within hotspot regions. This finding is attributed, in part, to the 
accumulation of DNV-derived mutations among derivative homologous 
sequences within hotspot regions. We also observed a strong positive correlation 
(R2 = 0.63) between the length and the incidence of DNVs within hotspot regions 
(Fig. 2.2d) . Oenome-wide read depth comparison revealed that a subset of high 
read depth regions is positively correlated with rearrangement hotspots (Fig. 
2.2e). 
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Figure 2.1 A schematic illustrating our hierarchical approach. mrsFAST was 
used to obtain read depth distribution of the NA 18507 human genome with 
maximum mismatch (n = 2) was allowed against the repeat masked reference 
human genome (build 36) . A mean-based approach was utilized to 
computationally predict the boundaries of regions associated with excessive 
read depth. MAO was used to obtain the consensus genome (mapping quality 
0.30 and n = 2) from the NA18507 genome assembly. The consensus 
51 
sequence for highly excessive read depth regions was obtained in order to 
apply a window-based alignment algorithm. The previously identified novel 
4.8 MBp sequence from de novo assembly within this genome was also 
included in the rearrangement analysis. ONVs within hotspot regions (Figure. 
2.2d). Genome-wide read depth comparison revealed that a subset of high 
read depth regions are positively correlated with rearrangement hotspots 
(Figure. 2.2e). 
Distribution of Inter- and Intra-chromosomal Rearrangements 
Segmental duplications (SOs) can be categorized according to the 
location of the rearrangement (supplementary 1, chapter 2) considering that 
recombination events can occur between homologues (i.e, inter-
chromosomal) or by looping out within a single homologue (i.e. , intra-
chromosomal). Our analysis revealed that 7% of genes (i.e. , 1 ,626/22, 159) 
overlapped with 5,502 nonredundant SO units which represented 73% (i .e. , 
41 /56) of the most highly variable genes previously identified in the human 
genome within three populations (Sudmant et al. 201 0) (Figure. 2.2b). We 
have identified 91,971 duplicons (i.e., average of 4.5 duplicons per SO unit) 
with overlapping breakpoints throughout the SO regions. Extreme inter- and 
intra-chromosomal rearrangements occurred in 1 0% of genes (i.e., 166/1626) 
that overlapped with SO units, of which 50% have been previously validated 
(Conrad et al. 201 Ob). Further analysis revealed that genic regions were 
enriched with intra-chromosomal recombination, whereas agenic regions 
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evolved through both inter- and intra-chromosomal recombination 
(supplementary 1, chapter 2). Such intra-chromosomarecombination with in 
genic SD units may represent conserved genomic organizations subject to 
gene conversion and concerted evolution (Bailey et al. 2002; Gu et al. 2008; 
Lieber et al. 2003). Extreme variation, attributed in part, to SDs has been 
reported in at least 20% of the copy number variable gene families in three 
human populations (Sudmant et al. 201 0). 
.. 2000 b . 
.!l 1800 
e. SOt)O r Jso:· 
I 
~ 1600 o Total SO Sub Unh 
~ • Autosomes 1400 
• AliSO Units I 
. -"--·-·-· I :: -'SOC • Overlapped SO Sub Unil !- 1200 • SUdmant et at. 
~ • Conrad &tal. 
li 1000 • Validated 
• 800 ~ 600 
c 400 
" 200 
NAJ8S01 18Jc 
c.. 80 
ll 70 - Hot.lilp(lt-§.D 
"' 
60 \ - Non.Hot.Jf'OfSD u i: 
.. so 
'l' ~ 5 40 z 30 '* 20 1.0 
0 01 OJ O !l 0 4 o_r, 06 07 OS Q_9 1 
Proportion of Gene Content 
Transfer 
d . 
2500 
2000 
~ 1>00 
u 
> 
Z lOOO 
0 
soo 
-lOOO 
3000 
2500 
200(1 _ .., 
fbi,HQf.spot.SD 1 5(1(1 
.. 
0 _1 !1..1 10..1 
SO Unit Lencth (KB) 
10{10 
., " 
~ N w ~ ~ ~ ~ N N W ~ ~ ~ ~ ~ ~ ~ ~ 
~· ~ o o o N ~ o ~ o ~ ~ o o ~ ~ m ~ 
C• ~ Q 0 0 C• C • 0 0 0 0 C• 0 ~ o o ~ ~ 
0 C• 0 ~ g % % ~ ~ ~ g ~ * ~ g ~ ~ ~ 
·~ .:;; 0 :? 
Figure 2.2 Segmental duplication (SD) units which represent the most 
complex rearrangements within the NA 18507 human genome. a) A total of 
1963 SD complex units (i.e., ;:::1 0 rearrangements) were identified that were 
significantly different (p < 1.0 X 1 o-6) compared with the rest of the NA 18507 
genome duplicated regions. The plot illustrates the concordance of the 
predicted autosomal complex regions compared with previous studies (Conrad 
et al. 201 Ob; Sudmant et al. 201 0) . b) Genes that completely or partially 
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overlapped with detected SO units in which 73% (41 /56) of the most variable 
genes in three different populations were detected in our analysis of the 
NA18507 human genome. Among the 1626 genes identified in this study, 10% 
(i.e., 166/1626) of genes that overlapped with a SO unit revealed extreme 
inter- and intra-chromosomal rearrangements, 50% of which have been 
previously validated (Conrad et al. 2010b). c) Observed gene content transfer 
between hotspot and non-hotspot agenic SO units. d) scatter plot illustrating 
ONV count for hotspot and non-hotspot SO units. e) A histogram illustrating the 
mean read depth (RO) of the computationally predicted SO unit breakpoints. 
The blue bars represent the mean read depth for each of the 20,237 SO unit 
breakpoints and the red bars represent the mean read depth for hotspot 
regions. 
Previous cytogenetic studies have demonstrated that pericentromeric 
and subtelomeric SO regions are strikingly polymorphic and both represent 
hotbeds for genomic rearrangement (Mefford et al. 2002; She et al. 2004). 
Investigation of recombination within SO units revealed that pericentromeric 
regions of chromosomes 2, 5, 7, 10, 15, 16, 17, 22 andY were enriched with 
inter-chromosomal recombination, whereas only chromosome 11 was 
associated with intra-chromosomal breakpoints (supplementary 1, chapter 2). 
Subtelomeric regions of chromosomes 1, 2, 4, 7, 9, 10, 11 , 16, 19, 20, 22, 
and X were enriched with inter-chromosomal recombination, whereas 
chromosomes 3, 6, 12, 13, 14 and Y were associated with extreme intra-
chromosomal breakpoints. This idiosyncratic rearrangement pattern suggests 
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that multiple translocations involving distal regions of chromosomes create 
complex breakpoints within SDs. This is exemplified by the pseudoautosomal 
region 1 (PAR 1) which displayed extensive inter- and intra-chromosomal 
tandem duplications, consistent with sex chromosome evolution 
(supplementary 1, chapter 2). Another complex region where extensive 
intrachromosomal rearrangements were identified 1s the distal 
heterochromatic region of the Y chromosome (i.e., Yq12), housing the male 
specific (MSY) region (supplementary 1, chapter 2). A comprehensive map of 
this complex region was generated using PCR analysis in a previous study 
(Skaletsky et al. 2003). In our analysis, we detected both homozygous and 
hemizygous duplications using read depth information which represents an 
extension to previous SO analysis (Sudmant et al. 201 0; Alkan et al. 2009) by 
the inclusion of sex chromosomes (supplementary 1, chapter 2). 
An intriguing observation was the identification of complex 
rearrangements in multiple gene families where rapid evolution of NBPF, 
PRAME, RGPD, GAGE, LRRC, TBC1, NPIP and TRIM gene famil ies appear 
to be predominantly attributed to intrachromosomal gene transfer, whereas 
other complex gene families (e.g. , ANKRD, OR, GUSB, FAM, POTE, ZNF 
and GOLG) appear to be more diverse with respect to transfer of gene 
content, occurring both within and between chromosomes (supplementary 2, 
chapter 2.) . As previously reported (Aikan et al. 2009) , the DUX family gene 
was associated with the most copies within the reference genome. The 
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rearrangement analysis of the novel sequence within 1 Oq26.3 region 
suggests at least 10 additional copies of the OUX4 gene is specific to novel 
sequences within the NA 18507 human genome. (supplementary 2, chapter 
2). 
Gene Ontology Analysis within 1Rearrangement Hotspots' 
To investigate the impact of genes residing within 'rearrangement 
hotspot' regions identified in this study and their relation to complex disease, 
genes were functionally categorized using PANTHER gene ontology analysis 
(supplementary 1, chapter 2). Genes residing within 'rearrangement hotspot' 
regions appear to be involved in functions associated primarily with nucleic 
acid metabolism (22%) and cellular processes (16%), although associations 
also exist for developmental process (9%), cell cycle (9%), and cell 
communication (8%). This finding is consistent with a previous report in which 
copy number gains were associated with genes involved in nucleic acid 
metabolism and developmental processes, whereas copy number losses 
were enriched for genes involved in cell adhesion (Park et al. 201 0). That 
genes residing in 'rearrangement hotspot' regions are consistently associated 
with functions affecting multiple processes important in normal growth and 
development, further underscores the critical role that rearrangement hotspots 
play in the genetic etiology of complex disease. 
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Clinical Relevance of 'Rearrangement Hotspots' 
We have produced a genome-wide high resolution map of 
'rearrangement hotspots' which likely serve as templates for NAHR and 
consequently may represent an underlying mechanism for development of 
constitutional and acquired diseases arising from de novo deletions or 
duplications. A collection of 24 previously identified genomic disorders 
predominantly mediated by de novo NAHR events are catalogued in the 
DECIPHER database (Firth et al. 2009). Comparison of our hotspot regions 
with pathogenic deletions/duplications breakpoints mapped for those genomic 
disorders constituting only 15 common genomic loci revealed that 20% of the 
detected hotspots are clustered within proximal and distal SDs that are 
flanked by these pathogenic deletions/duplications (Figure. 2.3). This finding 
indicates a higher rate of NAHR within the genome-wide rearrangement 
hotspot regions detected in this study. 
The rearrangement structure of these hotspots based on our in silica 
predictions (Figure. 2.4) reveals the complex architecture associated with 
SDs. To validate the complexity of these hotspots, FISH analysis was 
performed on selected regions harbouring hotspot clusters demonstrated 94% 
(i.e., 17/18) concordance with in silica predictions of co-localization (Figure. 
2.5a, 2.5b, and 2.6). One example of an identified 'rearrangement hotspot' is 
a duplication at the 16p12.1 complex region, which contains an S2 inversion 
(Park et al. 2,01 0), where the alignment localized multiple derivatives of the 
NPIPL3 gene within chromosomes 16 and 18 (Figure. 2.5a and 
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supplementary 1, chapter 2). The identified breakpoints revealed the 
presence of derivative copies of the NPIPL3 gene within the short arm of 
chromosomes 16 and 18, possibly attributed to NAHR-mediated 
recombination , where pathogenic deletions and duplications have been 
reported in patients with mental retardation and intellectual disability 
(Antonacci et al. 201 0; Nagamani et al. 2011 ; Heinzen et al. 201 0; Weiss et 
al. 2008; Walters et al. 201 0; Ball if et al. 2007; Tokutomi et al. 2009). The 
derivatives are located within the pathogenic deletion breakpoints among the 
patients with neurodevelopment disorders. Unfortunately, these studies used 
methodologies unable to localize derivative copies, and consequently the 
NPIPL3 gene was disregarded as a susceptibility gene. A second complex 
region , 22q11 .21 , housed a large duplication consisting of two copies, with 
the 'core duplicon' being copied multiple times in chromosomes 5, 6, 20 and 
22 (Figure. 2.5b). Phenotypes attributed to pathogenic deletions and 
duplications within chromosomes 5 and 22 (Ensenauer et al. 2003; Huang et 
al. 201 0) revealed breakpoint patterns within a 'core duplicon', suggestive of 
NAHR-mediated duplication. 
A third complex region, revealed a previously uncharacterized gene 
desert within 1 q21 indicating a possible harvest region for the NBPF gene 
family. This 68 Kbp gene desert region revealed extreme intra-chromosomal 
rearrangement without any signature of inter-chromosomal duplication in our 
1n silica analysis (Figure. 2.6) . The gene fragments from 
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NBPF1,3,9, 10, 14, 15,16,20 and 24 appear to be copied and transferred to 
1q21.1 (142867911-142935940) and consequently creating extreme 
overlapping tandem duplications. The fosmid clone G248P8712C10 covering 
this region was used on metaphase chromosomes to predict derivative 
duplicated loci. Multiple signals were obtained within 1 p36.12 and 1 q21.1 
regions, while a weak signal was obtained within the 1 p1 O-p13 region which 
was not detected by our in silico analysis. The donor region located 2 MBp 
distal from the gene desert transferred gene content to this 68 kbp region 
which is associated with recurrent pathogenic deletions and duplications 
implicated in developmental disorders and neuroblastoma (Firth et al. 2009; 
Diskin et al. 2009; Brunetti-Pierri et al. 2009). One may speculate that gene 
deserts may represent reservoirs for creation of novel genes and underscores 
the necessity to further explore this previously ignored region of the human 
genome. The complexity of tandem duplications (e.g. , 1q21 .1) can have a 
direct impact on estimating copy number for a gene (e.g. , NBPF) . In such 
cases, the estimation of copy number based solely on read depth may be 
affected due to the nature of the tandem duplication. 
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Figure 2.3 The physical position of rearrangement hotspots that has been 
mapped within the proximal/distal breakpoints of a pathogenic deletion (red 
horizontal block) or duplication (green horizontal block). 
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Figure 2.4 Landscape of chromosomal rearrangements in the NA18507 human 
genome. Chromosomal rearrangements located within duplicated regions are 
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plotted against the human genome. Green bars representt the signature of intra-
chromosomal rearrangements, black bars represent inter-chromosomal 
rearrangements and red bars represent 'rearrangement hotspots'. Cytobands 
with duplications for each chromosome and selected genes that completely or 
partially overlapped with SO units are also indicated. 
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Figure 2.5 Signature of rearrangement hotspots located at a) 16p12.1 and b) 
22q11 .21. A 40 KBp region within 16p12.1 is illustrated with its corresponding 
derivative copies which were localized by hierarchical analysis. This region 
consists of the NPIPL3 gene derivatives. The inter- and intra-chromosomal 
localization of the copies is approximated in the physical map within the 
chromosome contig (18p11.21).The alignments are color coded for 
chromosomes (i.e. , color coded rectangles below the read depth plot) and FISH 
validation is illustrated for both inter- and intra-chromosomal localization. The 
pathogenic deletions and duplications located within these regions (Antonacci et 
al. 201 0; Nagamani et al. 2011; Heinzen et al. 201 0; Weiss et al. 2008; Walters et 
al. 201 0; Ballif et al. 2007; Tokutomi et al. 2009) are depicted in red and green 
bars, respectively The blue bars under the contig represent the approximated 
inversions previously reported by Antonacci , F. et al (Antonacci et al. 2010). b) 
Analysis of a 37 KBp duplicated region within 22q11.21 revealed it is comprised 
of a core 2.7 kbp tandem duplicon copied from different chromosomes. Black 
lines represent the read depth (x-axis), green shade represent an SO unit, and 
blue bars represent the region with common repeat elements. The horizontal 
blocks (color coded according to chromosomes) are the rearrangement 
(intra/inter) fragments with >90% sequence similarity and >1 OObp in length. 
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Figure 2.6 Rearrangement hotspots comprising a 68kb gene desert located 
within 1 q21 .1 reg1on. Validation of a gene desert where extreme intra-
chromosomal rearrangement without any signature of inter-chromosomal 
duplication observed in our in silico predictions. The rearrangement consists of 
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gene fragments from the NBPF gene family located within the p and q arm of 
chromosome 1 . 
Limitations 
While the results of this study highlight the importance of restricting the 
number of vulnerable genomic regions that are targeted for clinical 
application, read depth-based approaches are associated with certain 
limitations. One of the limitations of our approach was the exclusion of 
inversions and insertions as the read map algorithm mrsFAST employed in 
this study was unable to return information regarding the orientation of 
duplicated loci (Hach et al. 201 0) and as a result the map of 'rearrangement 
hotspots' will miss regions with complex orientations. Coverage is another 
constraint to detect SDs due to the positive correlation between coverage and 
detection rate (Aikan et al. 2009). A much higher (i.e., .40x) coverage will 
significantly increase the detection capacity of SO units. It is widely accepted 
that no single method has the capacity to capture the entire content of 
structural variants in the genome. For example, read pair and read depth 
approach overlapped only 20% among the detected variants (Aikan et al. 
2011 ), therefore, a portion of 'rearrangement hotspots' will be missed by our 
analysis. Moreover, a portion of highly duplicated regions (.99% sequence 
identity) analyzed in this study is reference sequence-specific due to MAO's 
(mapping and assembly with quality) limitation to align short reads within 
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those region precisely (LiHeng, et al. 2008). While the results of this 
hypothesis-driven in silica study are consistent with limited FISH analysis, 
additional genome-wide validation is required. In a recent report, it has 
highlighted the current limitation of de novo assembly approaches that 
produce a consensus genome with at least 16.2% shorter than the reference 
genome (Aikan et al. 2011). As de novo assembly progresses with large 
genome initiatives (i.e., 1000 Genomes Project), integration of comprehensive 
de novo assembly with our hierarchical approach will afford maximum 
potential to detect a complete picture of population-specific 'rearrangement 
hotspots'. Collectively, the results of this study emphasize the complexity of 
genomic rearrangements and the importance of NAHR-mediated 
recombination events in the origin of deletions and duplications which underlie 
the manifestation of germline and somatic disease. 
Diseases arising from structural changes in the human genome are 
strongly correlated with the local sequence structure in which NAHR appears 
to be the predominant mechanism producing such vulnerable regions that 
often predispose to genomic diseases (Gu et al. 2008). Isolating these 
regions based on high sequence homology will significantly reduce target 
regions and enable the development of hotspot-specific genotyping assays to 
capture disease associated deletions/duplication with both higher sensitivity 
and coverage. The breakpoints previously reported in SDs by aligning 
nonoverlapping read depth windows of 5 kbp using the reference human 
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genome (Bailey et al. 2002; Alkan et al. 2009) limits the capacity to detect 
short highly homologous regions vulnerable to NAHR-mediated 
rearrangement. 
In this study, we have identified genome-wide 'rearrangement hotspots' 
with elevated frequency of pathogenic NAHR mediated events. We have also 
detected an overwhelming number of overlapping CNV breakpoints, 
accumulation of DNVs and gene content transfer within hotspot regions. The 
read depth distribution of these hotspot regions revealed considerably higher 
read depth compared with the rest of the duplicated regions in the genome. 
The genome-wide characterization of 'rearrangement hotspots' will enhance 
the clinical applicability of high resolution genome analysis to uncover 
uncharacterized genomic disorders. Although current microarray platforms 
vary in both coverage and sensitivity (Tucker et al. 2011 ), the generation of a 
genome-wide 'rearrangement hotspot' map will serve as a powerful tool for a 
custom design of microarrays targeting regions vulnerable to mutational 
events that predispose to genomic disorders. 
Although NAHR appears to be the dominant mechanism in the origin of 
pathogenic chromosomal rearrangements, the complete identification of 
hotspot breakpoints due to NAHR, NHEJ, MMBIR and FoSTeS remains to be 
fully characterized. The generation of a genome-wide high resolution map of 
'rearrangement hotspots', which likely serve as templates for NAHR, 
represents a risk factor for manifestation of constitutional and acquired 
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diseases as these regions are capable of mediating de novo deletions or 
duplications. Fine mapping limited to only 20% of detected hotspot regions 
identified in this study using microarray will detect NAHR-mediated 
deletions/duplications for 24 known genomic disorders and the remaining 
80% will increase the possibility of detecting novel de novo chromosomal loss 
or gain. We anticipate that discovery of genomic variants using this robust 
hierarchical approach will translate not into the replacement of microarray-
based methods with whole-genome or exome sequencing of patients 
suspected to have complex disease. Instead, it represents a valuable tool 
which can be utilized for superior design and selection of probes, and 
ultimately the creation of a customized microarray chip specifically targeting 
'rearrangement hotspot' signatures to detect complex genomic diseases. 
69 
2.3 MATERIALS AND METHODS 
Data Acquisition and Processing 
We haye obtained short read data for the NA 18507 human genome 
sequenced using reversible terminator chemistry on an lllumina Genome 
Analyzer (Bently et al. 2008). The original data consisted of >30X coverage of 
the genome. We have obtained more than half of the data from the Short 
Read Archive Provisional FTP (NCBK) site 
(ftp://ftp. ncbi. nih .gov/pub!TraceDB/ShortRead/SRA000271 /) with an average 
read length of approximately 36 bp. The analysis accuracy of this dataset has 
been previously described (Bently et al. 2008). The 4.8 MBp novel sequence 
detected in the NA 18507 genome by a previous de novo assembly was also 
integrated in our rearrangement analysis. The length distribution revealed that 
the contigs/scaffolds are over fragmented and >80% of the sequence length 
is <1 KBp in length. The NA18507 human genome was selected as it is 
representative of the ancestral African Euroban population which has been 
previously shown to contain the most diverse polymorphisms compared with 
other populations (Sudmant et al. 201 0; Alkan et al. 2009), rendering it an 
ideal sample to generate a 'rearrangement hotspot' map as the majority of the 
hotspot regions detected should exist within other populations. 
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Short Read Mapping 
We have applied mrsFAST (micro-read substitution only fast alignment 
search tool - version 2.3.0.2) which implements an all-to-all algorithm unlike 
other short read mapping algorithms (Hach et al. 201 0). Specifically, it is a 
fast alignment search tool which uses cache oblivious short read mapping 
algorithm to align short reads in an individual genome against a repeat 
masked reference human genome within a user-specified number of 
mismatches. We have mapped our short reads using mrsFAST with a 
maximum of two mismatches allowed against the repeat masked (UCSC 
hg 18) genome assembly (supplementary 1 , chapter 2). The advantage of 
using mrsFAST is that it returns all possible hits in the genome for a short 
read , allowing the detection of differential read depth distribution within 
duplicated regions of the human genome. Using the NA 18507 human 
genome (18x coverage) , 1.5 billion short reads were processed with 55.78% 
(i.e. , -839 million short reads) mapped to the repeat masked human 
reference genome with the mrsFAST aligner (supplementary 1, chapter 2) 
which returned all possible mapping locations of a read; a key requirement to 
accurately predicting the duplicated regions within the reference genome. 
GC Correction 
There exists a known bias with next generation sequencing technology 
towards GC-rich and GC-poor regions. Moreover, during library preparation 
using an lllumina Genome Analyzer, amplification artefacts are introduced in 
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both GC-poor and GC-rich regions producing an uneven distribution of read 
coverage (Aikan et al. 2009) which has the potential of detecting false positive 
duplicated regions. We have used a simple GC correction method to reduce 
this bias. Overlapping windows (i.e., by 1 bp) with length 'f was used for read 
depth computation. Each read was assigned only once by its starting position 
and read depth was computed for each chromosomal position. The original 
mean read depth was calculated for each 'f length (i.e. , 100 bp) block using 
equation (1 ). We have computed G+C percentage for every 100 bp window 
from the reference human genome and the read depth was subsequently 
interrogated for adjustment. The adjusted read depth was computed using the 
following equation: 
RD;,adj usted = RD; x ml 
m2 
(1) 
where RO;,adjusted is the read depth after GC correction , RO; is the original 
read depth computed for l h window, m1 is the overall median of all the 
windows with 1 00 bp length and m2 is the mean depth for all windows with 
same GC percentage. All subsequent analysis was carried out on the GC-
corrected read depth. 
Read Depth (RD) and Interval Detection 
The first step in dissecting SO unit breakpoints using the NA 18507 
genome from all hit map information was to compute read depth from short 
read sequence mapping and detect SO intervals that do not overlap with a 
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repeat region of the genome. Read depth was computed for each point after 
obtaining mapped anchoring positions of the short reads from mrsFAST. We 
have built a table for each chromosome, each containing coordinates where 
the common repeats are located. The read depth mean was computed for a 
chromosome Jrom the genome content excluding common repeat regions. For 
each window with I length (1 00 bp) an event was determined. Events with 
excessive read depth and with a deletion were detected using equation (2). 
2( ExcessiveRD) 
event(!) = O(Deletion) 
1 
I 
if I RD ~ mean+ 2 x st.d 
k=O 
ifRD < 1 
otherwise; 
(2) 
To investigate the interrogating window if it falls within a common repeat 
elements, we have built a library for the repeat masked regions (masked 
interspersed repeats, i.e. LINES, SINES, etc.) of the human genome. The 
mean length of the detected SO units was 822 bp (supplementary 1, chapter 
2) . The read depth distribution between the detected duplication subunits and 
the non-duplicated regions of the genome show significant read depth 
differences with an approximately 7% error rate (supplementary 1, chapter 2). 
NA 18507 Short Read Reference Guided Assembly 
The current version of mrsFAST does not return the quality of the aligned 
reads within a consensus genome. Instead, we have used MAO version 0.7.1 
(Mapping and Assembly with Quality) which assembles genomes with a 
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specified quality. MAQ searches for the un-gapped match with lowest 
mismatch score (i.e., maximum of 2) in the first 28 bp. To confidently map 
alignments, MAQ assigns each alignment a Phred scaled quality score which 
measures the probability that the true alignment is not the alignment that is 
detected by MAQ. If a short read maps to multiple positions in the genome, 
MAQ will randomly pick one position and give the excluded position a 
mapping quality of zero. We have mapped and assembled the NA 18507 
genome short reads into the reference genome using MAQ allowing at most 2 
mismatches. 
Detection ofGenomic Re-arrangements 
Using read depth as a measure to detect SO unit breakpoints may 
produce regions that share <90% sequence identity. To reduce false positive 
and computational burden after detecting SO unit breakpoints, we utilized a 
basic version of the end space alignment algorithm (without seed and extend 
approach) and performed pairwise alignment for each of the SO units against 
the rest of the genome SO units. We included only those SO units for 
rearrangement analysis described in the following section that contained at 
least one duplicon >100 bp with >90% sequence identity. We detected 20,237 
SO units when every 100 bp window was assessed for a possible 
rearrangement. 
74 
End-Space Free Alignment Algorithm 
The ability to detect highly homologous regions between two sequences is 
essential for duplicon detection. Multiple clusters of non-adjacent duplicons 
with >90% sequence identity cannot be mapped using basic alignment 
algorithms. As previously reported , the basic pairwise global alignment 
algorithm will miss duplicon breakpoints that are non-adjacent within an SO 
with different thresholds of sequence identity (Gu et al. 2008). Semi-global 
alignment has a tendency to produce pattern-like alignments (see example 
below), which are not informative for complex regions with multiple 
duplications. We have implemented a modified version of the pa1rw1se 
alignment algorithm where the alignments are scored ignoring end spaces of 
the two sequences. Adding the option of end spaces in our alignment does 
not produce pattern-like alignments and therefore accurately pinpoints the 
breakpoints of the duplicon with an allowed gap that crosses the threshold of 
>90% sequence identity. The neutral rate of evolutionary decay suggests that 
10% sequence divergence is required to accurately detect duplications that 
are primate-specific (Gu et al. 2008). 
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Example: 
S 1 :ACGCAATTCGACT AGATCGGGTCGATGATCGATCGATGATCGAGACAGCAT AGCAG 
S2: CAATTCGACTAGATCGATCGACGATCGATCGAT 
Semi-Global Alignment: 
S1 : ACGCAATTCGACTAGATCGGGTCGATGATCGATCGATGATCGAGACAGCATAGCAG 
82: ***CAATTCGACTAGATC*GATC***GA *CGATC***GA T*****C*G* AT***** 
End-Space Free Alignment: 
S1 : CAATTCGACTAGATCGGGTCGATGATCGATCGAT 
S2: CAATTCGACTAGATC*GATCGACGATCGATCGAT 
In order to implement the algorithm, a dynamic programming technique 
was utilized . which is a modified version of Smith-Waterman dynamic 
programming (Smith and Waterman 1981). This approach will detect the 
pairwise alignment relative to a penalty function corresponding to semi-global 
alignment. We used the dynamic programming (DP) algorithm to compute the 
above alignments and used the backtrack pointer to identify the best 
alignment. 
Dynamic Programming Matrix and Recursive Trace Back 
As a core searching algorithm, we have implemented a penalty function to 
complete the dynamic programming matrix M. First, we initialized the first 
column and row with zeroes which provided forgiving spaces at the beginning 
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of the sequences in order to obtain the highest similarity between the 
interrogated sequences. Our intention was to locate duplicons between a pair 
of sequences (i.e .. , s and t) with >90% identity and alignment with minimal 
gaps to avoid. pattern-like structures. We encoded A with 1, G with 2, C with 3 
and T with 4 to construct the (m +I) x (n +I) DP matrix M, where m and n is 
the length of two given sequences s and t, respectively. The algorithm uses a 
dynamic programming technique to fill a matrix M by a look up penalty 
function from the 5 x 5 matrix C. We have introduced penalty function g(i,j) for 
matched alignment with a score of 2. For the mismatches between a pair of 
bases, we introduced a penalty of -2 for mismatch and -3 for misaligned 
sequence produced by sequence assembly tools (i.e., MAQ). We used a -3 
penalty to reduce the amount of misaligned portions of the sequence into 
duplicon identification. To allow the algorithm to ignore the end positions of 
the sequences if it has low similarity, we have performed a trace back from 
the highest value returned by function Sim(s,t) in the matrix M (supplementary 
1, chapter 2) . For any two given sequences (i.e. , s and t) , a semi-global 
alignment is an alignment between a substring (in this case duplicon) of s and 
t. 
{
a[i, j - 1] - 3 
a[i, j ] = max a[i - 1, j - 1] + g(i - 1, j - 1) 
a[i - 1, j ] - 3 
Sim(s, t) = max qf M 
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(3) 
(4) 
The memory requirement to fill out DP matrix M is O(mn). The 
computational time to complete the dynamic programming Matrix M and to 
determine the maximum value in M for a given pair of sequence s and t with 
nearly similar length is O(n2) and to trace back starting from the maximum 
point in the matrix takes O(m+n) time to obtain optimal alignment. 
Now, it might be apparent that ignoring end spaces might not detect true 
breakpoints and for long sequences it might produce really short alignments. 
Considering that majority of the commonly used alignment search methods 
(i .e., BLAST, BLAT, and SHRiMP) implement a "seed and extend" method to 
obtain faster sequence comparison (Altschul et al. 1990; Kent, 2002; 
Yanovsky et al. 2008), this method was also applied in this study. To perform 
an exhaustive search within the scope of 100 bp windows for any two given 
segmental unit sequences obtained from NA 18507 genome, we have applied 
the dynamic programming algorithm for each 100 bp window with 10 bp 
overlaps as "seeds". The highly similar seeds (>90%) went through the 
"extend" step and the rest was ignored. We acknowledge that this approach 
might detect the same breakpoints multiple times if multiple seeding events 
are obtained from a highly duplicated region. Therefore, we have compared 
the previously extended duplicon breakpoints from the same SO unit and the 
overlapping "seeds" and only the maximum extended duplicon was kept 
(supplementary 1, chapter 2). 'Extend ' is a recursive procedure which extends 
bi-directionally by 10 bp and the extend step ceases in each direction when 
further extension does not cross the sequence identity threshold . As a result, 
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the procedure terminates if any further extension of both directions returns 
<90% sequence identity. 
FISH Validation 
Cytogenetic preparations were made from lymphoblastoid culture 
(obtained from Coriell cell repositories) for the NA 18507 sample. The cell 
suspension was dropped on slides using a thermotone, aged overnight and 
hybridized with test (i.e., spectrum orange) and control probes. Following 
post-hybridization washes and 4,6-diamidino-2-phenylindole (OAP1) 
counterstaining, slides were analyzed using fluorescence microscopy. 
Pseudocoloring and image editing was performed using Photoshop software. 
To validate our duplicon rearrangement within SO units, we selected three 
complex regions in the human genome: 1q21.1 , 16p12.1 and 22q11.21 . In 
this study, we used fosmid genomic clones corresponding to a duplicated 
locus as a probe against chromosomal metaphase. The localization of FISH 
clones within· these regions and the corresponding derivative loci validated 
>94% (i.e. , 17/18) of the in silica co-localization predictions. The FISH 
technique was unable to provide a precise estimate of rearrangement at the 
level of 100 bp due to resolution limitations (supplementary 1, chapter 2). 
Permutation 
The basic analyses were conducted using a permutation procedure to 
assess statistical significance of 1-sided tests. The rearrangement for each 
SO unit was permuted randomly between the two groups and test statistics 
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was computed in each permutation. All results reported in this study used 1 
million permutations to derive an empirical P-value. 
Gene Ontology Analysis 
Gene ontology data analysis was performed using PANTHER (version 
7.0) database (Mi et al. 201 0). We have analyzed the biological processes of 
the hotspots genes (supplementary 1, chapter 2). 
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Chapter 3 
Atypical Micro-duplications at 2q21.1-21.2 Co-
segregates with Tourette Syndrome in a Three 
Generation Family 
Mohammed Uddin 1 , Darren D. O'Reilli , Tanya R. Purchase2 , Hubert 
White2, Sandra Luscombe3 , Susan J Moore3, Terry- Lynn Young 1, Proton 
Rahman 1 Kathy A Hodgkinson 1 
1. Faculty of Medicine, Memorial University, 
2. Pediatric Psychiatry, Health Sciences Centre, St. John's, Canada 
3. Pediatric Development and Rehabilitation, Health Sciences Centre. 
PREFACE 
The primary contribution of this manuscript is the detection of 
microduplications at 2q21.1-21.2 within multigenerational family affected with 
Tourette syndrome (TS). The detection of these microduplications was carried 
out by applying a custom array that has been designed targeting the 
breakpoints identified in chapter 2. The larger block of microduplication 
consists a gehe C2orf27 A and the microduplication found to be rare in control 
population, implicates a link between 2q21.1 -21.2 locus with TS 
pathogenesis. A version of this manuscript has already been submitted in 
American Journal of Medical Genetics, Part A. 
The co-authors Drs. Proton Rahman, Darren O'Rielly, Kathy 
Hodgkinson helped the primary author Mohammed Uddin on the study 
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design. The primary author, Mohammed Uddin, conceptualized the problem 
and developed the framework of the study design. In addition, the primary 
author conducted all related computational analysis presented in this 
manuscript. All the co-authors worked as a team in preparation of the 
manuscript. 
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ABSTRACT 
Tourette syndrome (TS) is a developmental neuropsychiatric disorder 
characterized by the presence of both motor and verbal tics. TS may be 
accompanied by co-morbidities including obsessive compulsive disorder (OCD), 
attention deficit hyperactivity disorder (ADHD) and poor impulse control. The 
prevalence of TS is between 0.3-1% and affects males more than females (M:F-
3: 1 ). It has a major genetic component with concordance rates for monozygotic 
and dizygotic twins estimated at 50-70% and 10-23%, respectively. Despite 
numerous linkage and association studies, no common candidate genes have 
been identified. Recent analysis of copy number variations (CNVs) in TS reveal 
an association with genes previously implicated in autism spectrum disorder 
(ASD) although none have been reported unique to TS. 
We have imitated an epidemiological study of families with TS in 
Newfoundland and Labrador, Canada and have ascertained one multiplex family 
with five family members clinically diagnosed and another potentially affected (by 
collateral family history). Recruited family members include four young siblings, 
their parent and maternal grandfather. Three of the siblings are significantly 
affected with concomitant OCD, ADHD and anxiety. The fourth has TS with fewer 
co-morbidities. We designed a custom array CGH targeting genomic hotspots 
susceptible to rearrangements. The high density array included 2 X 1 million 
probes with a mean spacing of 270bp. We found two common micro-duplications, 
one 38KB and the other 131 KB in length. The larger duplication comprised the 
C2orf27A gene located at 2q21 .1-21.2 that co-segregated with six family 
83 
members diagnosed with TS and also detected in an unrelated affected 
individual. Our finding has been validated using rt-PCR. Addition rt-PCR analysis 
on 443 control individuals from Newfoundland population revealed rare frequency 
of the larger block, 4/443. The function of the C2orf27 A gene is currently 
unknown. In summary, we have identified CNVs that segregates with TS in a 
multiplex family. The importance of this and other disease-associated CNVs to 
the pathogenesis of TS (and associated syndromes) is currently being explored 
through ascertainment of other multiplex families from the Newfoundland and 
Labrador population. 
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3.1 INTRODUCTION 
Newfoundland Population Genetics 
In this thesis, the genetic predisposition to neuropsychiatric and ankylosing 
spondylitis was analyzed in the population of Newfoundland and Labrador. As 
Newfoundland population a well known founder populations (Figure 3.1 ), it s 
prudent to beware about the genetic architecture of Newfoundland founder 
population. 
Giovanni Caboto, an Italian navigator, first reached Newfoundland in 1497 
and seasonal colonies were first established around 1610. The major influx of 
immigration to Newfoundland occurred in the mid-1700s, who are the early 
settlers and included mainly Protestant settlers from the south-west of England 
and Roman Catholic settlers from the south of Ireland (Rahman et al. 2003) 
(approximateiy 20,000 founder) . This population grew by natural expansion and 
settled in other geographic locations in the province by 1850 (Figure 3.2). The 
population reached approximately 200,000 in 1890(Fernandez 2009). This rate of 
expansion as a young genetic isolates is comparable with other isolate 
populations (rahman et al. 1 003). The population is genetically isolated and 
geographically consists of the island of Newfoundland and the mainland 
Labrador. According to statics Canada, 2011, the current population is 
approximately 510,000 with 95% of English or Irish descent. 
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Figure 3.1 Geogrphic locations of world founder populations. (The original image 
is used from Rahman et al. 2003 with the permission of the corresponding 
author). 
The Newfoundland population inbreeding analysis shows the presence of 
high degree of relatedness that leads to persistent homogeneity of Newfoundland 
population (Bear et al. 1987; Bear et al. 1988). This homogeneity of 
Newfoundland population is directly correlated with the presence of genetic drift. 
Genetic drift is a phenomenon that refers to the fluctuation in allele frequency 
(comparing other populations) due to small gene pool contained within a small 
population. Genetic drift is a strong force that is responsible for the imbalance of 
disease prevalence within a founder population. It can force the diseases 
incidence in both extreme and often can lead to an increase incidence of rare 
diseases or decrease incidence of common disease can be rare. Hence, similar 
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to other isolated populations in the world, there exists a high burden of genetic 
diseases in Newfoundland (Fernandez 2009). For example, Bardet-Biedle 
syndrome (BBS) (is a form of retinal dystrophy) is a autosomal recessive disease 
has a higher incidence rate in Newfoundland population (1/18,000) compared 
with (1/160,000) admixed Caucasian populations of northern European ancestry 
(Green et al. 1989). 
Newfoundland 
and Labrador 
Nova 
Scotia 
0 
Halifax 
... 
\ 
• English Protestant and Irish Catholic 
between 1780-1830 
• Late Settlers between 1841-1850 
Figure 3.2 Geographic locations of early and late settlers. 
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The trend of high incidence rate also observed within complex diseases 
among Nefoundland population. The incidence rate for Psoriasis is 2 to 3 fold 
higher compared with most other Caucasian populations (Nail et al. 1999). 
Juvenile type 1 diabetes in Newfoundland has a incidence rate of 40/100,000 
each year, representing the highest known incidence of juvenile type 1 diabetes 
worldwide. This exceeds the incidence rate in admixed US population (7-
15/1 00,000) and other recognized founder populations i.e. Sardinia and Finland 
(36.5-36.8/1 00,000) (Karvonen et al. 2000). 
Founder mutation is another concept where one of the original founders 
carries a rare allele that can be observed higher in frequency after few 
successive generations. Founder mutations have been noted in multiple diseases 
in Newfoundland population including multiple endocrine neoplasia type 1, 
hereditary non-polyposis colorectal cancer syndrome (HNPCC), hemophilia A, 
and Bardet-Biedl syndrome (Oiufemi et al. 1998; Spirio et al. 1999; Xie et al. 
2002; Young et al. 1999). Although it is a daunting task to identify founder 
mutations, a deviation in frequencies is observed in many diseases within 
Newfoundland population. For example, a single MSH2 mutation has been 
reported in 50% of Newfoundland families with HNPCC whereas the mutation 
was only observed 8% of English HNPCC families (Spirio et al. 1999). These 
observations highlight the stratified nature of disease incidence as well as unique 
genetic architecture within the Newfoundland population, and provide a unique 
opportunity to identify disease causal variants. 
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Tourette Syndrome 
Tourette syndrome (TS) is a developmental neuropsychiatric disorder 
characterized· by the presence of motor (simple and/or complex) and verbal tics 
with a duration longer than one year. TS often manifests with features associated 
with obsessive compulsive disorder (OCD), attention deficit hyperactivity disorder 
(AOHD), poor impulse control and other behavioural abnormalities (Robertson, 
2012). The pathophysiology of the complex comorbidities associated with TS 
remains to be elucidated. The prevalence of TS is between 0.3-1 percent in any 
given population (Robertson et al. 2009; Robertson 2008; Centers for Disease 
Control and Prevention 2009), and consistently is shown to affect males more 
than females (Robertson, 2012). Twin studies consistently show higher 
concordance rates in monozygotic compared with dizygotic twins (Price et al. 
1985; Walkup et al. 1988; Pauls et al. 1991) suggestive of a strong genetic 
component contributing to disease pathogenesis. Although early segregation 
analyses suggested an autosomal dominant inheritance pattern, recent evidence 
suggests a heterogeneous complex genetic architecture underpins the 
pathogenesis of TS (Pauls et al. 1986; Eapen et al. 1993; State 201 0; State 
2011 ). 
In the last decade, emphasis has focused on identifying common variants 
(i.e., >1% frequency) associated with common complex diseases. Several recent 
TS studies highlight the contribution of rare gene mutations and chromosomal 
abnormalities in disease pathogenesis. For example, a rare mutation (var321) 
has been identified in the SLIT and NTRK-Iike family, member 1 (SLITRK1) gene 
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(Abelson et al. 2005). The var321 variant was demonstrated to be highly stratified 
within multiple populations, however replication analyses have produced 
conflicting results (Scharf et al. 2008, O'Roak et al. 2010). Another rare functional 
mutation was identified in a two-generation pedigree in the L-histidine 
decarboxylase (HOC) gene and suggests a role for histaminergic (HA) 
neurotransmission in the genesis or modulation of tics (Ercan-Sencicek et al. 
201 0). That mutation was identified as a heterozygous G-to-A transition at 
position 951 in exon 9 of the HOC gene, resulting in a premature termination 
codon (p.W317X). This nonsense mutation was present in the affected father and 
all affected offspring within the pedigree and absent in the unaffected mother and 
in 3000 control samples. Subsequent replication analysis demonstrated the 
absence of this mutation in a cohort comprising 720 TS and 320 control samples 
(Ercan-Sencicek et al. 201 0). Likewise, replication in a Chinese population also 
failed to show significant association (Lei et al. 2011 ). Collectively, this evidence 
strongly suggests that this nonsense mutation is thus likely to be a private, rare 
mutation segregating in this family. 
Structural variations are a major risk factor for numerous neuropsychiatric 
diseases. Recent analysis of copy number variations (CNVs) in TS have 
demonstrated an association with genes previously implicated in autism spectrum 
disorders (ASD) and other neuropsychiatric disorders (Senthil et al. 201 0; 
Lawson-Yuen et al. 2008; Fernandez et al. 2012). A rare deletion of exons 
located 5' in the neurexin 1 (NRXN1) gene was identified in 2 unrelated TS 
patients (Senthil et al. 201 0). A second deletion in the a-T catenin (CTNNA3) 
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gene was identified in two independent TS studies (Senthil et al. 201 0; 
Fernandez et al. 2012). Interestingly, deletions encompassing both NRXN1 and 
CTXN1 gene have been reported in ASD and schizophrenia (SCHZ). Another 
rare deletion comprising the NLGN4 gene (i.e. exons 4, 5 and 6) was been 
previously reported in TS and ASD (Lawson-Yuen et al. 2008). A complex 
rearrangement (insertion/translocation) between chromosome 2 and 7 was 
reported to have disrupted the CNTNAP2 gene in a two generational pedigree 
(affected father and two children) (Verkerk et al. 2003). The identification of 
these CNVs that may be implicated in multiple neuropsychiatric disorders 
complicates genotype-phenotype elucidation. That no single CNV has been 
reported that is unique or that the segregation is unique to families affected with 
TS, provides a great opportunity to detect novel CNVs specific to TS which , in 
turn , may help simplify genotype-phenotype correlation . 
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3.2 RESULTS 
We have designed a high-density array-based comparative genomic 
hybridization (CGH) experiment by mapping with 2 X 1 million probes in regions 
that are susceptible to genomic rearrangements. We applied our custom 2M 
microarray on eight members from a three generational family which yielded 
approximately 2000 aberrations (Figure 3.3, Table 3.1 ). Comprehensive data 
analysis revealed the discovery of atypical microduplications located at 
chromosome 2q21 .1 which segregated with the cases in family A, whereas large 
de novo variants were not detected within the family members affected with TS. 
Within a 221KB (chr2:132305299-132526804) region , two (2) common blocks of 
microduplications were identified that segregate together in five (5) out of the six 
(6) affected individuals with a smaller region of overlap of block2 in the remaining 
individual (Figure 3.4; 103003). The blocks, which are separated by 51 Kb, are 
38KB (block1 chr2:132305299-132343808) and 131KB block2 
chr2:132395155-132526804) in length. All affected family members carry nearly 
identical breakpoints except the fourth affected sibling (103003) who has a partial 
30KBp duplication within block2 (chr2: 132480185-1 32510827). All affected 
family members carry a microduplication which comprises the C2orf27 A gene. 
Complex rearrangements were also detected in block2 for individuals 101002 and 
102002 which contained small microdeletions of 4.1 and 2.4KBp, respectively. 
The presence of block2 among five (5) of the six (6) affected family 
members has been validated using the QF-PCR assay which demonstrated that 
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a relative copy number of 4 within the affected siblings and mother whereas 
unaffected members have a copy number of 2 or 3 (Figure 3.4). We performed rt-
PCR analysis on two additional famil ies and 10 unrelated individuals affected with 
TS. The block2 micro-duplication with copy number of 4 was detected in one 
additional affected individual (101 0003), but absent in all other unrelated affected 
or unaffected samples tested. To quantify the population frequency of these 
duplication blocks using QF-PCR, we have analyzed a set of 443 individuals 
where copy number was determined with 99% confidence interval. The frequency 
of a copy number of 4 was observed in 4/443 (0.009). 
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Figure 3.3 Tourette Syndrome samples - Family A. a three generation pedigree, 
Families Band C: Two trios with affected offspring, D. Ten unrelated TS affected 
individuals. 
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Table 3.1 Clinical Features of Family A and Proband B. 
Birth Age Presentation IQ/ Cognitive Tics Treatment Co- Other 
ID Hx at and Profile Morbid it Medical 
dx.o Development y and Problems 
fTS al History age of 
diagnosi 
s 
3000 c 9y Normal early WISC Vocal and Melatonin ADHD Allergic to 
section milestones. (8y):Overall high- motor tics Risperidon combine dust mites 
Breech Referred to average IQ. FSIQ since 6y. e d type 9y. Mild 
Breast Development 109, VIQ 123, Increased Ritalin By asthma 12y. 
fed al PIQ 93. tics at 12y. Concerta OCD 9y Gynecomast 
10/12 Paediatrician Psychoeducatio Worst tics Strattera Anxiety ia 13y. 
(By) by nal assessment reduced by Prozac 9y school Chronic 
School (15y): written 14y. Adderall refusal headache 
Guidance output learning Accutane 14y. 13y. Sleep 
Counsellor for disability. Addiction disorder 14y 
possible WAIS IV (18 to (difficulty 
ADHD y):FSIQ 104 gaming falling 
(61 %); VCI 108 19y asleep, 
(70%); PRI 116 waking 
(86%); WMI 102 early, 
(55%); PS 77 snoring: 
(6%) sleep study 
WIATII (18 y): negative). 
spelling superior, Possible 
listening mood 
comprehension disorder, 
high average, (very 
other areas apathetic) 
average. ongoing 
assessment 
with 
Psychiatrist 
19y. 
Acne 16y 
3001 c 6y Normal early WISC ( 8y): Vocal and Melatonin ADHD 7y Nocturnal 
section milestones. overall average: motor tics Risperidon Dyslexia enuresis 6y 
Pia cent Referred to FSIQ 93, VIQ 95, since 6y e (severe) Sleep 
al Development PIQ 111 ,WMI 86, Ritalin 9y disorder(? 
failure al PS, B8 Concerta Sensory sleep 
Breast Paediatrician WIATII (By) Strattera integratio apnea) 8y 
fed at 4 yrs for composite score: Clonidine n Acne 13y 
12/12 assessment extremely low for Accutane disorder 
of speech reading writing, 9y 
problems low average for OCD9y 
aggression oral language and Auditory 
frustration borderline for processi 
and fine math. ng 
motor skill disorder 
delay . 14y 
Possible 
ADHD!TS 
3002 c By Normal early WISC (10 Vocal and Melatonin ADHD 7y Trace 
section milestones. y) :Overall high- motor tics Concerta OCD 9y tricuspid and 
2.5 Referred to average IQ. FSIQ since 6y. Strattera Anxiety pulmonic 
weeks developmenta 117, VIQ 120, complex tics Prozac 9y regurgitation 
early I paediatrician PIQ 120. WMI, at 8y Adderall 9y 
95 
Breast at 5y re- 97, PS 109 Paxil Sleep 
fed 8/12 concerns Spelling skills, disturbance 
about fine borderline, 5y 
motor skills, listening 
speech comprehension 
development, average 
hyperactivity 
poor impulse 
control and 
aQQression. 
3003 c 9y Normal early Not done Vocal and Melatonin OCD 6y Sleep 
section milestones. motor tics Dyslexia disturbance 
2.5 Referred to since 6y 9y 7y 
weeks developmenta Anxiety Sensory 
early I paediatrician Fearful of issues 5y 
Breast at 5y re- school 
fed 8/12 aggressive 10y 
behaviour 
and 
obsessions. 
Easily 
frustrated 
2002 NVD 44y Normal early Not done Vocal and Concerta ADHD Cervical 
milestones motor tics Strattera 38y dysplasia 
since Self 22y 
childhood manages Renal colic 
anxiety 25y 
and Sensory 
OCD. issues and 
Migraine 
headaches 
31y 
1001 N/A N/A N/A Not done Vocal and Has Atrial Fib 
motor tics* OCD 69y 
Easily traits* Basal cell 
frustrated* carcimoma 
78y 
Colon 
Cancer 79y 
Abdominal 
aortic 
aneurysm 
80y 
1000 NVD 12y Normal early Not done Motor tics 5y Risperidon ADHD tympanosto 
3 milestones Vocal e 12y my tubes 6y 
Referred to tics1 0y Strattera OCD 13y Systolic 
pediatrician OCD Clonidine Anxiety heart 
12y. History worsening 15 Seroquel NOS 17y murmer 11y 
of y, resolving Prozac Sleep 
hyperactivity, 19y Celexa problems 
ADHD, short Haldol (difficulty 
attention Clonazepa falling 
span, anger m asleep) 13y 
issues, sleep Luvox Equinus 
problems deformity of 
foot 14y 
TS: Tourette Syndrome 
ADHD: Attention Deficit and Hyperactivity Disorder 
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FSIQ: Full Scale Intelligent Quotient 
VIQ: Verbal Intelligent Quotient 
PIQ: Performance Intelligent Quotient 
VCI : Verbal Comprehension Index 
PRI: Perceptual Reasoning Index 
WMI: Working Memory Index 
PS: Processing Speed 
y: years 
NVD: normal vaginal delivery 
N/A: Not available 
* Family information only 
X/12: number of months 
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Figure 3.4 Array CGH result from the three generation pedigree of Family A. 
Each point (red/black/green) represents a probe intensity value. The dotted line 
shows genomic gains in two distinct genomic blocks within the affected samples. 
The horizontal geenline for sample 103002 shows partial gains. 
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126MB • ----------- 9MB Dystonia Critical Region -------135MB 
2q21.2 
- .. 
-
Figure 3.5 Illustration of the 9MB critical region at 2q14.3-q21.2 found in 
multiplex family with Dystonia. The reciprocal micro-duplications and deletions 
region found in TS and ADHD samples is also shown in blue and red vertical 
block, respectively. The micro-duplications reported in this study at 2q21.1-21.2 
also shown. 
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3.3 DISCUSSION 
The salient characteristics of TS are manifest in the subjects presenting 
with the microduplications. These are multiple motor and vocal tics, and common 
co-morbidities including ADHD, OCD, major depression, anxiety, behavioural 
problems, and learning disability (Termine et al. , 2006). Additionally recognised 
phenotypic co morbidities include migraine and sleep difficulties (Abelson et al, 
2005; Freeman et al, 2000; Kwak, 2003; Lesperance et al. , 2004; Singer, 2005) 
which are also clearly present. 
TS appears to segregate with the microduplications described in the 
manuscript. The morbidity of disease however varies with the individuals 
represented . The proband (Figure 3.3, 3001) and his three siblings exhibit 
various features of TS, with the three oldest siblings manifesting the greatest 
phenotypic morbidity. The mother (2002) and father (2001) of the boys function at 
a high level socially and occupationally, as do the grandparents. Subjects 1001 
and 2002 function well in all objective measures of functionality, and have done 
so throughout life, although 2002 has been diagnosed with TS, and childhood 
information suggests that the TS diagnosis would have been made in childhood 
were she to present to the medical profession as a child today. Subject 1 001 has 
manifested only tics throughout his lifetime. Of early interest in Family A was 
subject 3003 who presents with the a partial 30KBp duplication within block2 and 
has a more benign phenotype than his siblings. However, subject 10003 also 
has the same partial duplication and has a phenotypic presentation similar to the 
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older three siblings in family A, and the common two blocks of microduplications 
are also present in the mother (2002) and grandfather (1 001 ), neither of whom 
present with the same burden of disease. Although TS has been considered a 
single problem, evidence from factor analysis suggests that the disorder can be 
separated into symptom groupings, with potentially different etiologies (Cavanna 
et al. 2011 ). Hence, genotype-phenotype correlation is much more complicated. 
We provide here a description of a region containing two micro-duplication 
blocks that segregates within a family with TS. Unlike previous TS reports on 
CNV association, these micro-duplications not yet found to be reported with any 
other neuropsychiatric disorders. This region previously was identified as a locus 
for distonia by a linkage analysis on a four generation family (Norgren et al. 
2011 ). A 8.9 MBP critical region shown to have the highest LOD score that 
includes the micro-duplications region identified in this report (Figure 3.5). 
Extensive analysis was carried out to detect mutation and CNVs within this region 
applying re-sequencing and lllumina 2 million CNV microarray. This is particularly 
interesting because of the apparent phenotypic similarities between dystonia and 
Tourette Syndrome. In a recent report, small recurrent deletions and reciprocal 
duplications were identified within 2q21.1-21.2 region. The deletions are identified 
within a patient with ADHD, and the duplications are detected among unrelated 
individuals with developmental delay (DD)/intellectual disability (10), ADHD, 
epilepsy, and other neurobehavioral abnormalities (Dharmadhikari et al. 2012). 
This region is approximately 500kb downstream from duplication blocks identified 
in this report (Figure 3.5). 
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Previously published high-density CNV datasets from Conrad et al. 
(Conrad et al. 201 Ob) demonstrated the presence of common deletions 
interspersed within the region . Very low frequency (between 0.01-0.07) typical 
duplications have been reported in the Database of Genomic Variants (DGV) 
within this region (with no validation result). The DGV demonstrated typical CNV 
gains with low frequencies and of the reported studies, no single individual 
carries two duplication blocks within this region . This implies the unusual 
segregation of the two micro-duplication blocks within TS family is highly 
correlated with TS. These breakpoints are also absent within the large study that 
investigated 15,767 children with various types of intellectual disability (Cooper et 
al. 2011 ). 
The finding in this study emphasizes the impact of CNVs with respect to 
human health and genomic susceptibility to Tourette syndrome. The larger 
microduplication that segregates within the affected individuals of Family A 
consists C2orf27 A gene. The function of this gene is yet to be elucidated. The 
rare frequency of this microduplication within the control population indicative of a 
possible link between 2q21 .1-21.2 locus with TS and its pathogenesis. Until a 
large TS cohort is analyzed, it is difficult to know the actual frequencies of these 
microduplications within TS individuals in a population. CNV variants within other 
neuropsychiatric diseases often show the property of manifesting within a family. 
These variants are found to be extremely rare or absent within the control and the 
disease group for a population (Sato et al. 2012). Further investigation on large 
cohorts is required to quantify the frequencies of these microduplications within 
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TS individuals. The microduplication in this study within 2q21.1 -21.2 locus add to 
the growing Ust of recurrent CNVs associated with Tourette syndrome and its 
related features (i.e. ADHD, OCD). Further delineation of the 9MB (Figure 3.5) 
locus will strengthen the hypothesis of a major risk factor for TS at 2q14.3-
2q21.3. 
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3.4 MATERIALS AND METHODS 
Creation of Custom Design Microarray 
The genome wide CNV detection was carried out by designing a custom 
microarray. After the detection of 'rearrangement hotspot' regions in chapter 2, 
we grouped the distal and proximal breakpoints that are clustered within 1 MBp 
regions based on physical genomic coordinates. This enabled the ability to detect 
genomic losses and gains, not only in the rearrangement hotspots but also to 
investigate the critical region between the hotspots. These critical regions are 
often overlapped with SDs and are often prone to copy number changes. The 
importance of the identified breakpoints are evidenced by analysis which 
revealed that 20% of the detected hotspots are clustered within the proximal and 
distal SD breakpoints flanked by the pathogenic deletions/duplications that have 
been mapped for 24 NAHR-mediated genomic disorders (see Figure 2.3) . 
Implementing the custom designed chip using aCGH technology will enhance the 
ability to detect novel SVs by expanding the scope of coverage by a further 80%. 
Further analysis revealed that the detected hotspots encompass all of the 
centromeric and telomeric regions which are often susceptible to genome 
rearrnagment that are associated with complex disorders (i.e., 3q29 recurrent 
deletion/duplication syndrome). Selection of Microarray Platform Given that 
detection of a CNV typically requires a signal from at least 3 to 10 consecutive 
probes, CGH, microarrays can routinely detect anywhere from dozens to several 
hundred events per genome depending on the platform applied (Aikan et al. 
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2011 ). That on the Agilent CGH platform there is little additional genotyping 
power to be gained from placing more than 10 probes in each CNV. There 
appears to be a correlation between probe-length and variability, with longer 
probes giving less variance in fluorescence intensity (Pinto et al. 201 ). The 
number of probes required to detect a single-copy alteration varies between 
platforms, with Agilent Technologies offering the highest per-probe performance 
and in silica probe performance score provides a meaningful metric for prioritizing 
probes for inclusion in microarrays. Although alterations can, theoretically, be 
detected with a single probe using the Agilent platform, a more conservative 
detection limit of three to five probes is advised (Aikan et al. 2011 ). Of the 
commercially available CGH platforms, the Agilent platform produced the largest 
number of CNV calls (Pinto et al. 201 ). Moreover, higher resolution platforms 
have been previously demonstrated to more accurately capture the true 
proportion of genic CNVs and those in close proximity to segmental duplications. 
The superiority of array CGH over SNP arrays is attributed to a 
combination of differences in probe coverage and the type of reference used. 
Therefore, CGH arrays, and in particular, the Agilent platform, have greater 
sensitivity to detect small differences in copy number (e.g., four versus five 
copies) ; a finding of critical importance in the investigation of structural variants in 
disease asso~iation (Pinto et al. 201 ). Although CNVs can be better detected by 
aCGH in terms of resolution, this will undoubtedly change in the coming years 
with modifications to existing next generation sequencing (NGS) platforms but 
still economically unfeasible for studies with large cohort. Storage and 
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subsequent analysis of NGS and full exome data is complex, computationally 
exhaustive, time-consuming and expensive and is therefore considered 
impractical for large scale investigations of structural variants underlying disease 
pathogenesis. To alleviate the identified problems and cost associated with NGS 
approach to studying large cohorts, we have compiled from chapter 2, all of the 
hotspot breakpoints analyzed from our African individual based on NGS into 2 x 
1M microarray chips from Agilent to be used as our custom microarray. We 
converted the grouped breakpoints from human genome 18 build to human 
genome 19 build using the Lift-over application provided by University of 
California, Santa Cruz (UCSC) genome browser. 
The eArray platform created by Agilent was used to search for probes to 
include in the custom array design. As we are focusing on the more complex 
regions of the genome, there is lack of validated probes located within these 
regions. To overcome this limitation, we included genome-tiling probes in addition 
to high-quality, validated probes to achieve maximum coverage in these complex 
regions. To achieve adequate high resolution throughout the genome, we 
grouped the rearrangement hotspot breakpoints into four different probe sets with 
defined probe spacing. The first three probe groups consist of recently 
discovered CNVs (Conrad et al. 201 Ob) which represents -10% of probes within 
this probe group (i .e., 190 bp spacing for breakpoints <1 KBp; 300 bp spacing for 
breakpoints within 1-5 KBp; and 450 bp spacing for breakpoints >10 KBp). The 
final probe group, which comprises 90% of the selected probes, contains all of 
our detected hotspot breakpoints with an average probe spacing of 280 bp. A 
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primary advantage of using a genomic-tiling approach is that it consists of probes 
that are uniformly distributed which is likely to cover all exons that are located 
within the specified breakpoints. Normalization control probes that represent 
nonaberrantlnon-variant regions were included in the design for accurate 
normalization of the data using Agilent's Feature Extraction software. Replicate 
probes were also included in the design to compute the reproducibility QC metric 
in Agilent's Feature Extraction and DNA analysis software. 
QC measure was applied and the derivative of log ratio spread (DLRS) 
<0.25 was considered as a threshold. CNVs were detected using the built-in 
Aberration Detection Method-2 (ADM-2) algorithm DNA Analytics v.4.0.85 
(Agilent Technologies) using the following criteria: at least 5 probes for a CNV 
call on GC corrected intensity, nested filter was set to 2, log intensity >0.25 for 
duplication and <-0.25 for deletion was considered. Custom script was applied to 
detect gene enriched CNVs (overlaps or consist a gene) that segregates (at least 
three cases) within the affected and absent in the unaffected members of the 
family. 
Study Population 
Probands and families (Figure 3.3) were ascertained through a 
prospective study of TS in Newfoundland and Labrador, from the Janeway 
tertiary children's hospital psychiatric department (HW, TP) and child 
development services (SL, SM). This study obtains extended family histories and 
in depth phenotyping, and is approved by the Human Research Ethics Board (# 
07-71). To date 28 probands have been recruited and eight multigenerational 
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family histories completed. DNA samples are collected routinely from all affected 
subjects, their parents and extended family members (in multiplex pedigrees) 
following consent and completion of multiple rating scales. To date, one multiplex 
pedigree has been ascertained (Family A). 
Family A 
The proband (Figure 3.3, 3000) presented at 9 y to a developmental 
pediatrician following a referral from a school counsellor and was diagnosed with 
TS. His three siblings were subsequently diagnosed at 6, 8 and 9 years 
respectively (Figure 3.3, 3001, 3002, 3003). The mother of these boys had 
several issues relating to anxiety and obsessive traits and vocal and motor tics 
since childhood, however, was only diagnosed as having TS at 44y (Table 3.1 ). 
The father of the four affected boys has mild anxiety but no tics. The grandfather 
has no diagnosis, but has manifested both verbal and motor tics through his 
lifespan according to family information, although these were not obvious during 
a recent assessment by a psychiatrist. The grandmother was diagnosed with 
bipolar disorder in her 70s and is treated effectively but has no current tics, nor 
any history of tics. 
Proband 10003 
The proband presented at 12 years to a pediatric psychiatrist and was 
subsequently diagnosed with TS (Table 3.1 ). The extended family history is in 
progress, but is complicated by missing information due to adoption. 
Families Band C have no known extended history of TS or other co morbidities. 
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Control Population 
To assess the population frequency of the CNV detected using the custom 
2M microarray, we used 590 control samples from the NL population with no 
clinical report of TS and performed real time quantitative polymerase chain 
reactions (rt-PCR). The recruitment of the controls was approved by the Human 
Research Ethics Board. 
QF-PCR Validation 
To confirm the duplication detected using the custom 2M microarray, a 
Taqman copy number assay Hs03417816_cn (Life Technologies) was performed 
using the manufacturer's recommended protocol. The assay was performed in 
quadruplicate on 1 Ong genomic DNA for each sample in a 96-well plate. The 10 
1-11 reaction mix consisted of 2x1-11 2x Taqman Genotyping Master Mix (Life 
Technologies) , 0.5 1-11 of 20X copy number assay (described above), 0.5 1-11 
TaqMan RNAse P Copy Number Reference Assay (Life Technologies, part 
4403326), 2 1-11 water and 2 1-11 of 5ng/1JI genomic DNA. Cycling conditions for the 
reaction were, 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 60°C 
for 1 min. Samples were analyzed using the ViiA ™ 7 Real-Time PCR System 
(Life Technologies) and analyzed using CopyCaller Software (Life Technologies, 
PN 4412907). Three reference (calibrator) DNA HapMap samples (NA 1 0851 , 
NA 15510 and NA07048 (Coriell Institute)) plus one non-template control were 
included with the test samples. 
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PREFACE 
This manuscript provides an insight into the challenges how to use 
existing genome-wide association study (GWAS) SNP array data to detect 
CNVs and highlights the limitation. Using statistical model , this manuscript 
shows how to infer genomic gains/losses from a large case-control cohort for 
rheumatoid arthritis (RA). A version of this manuscript has been published in 
The Journal of Rheumatology. 
The co-authors, Drs. Proton Rahman, Michael 0. Wodds provided 
guidance the primary author, Mohammed Uddin, on the study design. Mitch 
sturge helped setup computational analysis. Mohammed Uddin conducted 
extensive literature review, the computational analysis and developed the 
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overall concepts and framework. In addition, the primary author demonstrated 
the existing limitations and challenges in current techniques to detect CNVs 
sing SNP arrays. 
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ABSTRACT 
Rheumatoid arthritis (RA) is a complex autoimmune rheumatic disease 
that is strongly influenced by genetic factors. Numerous genes are 
convincingly associated with RA, including genes in tumor necrosis factor 
signaling (TNF) and the nuclear factor-KB pathway. To date, except for genes 
within the HLA region, no data exist regarding potential copy number 
variations (CNV) involving RA-associated genes. We set out to identify genes 
affected by CNV that are associated with RA at a genome-wide level. Data 
from the Wellcome Trust Case Control Consortium (WTCCC) were used in 
our analyses. The initial WTCCC cohort genotyped 3004 controls and 1999 
RA cases using the GeneChip 500k Mapping Array Set. We performed a 
comparative intensity analysis using the PennCNV algorithm, which uses a 
hidden Markov model to detect CNV. A total of 2271 controls and 1572 RA 
samples passed quality control criteria and were included for association 
analysis. Association analysis was performed in 2 phases: (1) to identify CNV 
that are < 1 MBp with a population frequency < 5%; and (2) to identify large 
CNV that are > 1 MBp. Fishers' exact test was performed to quantify 
significance of the CNV. 
We observed that the genome-wide CNV burden is 2-fold higher in 
patients with RA compared with controls. We identified 11 rare copy number 
variable regions with < 5% frequency that had an association with RA that 
reached a p < 1 x 10-4. These include TNFAIP3 and TNIP1 , which has been 
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implicated in 'association studies for RA, systemic lupus erythematosus, and 
psoriasis. We identified CNV involving IRF1 , which functions as a 
transcription activator of genes induced by interferons; ALOX5AP and LCP2, 
involved in inflammatory mediation; B2M, an MHC-class I associated gene; 
and PRKCH, a gene involved in T cell signaling pathways. A 57 KBp deletion 
with 1% frequency in RA cases at 7p21.3 was also observed. Six of these loci 
overlap with CNV catalogued in the Database of Genomic Variants. This is 
the first study to identify non-HLA RA-associated CNV using genome-wide 
analyses. Validation and functional significance of these 
deletions/duplications in RA and other autoimmune diseases need to be 
further investigated. 
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4.1 INTRODUCTION 
Rheumatoid arthritis (RA) is the prototypic seropositive inflammatory 
arthritis. The heritability of RA is between 50% and 60%, with HLA-DRB1 
accounting for 30% of the genetic risk of developing RA (Wordsworth and 
Bell, 1992). The RA-associated genes can be broadly characterized as being 
involved in T cell activation (PTPN22, STAT4, and CTLA4) and the nuclear 
factor- KB (NF-KB) signaling pathway (CD40, TRAF1, TNFSF14, and 
TNFAIP3) (Raychaudhuri, et al. 2009). Recently, structural variation of DNA, 
namely copy number variation (CNV), has been recognized as important for 
both normal genomic variability and in disease susceptibility. A CNV is a 
common type of genomic variation ranging in size from 1 kilobase (KBp) to 
several megabases (MBp) and they cover at least 25% of the human genome 
(Kidd, et al. . 2008). Among different individuals, a single CNV can have 
different forms (i .e., duplication, deletion). The variable region that contains 
these different CNV is known as the copy number variation region (CNVR). 
CNV have the potential to disrupt genes and are associated with many 
complex diseases, including psoriasis, systemic lupus erythematosus (SLE), 
Grahn's disease, autism, and osteoporosis (Hollox et al. 2008; Conrad et 
al. 201 Ob; Fanciulli et al. 2007; McCarroll et al. 2008; Fernandez et al. 201 0; 
Yang et al. 2008) . Thus, it is important to assess the influence of CNV to 
obtain a thorough understanding of genetic susceptibility in complex disease. 
114 
Previous CNV studies in RA have noted association with chemokine 
ligand 3-like 1 (CCL3L 1) and Fe fragment of lgG, low affinity I lib, receptor 
(FCGR3B). CCL3L 1 binds to several proinflammatory cytokine receptors, 
including chemokine receptor 5 (CCR5). In a recent New Zealand study, a 
copy number higher than 2 at the CCL3L 1 locus was a risk factor for RA, but 
this was not replicated in a smaller UK cohort (McKinney et al. 2008). Two 
independent Dutch studies have reported that the 1q23 region, containing 
FCGR3B, has been associated with CNV that influence susceptibility to RA 
(McKinney et al. 201 0; Thabet et al. 2009). However, no such association was 
noted in the UK cohort1, nor in the recent WTCCC CNV analysis (The 
Wellcome Trust Case Control Consortium, 201 0). We performed a 
comparative intensity analysis to detect CNV using the WTCCC single-
nucleotide polymorphism (SNP) genotype array data. In addition, we 
performed a CNV genome-wide association analysis to identify disease-
susceptible loci in the WTCCC RA cohort. 
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4.2 RESULTS 
Genome-wide CNV distribution: High-resolution SNP obtained from the 
WTCCC data center had an average call rate of 99.63%, demonstrating high 
quality intensity data. The log R spread for the controls and cases showed 
that -90% of the samples were within mean standard deviation of 0.15 to 0.22 
in controls and 0.13 to 0.20 for the RA cases. After quality control , we 
identified 5927 CNV in RA cases and 4333 in WTCCC controls that were at 
least 1 KBp in length. There was almost a 2-fold increase in the total CNV 
burden of 1 KBp or more in size among RA patients compared to controls. 
The excessive burden of CNV compared to controls has also been noted in 
patients with schizophrenia and autism (Dalila et al. 201 0; The International 
Schizophrenia Consortium, 2008). However, without experimental validation 
of CNV it is difficult to exclude the possibility that this may be due to an 
experimental artefact. Most of these CNV were found in fewer than 3 samples 
and thus were omitted from the association analysis. Fifty-four percent of the 
CNV detected in this study overlapped with CNV in the DGV. 
Association analysis 
Our association analysis revealed significance for the HLA region chr6 
30583394-30889981 (p < 5 x 10-7}, which overlaps with DGV 10 3600. There 
were 11 CNV that achieved significance (p < 1 x 1 0-4), shown in Table 4.1. The 
association analysis showed mostly one-sided CNV occurrences (in cases more 
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than in controls). The disease-associated CNV involved numerous genes, 
including the interferon regulatory factor 1 (IRF1) gene; the tumor necrosis factor 
(TN F)-induced gene TNFAIP3 and its interacting protein 1 gene TNIP1 ; 2 
autoimmune related genes, lymphocyte cytosolic protein 2 (LCP2) and beta-2-
micro - globulin (B2M); 2 genes, protein kinase C-eta (PRKCH) and 
phosphatidylinositol-3,4,5-trisphosphate-dependent rae exchange factor 1 
(PREX1), involved in cell-signaling pathways; 2 known inflammatory mediator 
genes, arachidonate 5-lipoxygenase-activating protein (ALOXSAP) and lipopoly -
saccharide-induced TNF factor (LITAF); and the cell proliferation gene serglycin 
(SRGN). One CNVR contained deletions located in an intergenic region on 
chromosome 7p21 .3, with the nearest gene, thrombospondin type-1 domain-
containing protein 7 A (THSD7 A) , located approximately 50 KBp away from the 
deletion. 
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Table 4.1 The association results of the most significant CNVRs. The listed 
genes are contained within, or overlap, with CNV breakpoints. All CNV positions 
are given in NCBI build 35 coordinates. 
Genes Chr CNVR Deletion Duplication Fisher 
Start-End 
Exact P DGVId 
Position 
Case Control Case Control 
ALOX5AP 13q12.3 30136207- 0 0 35 2 5.06x10-
30264780 12 
SRGN 1 Oq22.1 70423581- 6 1 21 1 4.35x10-!i 48614 
70542187 
Gene 7p21 .3 11696007- 20 0 0 0 1.60x1o-" 
Desert 11753538 
(nearby 
gene 
THSD7A) 
LCP2 5q35.1 169605980- 0 0 24 2 5.26x10-" 
169668498 
PREX1 20q13.13 46676571- 0 0 18 0 9.70x10-" 12195 
46882578 
B2M 15q21 .1 42606873- 0 0 26 4 2.71x1o- 3961 
42824209 
L/TAF 16p13.13 1150647 4- 1 0 15 0 5.87x10-1 
11695215 
PRKCH 14q23.1 60986674- 0 0 20 2 1.39x10-o 49385 
61130641 
IRF1 5q31 .1 131735192- 2 0 18 2 1.39x10-o 
131863294 
TNFAIP3 6q23.3 138064233- 0 0 11 0 5.25x1o-o 
138239517 
TNIP1 5q23.3 150379418- 2 0 18 2 7.59x1o-o 6455 
150470998 
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The association analysis of large CNV with RA (Table 4.2) revealed a 
duplication on chromosome 16p11.2 that was 1.46 MBp (p < 0.001 ). 
Duplications and deletions on 16p11.2 have previously been reported and 
validated in 2 independent studies (Need et al. 2009; Sebat et al. 2004). 
However, our data confirmation revealed there was very low probe intensity in 
this region and therefore this result should be interpreted with caution. 
Table 4.2 Association analysis of rare large CNVs that are greater than 1 MBp. 
CNVR CNVR Start- Case Control Fisher 
End CNV CNV Exact TP-~t 
16p11 .2 29053928 - 7 0 0.001 
3051 4652 
22q11.21 17275227 - 0 7 0.02 
18602641 
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4.3 DISCUSSION 
Copy number variation may play a significant role in genetic 
susceptibility and expression of complex autoimmune disease. An example of 
this is the role of CNV in beta defensins in Crohn disease and psoriasis. Beta-
defensins are small antimicrobial peptides that play an important role in the 
innate immun·e system. A cluster of beta-defensin genes contain an extensive 
array of CNV in humans. It has been demonstrated that individuals with 
Grahn's disease have significantly lower beta-defensin copy number than that 
in controls. It is hypothesized that this results in the reduction of the 
antimicrobial barrier in the gut leading to Crohn disease (Fellermann et al. 
2006). Meanwhile, individuals with psoriasis have significantly higher copy 
numbers than controls. The association analysis suggests 6 or more copies of 
betadefensin is correlated with susceptibility to psoriasis. Due to the cytokine-
like properties of the beta-defensin this could lead to an inappropriate 
inflammatory response generating psoriatic lesions after minor injury, 
infection, or other environmental triggers (Hollox et al. 2008). 
In our study assessing CNV in RA by analyzing a genome-wide 
association study, we first report the greater genome-wide burden of CNV in 
RA patients compared with controls. We found an approximately 2-fold 
increase in the number of CNV carried by an individual with RA. We also 
identified 11 rare CNVR, with < 5% frequency that showed evidence of 
association with RA. Some of the loci identified encoded genes with in the 
120 
CNVR previously implicated in autoimmune diseases. The 2 most interesting 
candidates are TNFAIP3 and TNIP1. The products of the TNFAIP3 and 
TNIP1 genes are A20 and ABIN1/Nafla, respectively. These proteins 
physically interact with each other to influence the ubiquitin-mediated 
destruction of IKKg (lkB kinase-g)/NEMO, which is an essential nexus of NF-
KB signaling (Elder et al. 2009). A20 also regulates the degradation of several 
other components of the TNF signaling pathway. Polymorphisms of TNFAIP3 
have been associated with RA, SLE, and psoriasis, although the specific 
variants differ among these auto - immune diseases (Pienge et al. 2007; 
Graham et al. 2008; Nair et al. 2009; Turer et al. 2008). TNFAIP3 knockout 
mice develop multiorgan inflammation and arthritis (Pienge et al. 2007). As 
well, gene-disruptive CNV in classical Hodgkin's lymphoma are found in 
TNFAIP3. This may be of potential interest as there is increased incidence of 
lymphoma among patients with moderate to severe RA. 
Another candidate of potential interest is interferon regulatory factor 1. 
Type I interferons are a family of cytokines typically produced during viral 
infection but their multiple immune-modulatory effects are increasingly being 
recognized, including up regulation of innate immune receptors, polarization 
ofT cells towards a TH1 phenotype, and activation of B cells. Recent studies 
provide strong evidence for an association between IRF-5 gene variants and 
RA, particularly for patients with RA who are negative for anti-cyclic 
citrullinated peptide (Sigurdsson et al. 2007). An insertion-deletion 
polymorphism in the /RF-5 gene has also been shown to confer risk to 
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inflammatory bowel disease (Dideberg et al. 2007). The most significant CNV 
detected in our study overlaps with ALOX5AP, also known as FLAP. 
Expression of ALOX5AP is regulated by the binding of TN F-a to the promoter 
of ALOX5AP, thus modulating its gene expression (Reddy et al. 2003). 
In a functional study using collagen-induced arthritis in the DBA/1 
mouse, it was shown that the severity of arthritis in FLAP-deficient mice was 
substantially reduced (Griffiths et al. 1997). This implies the potential 
importance of ALOX5AP in arthritis. As well , LITAF showed upregulation in 
mice with glu - cose-6-phosphate isomerase (GPI)-induced arthritis (Inoue et 
al. 2009). CNV involving 2 other genes reported here, PRKCH and PREX1 , 
have also been observed in acute myeloid leukemia and gastric cancer cell 
line, respectively (Bullinger et al. 201 0; Takada et al. 2005). PRKCH was 
reported to be associated with RA in a Japanese population (Takata et al. 
2007). LCP2 and B2M are 2 additional autoimmune-related genes (Table 
4.1 ). LCP2 is important for normal T cell development and 82M is an MHC 
class I associated gene that is associated with Spondylitis (Clements et al. 
1998). The CNVR at locus 7p21 .3 is of particular interest. First, it contains 
deletions rather than duplications, and, in general, deletions are known to 
have higher phenotypic consequences (or penetrance)5. Second, this 
deletion occurs in at least 1% of RA cases and it is a validated deletion 
annotated in DGV (ID 3665). Finally, in a recent study, it was shown that CNV 
can have long-range effects (up to 1 MBp) on gene expression (Henrichsen et 
122 
al. 2009); therefore, validation of the detected CNVR in the intergenic region 
near THSD7A on 7p21.3 is warranted. 
Variation in copy number of FCGR3B was shown to influence 
susceptibility to RA in 2 independent studies in a Dutch population (Takata et 
al. 2007; Clements et al. 1998). However, in our analysis, no evidence of 
association was observed due to poor coverage of the regions [FCGR1 A 
(chr1 : 1146567361-146577146) and FCGR-A/2A/2B/2C/3A/3B (chr1: 
158,288,275-158,382,415)]. Limitations of our study include the issue of 
multiple testing and possibly under-estimating the number of common CNV 
due to inaccurate measurement of CNV breakpoints using SNP microarray 
data. Technological developments in sequencing will allow efficient 
identification of these breakpoints. Although we do not know the number of 
CNV in the human genome, we have done an exploratory analysis detecting 
disease-associated CNV that are p < 1.0 x 10-4. The false-positive error in the 
detection of duplications is significantly higher in Affymetrix arrays than in 
lllumina arrays38. Hence, we used a more restricted LRR standard deviation 
in our analysis than that used in the previously reported lllumina array CNV 
analysis using PennCNV (Need et al. 2009). Default parameters were used 
for the BAF drift and wave factor adjustment. As in a previous study, for the 
SNP intensity parameter, we have used the criteria where intensities of at 
least 15 SNP are considered for CNV < 1 MBp and intensities of 50 SNP are 
considered for CNV > 1 MBp. 
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In a recent CNV analysis carried out by the WTCCC, there were no 
associations of 3432 common CNV with common diseases, including RA. 
That analysis used the same cohort as in our study and a custom-designed 
Agilent Comparative Genomic Hybridization (CGH) chip for CNV detection, 
which is much more accurate than using SNP arrays for identifying CNV. 
However, even with CGH they identified a 15% false-positive rate when 
detecting duplications. Among the true-positive CNV, 50% had a frequency ;::: 
5%, all were > 500 bp in length, and most were tagged by nearby SNP (The 
Wellcome Trust Case Control Consortium, 201 0). Similarly, our analyses also 
showed no strong associations of common CNV with RA other than those 
within the HLA region. One possible reason for this observation is that the 
probes for Affymetrix 500k are not uniformly distributed across the genome 
(median 2.5 KBp space between SNP), hence the poor coverage affects the 
detection capacity and the frequency of CNV (Carteret al. 2007). 
In summary, we are at the early stages of identification of CNV 
involved in inflammatory rheumatic diseases. Our study identified 11 rare 
CNVR associated with RA, and these now need to be verified by additional 
molecular studies. The functional significance of the validated CNV would 
then need to be elucidated. We suggest that CNV should be routinely 
analyzed during a genome-wide association study, which may reveal 
additional alleles with low to modest disease risk associated with RA. 
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4.4 MATHERIALS AND METHODS 
Cohort 
The initial cohort data consist of 3004 shared controls and 1999 
individuals with RA obtained from the WTCCC data center. The controls were 
taken from 2 groups: 1504 samples from the 1958 British Birth Cohort (58C) 
and 1500 additional controls recruited from the UK Blood Services (UKBS). A 
set of 500,568 SNP were genotyped using Affymetrix GeneChip 500K 
Mapping Array Set (Affymetrix Inc., Santa Clara, CA,USA) (The Wellcome 
Trust Case Control Consortium, 2007). 
Quality control 
We used PennCNV software to detect high-resolution copy number 
variation. PennCNV uses a hidden Markov model to detect kilobase resolution 
detection of CNV with low false positives (Wang et al. 2007). Prior to the 
analysis, the sample inclusion/exclusion criteria were set based on WTCCC 
SNP analysis. All subjects that passed quality control criteria of the WTCCC 
original SNP 'association analysis were included for CNV analysis. Samples 
were excluded after a check for contamination , false identity, relatedness, and 
non-Caucasian ancestry. Affymetrix Power Tool, a BRLMM (Bayesian robust 
linear model with Mahalanobis distance classifier) algorithm, was used to 
make genotype calls for NSP and STY arrays separately (Rabbee et al. 
2006). The first array uses the NSP I restriction enzyme to genotype 250K 
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SNP while the second array uses STY I restriction enzyme to genotype 250K 
SNP. To reduce signal-to-noise ratio we used the WTCCC data to model 
parameters for canonical genotype clustering , instead of using default 
canonical genotype clustering information provided by PennCNV, which is 
used to calculate log R ratio (LRR) and B allele frequency (BAF) values. After 
separate calculations of LRR and BAF, the 2 array sets, NSP and STY, were 
combined to make CNV detection calls in the autosomes. Many of the 
genomic samples can have below-optimum genomic wave quality control 
values; hence, in our sample inclusion criteria we used the default parameters 
of PennCNV to restrict case or control samples - LRR standard deviation < 
0.25, BAF drift > 0.01 , and wave factor > 0.05 or < -0.05. A total of 2271 
controls (1123 58C and 1148 UKBS) and 1572 RA samples passed all the 
quality control criteria and were included for association analysis 
(supplementary 3, chapter 4) . 
After exclusion of samples, we performed quality control on CNV calls. 
PennCNV tends to show false-positive CNV calls on centromeric and 
telomeric regions. Due to the complex nature of hemizygosity in sex 
chromosomes, we excluded all CNV detected from sex chromosomes. In 
addition, human immunoglobulin coding regions showed false-positive CNV 
calls using PennCNV, therefore we excluded CNV that overlapped at 50% or 
more of its length with the following immunoglobulin regions: chr2:88.9- 89.4 
MBp, chr14: 21.1 - 22.0 MBp, chr15: 17.0-21 .0 MBp, chr16:31.8-36.8 MBp, 
and chr22: 20.7- 21 .5 MBp. Also, large CNV that overlap with centromeres 
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and telomeres were excluded from the following regions: chr1: 12.0-14.1 
MBp, chr1 0: 46.3-47.1 MBp, chr14: 19.2-19.4 MBp, chr15: 18.4-20.0 MBp, 
and chr19: 24.2-32.7 MBp (build 35). The boundaries for immunoglobulin, 
centromere, and telomere regions were obtained from a previous study that 
used PennCNV (Need et al. 2009). 
Association analysis 
Association analysis was performed on the detected CNV that were < 
1 MBp, and Fisher's exact test was performed to quantify the significance of 
the CNV with exact breakpoint match or within a CNVR. Association analysis 
was considered to be suggestively significant if (1) p < 1.0 x 1 0-4; (2) there 
were at least 15 SNP within the CNV; and (3) the population frequency was < 
5%. To avoid possible plate/batch effects, we manually checked the 
significant CNV samples and ignored any association if a CNV was identified 
in > 50% of samples from the same plate/batch. We also excluded CNV with 
strong p values if the LRR standard deviation for that CNV call was between 
0.20 and 0.25 to avoid borderline CNV calls (supplementary 3, chapter 4). A 
second association analysis was performed on large CNV that were > 1 MBp. 
Large CNVs are not frequent, but any CNV in fewer than 3 samples were 
ignored. Fisher's exact test was performed to quantify the significance of the 
CNV. The cutoff value for significance at p < 1 x 1 0-4 was arbitrary, since we 
are not aware of the total number of CNV in the human genome. However, 
this level of significance was also used in the recent CNV analysis by WTCCC 
that introduced the population frequency threshold for rare CNV of < 5%. The 
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Database of Genomic Variants (DGV) includes CNV that have been 
annotated . The detected CNV in our case and control samples were 
compared with the DGV (Build 35). 
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PREFACE 
The previous chapter shows the challenges that exist in using SNP 
microarrays in the detection of CNVs for common complex diseases. In this 
manuscript, we have applied our custom design microarray (see chapter 3 
method section) in a well defined multiplex family with Ankylosing Spondylitis 
(AS). The findings of a proposed candidate gene UGT2817 from the initial 
analysis from the multiplex family and subsequently analyzed in two Canadian 
AS cohorts. This manuscript illustrates the important correlation of genomic 
rearrangement hotspots detected in chapter 2 with human complex diseases. 
A version of th is manuscript has been submitted to BMC Genetics Journal. 
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ABSTRACT 
Ankylosing spondylitis (AS) is the prototypic spondyloarthritis with strong 
genetic predisposition. The genetic basis for AS is yet to be elucidated. The 
primary objective of this study is to identify novel copy number variations (CNVs) 
associated with familial ankylosing spondylitis (AS). A custom genome-wide 
microarray was designed to detect CNVs and applied to our multiplex AS family 
with six (6) out of ten (1 0) affected family members. CNVs were detected using 
the built-in DNA analytics aberration detection method-2 (ADM-2) algorithm. 
Gene enrichment analysis was performed to observe the segregation. 
Subsequent validation was performed using real time quantitative fluorescence 
polymerase reaction (QF-PCR). The frequency of copy number variation for the 
UGT2B17 gene was then performed on two (2) separate well-defined AS cohorts. 
Fisher exact test was performed to quantify the association. 
Our family-based analysis revealed ten (1 0) gene-enriched CNVs that 
segregate with all six (6) family members affected with AS. Based on the 
proposed function of the UGT2B17 gene, the UGT2B17 gene CNV was selected 
for validated using real time QF-PCR with 100% concordance. The frequency of 
two (2) copies of the UGT2B17 gene CNV was 0.41 in the Newfoundland AS 
cases and 0.35 in the Newfoundland controls (OR = 1.26(0.99-1 .59) ; p < 0.05)) , 
whereas the frequency of two (2) copies of the UGT2B17 gene CNV was 0.40 in 
the Alberta AS cases and 0.39 in the Alberta controls (OR = 1.05(95% Cl: 0.83-
1.33); p < 0. 71 )) . In conclusion , a genome-wide microarray interrogation of a 
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large multiplex AS family revealed segregation of the UGT2817 gene CNV 
among all affected family members. The association of the UGT2817 CNV with 
AS is particularly interesting given the recent association of this CNV with 
osteoporosis and the proposed function as it encodes a key enzyme that inhibits 
androgens. However, two copies of the UGT2817 gene CNV was only marginally 
significant in a uniplex AS cohort from Newfounland but excess copies was not 
detected in AS cohort from Alberta. 
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5.1 INTRODUCTION 
Ankylosing spondylitis (AS) is the prototypic spondyloarthritis as it is a 
chronic inflammatory axial disease with a peak onset between 20 to 30 years 
(Brown et al. 2000; Brown et al. 1997). Extra-articular features of AS include 
inflammation _of the eyes, skin, bowels, and more rarely the lungs and heart. 
There is a male preponderance as men are affected 2 to 3 times more frequently 
than females (Galin et al. 1983; van der Linden et al. 1983). 
Genetic factors are of major importance in the susceptibility of AS and, in 
fact, genetic epidemiological studies suggest that AS represents one of the most 
heritable complex autoimmune diseases with a heritability greater than 90% and 
a sibling recurrence ratio of at least 52 (Brown et al. 2000; Galin et al. 1983; van 
der Linden et al. 1983). HLA-827, which was first recognized in 1973, remains 
the strongest genetic association signal with AS and it is estimated that HLA-827 
accounts for 23% of the genetic heritability. Despite this strong association, only 
a fraction (1-5%) of HLA-827 positive individuals develop AS (Brown et al. 2000; 
Galin et al. 1983; van der Linden et al. 1983). Recent genome-wide association 
studies (GWAS) in several European populations and in the Hans Chinese 
population have identified up to 15 high priority genes including /L23R, RUNX3, 
KIF218, 2p15, IL 1R2, PTGER4, ERAP1, IL 128, CARD9, TNFR11 LT8R, 
T8K8P1 (Evans et al. 2011 ). These associations were primarily reported based 
on single nucleotide polymorphisms (SNPs) analysis. Recently, one association 
study revealed the complex interactions between the non-HLA gene, ERAP1, 
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with the HLA-827 gene (Evans et al. 2011 ; Australo-Anglo-American 
Spondyloarthritis Consortium (TASC) et al. 201 0). However, the genetic risk 
describe by HLA or non-HLA genes suggests that other genomic variants may 
contribute to the risk factor for AS. 
That CNVs contribute to disease pathogenesis is supported by their 
capacity to disrupt gene expression and to interrupt functional pathways (Cooper 
et al. 2011 ; Conrad et al. 201 Oa,b). In recent years, many CNVs have been 
associated with complex diseases and the majority of these associations were in 
autoimmune-mediated diseases, including Rheumatoid Arthritis, Psoriasis, 
Crohn's disease, and Systemic Lupus Erithmatosis (Conrad et al. 201 Ob; Hollox 
et al. 2008; Fellermann et al. 2006; Molokhia et al. 2011 ). Here, we report a CNV 
associated specifically with AS using a custom genome-wide microarray using a 
well-defined multiplex AS family. 
5.2 RESULTS 
Multiplex family 
The quality control (QC) measures for the custom microarray chip were 
very good as all samples exhibited <0.25 DLRS. Approximately 1700 CNVs were 
detected in each individual sample using our custom microarray. Segregated 
gene-centric CNV analysis (i.e., a CNV that consists or overlaps with a gene) 
revealed that 56 CNVs are enriched in affected family members (at least three) 
and absent in the unaffected family members. Among these 56 CNVs, we have 
identified ten (1 0) gene copy number variation regions (CNVRs) that segregate 
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with at least six (6) affected family members (supplementary 4, chapter 5). Our 
microarray analysis revealed multiple duplications within the UGT2B17 gene 
region that segregate in the affected family members that is absent in unaffected 
family members. One 7kb duplication (chr4:69423002-69430016) disrupts exon 3 
of the UGT2B17 gene and segregates with six (6) AS affected family members 
(Figure 5.1 ). The breakpoint encompassing the UGT2B17 gene region was 
covered with probes with 280bp spacing, providing high resolution to detect 
genomic aberrations. Validation of this targeted region using real time QF-PCR 
demonstrated 100% concordance with the microarray analysis (Figure 5.2) . The 
real time QF-PCR CNV call (>99% confidence) revealed that affected family 
members carried two (2) copies of the UGT2B17 gene, whereas unaffected 
members carried a single copy. All individual with AS family members were HLA-
B27 positive and all six (6) affected family members carried two (2) copies of the 
UGT2B17 gene. 
Disease prevalence (case control studies) 
In the ~ case-control cohorts, real time QF-PCR analysis targeting the 
identical CNVR (from family analysis) revealed the presence of three (3) alleles 
(0 copy - homozygous deletion, 1 copy - heterozygous deletion, and 2 copies) 
within this population for the UGT2B17 gene (supplementary 5, chapter 5). 
In the Newfoundland population, the frequency of the three alleles was 
0.13, 0.51 , and 0.35 for 0, 1 and 2 copies in controls, respectively. The frequency 
of two (2) copies of the UGT2B17 gene CNV was 0.41 in the Newfoundland AS 
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cases and 0.35 in the Newfoundland controls (OR = 1.26 (95% Cl: 0.99-1 .59); p 
< 0.05). Similarly, the frequency of two (2) copies of the UGT2817 gene in the 
Alberta population was 0.40 and 0.39 for AS cases and controls, respectively 
(OR = 1.05 (95% Cl : 0.83-1 .33) ; p < 0.71). The association analysis for the 
combined cohort (Newfoundland and Alberta population) show two (2) copies of 
UGT2817 gene frequency 0.40 and 0.37, for the cases and controls, 
respectively, with association significance p < 0.09 (Table 5.1 ). 
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Figure 5.1 a) A three generational pedigree comprising 13 individuals. DNA was 
available only for the individuals with an identification number (Ids). The affected 
family members are indicated by solid colors and member 002 has systemic 
lupus erithmatosis (SLE). b) The microarray intensity values for the UGT2B17 
region are indicated below the pedigree for each of the family members. The 
horizontal dark blue rectangles represent duplications detected by the genome-
wide analysis of CNVs. 
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Figure 5.2 UGT2B17 gene copy number validation using real time rt-PCR on the 
family members and three reference samples from HapMap. 
Table 5.1 UGT2B17 gene CNV association. The association result for 
Newfoundland, Alberta and the combined cohort. The significance is observed 
with Newfoundland population with the higher copy (2 copy) number of UGT2B17 
between AS cases and controls. 
Population Copy Cases Controls OR (95% CI) p 
' 
Newfoundland 2 0.41 0.35 1.26(0.99-1.59) <0.05 
(298 cases, 299 controls) 
Alberta 2 0.40 0.39 1.05(0.83-1.33) <0.71 
(289 cases, 285 controls) 
Combined 2 0.40 0.37 1.15(0.97-1.36) <0.09 
(587 cases, 584 controls) 
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5.3 DISCUSSIONS 
Copy number variations are increasingly being recognized in complex 
autoimmune diseases as they are capable of altering gene dosage and 
consequently affect gene function (Henrichsen et al. 2009). The contribution of 
CNVs to AS pathogenesis remains to be systematically evaluated. The primary 
goal of this study was to identify CNVs segregating within a multiplex AS family 
and then subsequently determine the allele frequencies of CNV in a case-control 
cohorts. The genome-wide CNV analysis performed in this study revealed that 
increased copy number of the UGT2817 gene is a risk factor for AS. 
The UGT2817 gene represents an excellent candidate gene for 
susceptibility to AS. UGT2817 is a functional gene as it encodes an enzyme that 
metabolizes steroid hormones including testosterone and selected xenobiotics 
(Xue et al. 2008; Yang et al. 2008; Karypidis et al. 2008; Olsson et al. 2008). A 
gene-dosage effect is present as the CNV is associated with urine testosterone 
level, male insulin sensitivity, fat mass, and prostate-cancer risk (as summarized 
by Xue et al. 2008). Importantly, copies of the UGT2817 gene has recently been 
associated with osteoporosis (including hip fracture) (Yang et al. 2008). The dose 
of the UGT2817 gene was significantly associated with bone mineral density, 
cortical thickness, and buckling ratio. These results support the role of UGT2817 
CNVs in the pathogenesis of osteoporosis. Although AS is characterized by new 
bone formation, osteoporosis is a well recognized complication of AS and the risk 
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of clinical vertebral fractures is increased in AS patients (Cooper et al. 1994; 
Vosse et al. 2009). 
The deletion polymorphism identified as a risk factor for prostate cancer as 
it exposes androgen in prostate, whereas individuals with two copy of UGT2817 
gene is shown to have significantly lower risk of prostate cancer in a well defined 
Caucasian population from Sweden (Karypidis et al. 2008). The replication of this 
association failed in a large cohort from the original population. The deletion (0 
copy) frequency within the controls of the Swedish prostate cancer study is 4% 
whereas, the large replication cohort reported frequency is consistent with most 
European population (Olsson et al. 2008). Replication in other populations on the 
association of the UGT2817 gene in large cohorts is required for both prostate 
cancer and osteoporosis. Particularly for this gene, failed replication does not 
undermine the original report of association due to its dynamic nature with 
respect to population stratification. From an evolutionary perspective, the 
UGT2817 gene in humans is highly stratified which makes it more likely for it to 
be associated with disease. The deletion allele (or 0 copies) frequency varies 
significantly among populations. For example, the frequency of the deletion allele 
is approximately 0.15 in Europeans, -0.22 in Africans, and -0.80-0.90 in Asians 
(Conrad et al. 201 Ob; Xue et al. 2008). In contrast, the frequency of two (2) 
copies of the UGT2817 gene is rare in Asian populations (-0.01-0.03), -0.30-
0.40 (reports with varying frequencies) in Europeans, and -0.60 in African 
populations. 
140 
In this study, two (2) copies of the UGT2817 gene segregates within a 
large well-defined AS multiplex family. Given the nature and proposed function of 
the UGT2817 gene (Schulze et al. 2008; Clarke et al. 2009), the UGT2817 CNV 
may account for the susceptibility of AS within this family. Conflicting results were 
obtained regarding the excess prevalence of this CNV in large uniplex AS 
cohorts. The population from Newfoundland suggests a trend, however this was 
not replicated in the Alberta cohort. In this study, the deletion (0 copy) frequency 
of the UGT2817 gene in the Newfoundland population is consistent with the 
Alberta population. There was a noticeable frequency difference between the 
Alberta (0.51) and Newfoundland (0.46) populations for a single copy of the 
UGT2817 gene. This stratification may represent a contributing factor for the 
absence of association. 
The analysis of CNVs within multiplex families provides a unique 
opportunity to detect variants that can be family specific. There are ample reports 
in psychiatric diseases where family specific CNVs manifest with the disease 
(Cook et al. 2008). Although it is a daunting task to obtain more multi-
generational pedigrees to follow up the segregation of this CNV, the trend 
observed within the investigated family suggests that segregation analysis into 
multiple multi-generation pedigrees is promising. The microarray analysis 
revealed paternal inheritance of the CNV within the sub-family (samples 007, 
008, 01 0). While the multiplex family in this study is a unique family with high 
penetrance of AS, it is important to assess other large multiplex families to 
determine if this CNV may be a causal in familial AS. 
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5.4 MATERIALS AND METHODS 
Multiplex AS Family 
A multiplex AS family from Newfoundland was identified for this study. All 
members of · the multiplex family were "native Newfoundlanders" of North 
European ancestry. Ten (1 0) members from this large family participated in the 
study. Each individual was assessed clinically including imaging studies. Six (6) 
of the ten (1 0) family members had AS as defined by the 1984 modified New 
York criteria, while the remaining family members were not affected. After 
consent was obtained, all participating family members had their DNA collected. 
Case-control Cohorts 
DNA was obtained from two (2) well-defined AS cohorts from the 
Newfoundland and Alberta populations. All cases and controls were of North 
European ancestry. We assessed 298 AS cases satisfying the modified New 
York criteria and 299 ethnically-matched controls from a homogenous population 
of Newfoundland. The second cohort consisted of 289 AS cases satisfying the 
modified New York criteria and 285 ethnically-matched controls from Alberta. 
Custom Microarray 
We designed a custom genome-wide microarray based on genomic 
hotspot breakpoints previously identified (Uddin et al. 2011) (see Chapter 3 
Method section and supplementary 2, chapter 2). The custom microarray 
consisted of 2 X 1 million probes covering the genome with a mean spacing of 
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280bp. Prior to CNV analysis, QC measures were applied and the derivative of 
log ratio spread (DLRS) <0.25 was considered as threshold . CNVs were detected 
using the built-in Aberration Detection Method-2 (ADM-2) algorithm DNA 
Analytics v.4.0.85 (Agilent Technologies) using the following criteria: 1) at least 5 
probes for a CNV call on GC-corrected intensity; 2) nested filter was set to 2; and 
3) log intensity >0.25 for duplication and <-0.25 for deletion. A custom script was 
applied to detect gene-enriched CNVs (i.e., overlaps or consist a gene) that 
segregate (at least three cases) within affected AS family members and absent in 
the unaffected family members. 
rt-PCR Validation 
To validate the CNV encompassing the UGT2817 (UDP 
glucuronosyltransferase 2 family, polypeptide 817) gene in the family members 
and in the case-control cohorts, copy number estimation of the UGT2B17 gene 
was performed using the Taqman copy number assay Hs03185327 _en (Life 
Technologies) using the manufacturer's recommended protocol. The assay was 
performed in quadruplicate using 1 Ong genomic DNA for each sample in a 96-
well plate. The 1 01-JI reaction mix consisted of 21-11 of 2x Taqman Genotyping 
Master Mix (Life Technologies), 0.51-JI of 20X copy number assay (described 
above), 0.51-JI of TaqMan RNAse P Copy Number Reference Assay (Life 
Technologies, part 4403326), 21-11 of water, and 21-11 of 5ng/1-JI genomic DNA. 
Cycling conditions for the reaction were 95°C for 10 min, followed by 40 cycles of 
95°C for 15 sec and 60°C for 1 min. Samples were analyzed using the ViiA TM 7 
Real-Time PCR System (Life Technologies) and analyzed using CopyCaller 
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Software (Life Technologies, PN 4412907). Three reference (calibrator) DNA 
HapMap samples (NA10851, NA15510 and NA07048 (Coriell Institute)) plus one 
non-template control were included with the test samples. Fisher exact test was 
performed to determine association of the UGT2817 gene copy number with AS 
in our case-control data. 
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Chapter 6 
GENERAL DISCUSSION 
This chapter comprises four major sections which begin with the 
background of CNVs (i .e., detection methods and disease implications) in the 
human genome. The latter two subsequent sections discuss the detection of 
rearrangement hotspots and the creation of a custom microarray. The final 
section focuses on the application of the custom microarray in two complex 
diseases and the detection of novel genetic variants. 
The human genome consists of multiple variations that range from 1 base 
pair (bp) to an entire extra chromosome in length. Primarily, we observe six major 
sub-microscopic types of variation in the human genome including single 
nucleotide polymorphisms (SNPs) , various repeat elements like microsatellites, 
LINE, SINE; deletions, duplications, insertions, and inversions. This thesis 
primarily focuses on sub-microscopic structural variants (primarily genomic gains 
and losses), as they represent the most recently discovered form of genetic 
variation in the human genome and their role in complex disease etiology largely 
remains unknown. Genomic gains and losses usually range from 500bp to mega 
base-pair (Mi3p) level. Although, these variants are small in size, their overall 
potential contribution to human genetic disease is suspected to be high as they 
occur at a relatively high frequency. Although, the first report of gene copy 
number variation occurred in 1936 (Bridges 1936), it was not until the last decade 
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that significant technological advancements made capturing genomic aberrations 
much more efficient and more comprehensive. 
For the identification of causal variants, it is imperative to investigate all 
spectrums of mutations in the human genome. Copy number variants are 
responsible for a large portion of variability observed between human genomes. 
Deletions, duplications, insertions and complex rearrangements collectively 
contribute a significant proportion of the total variation in copy numbers among 
individuals, thus it is prudent to investigate the detection of such variants in 
disease susceptibility. Applying numerous approaches in large complex disease 
cohorts, CNVs have been shown to be associated with numerous disease 
phenotypes and traits. Although, there has been significant progress in assessing 
CNV content in the human genome, this class of variation has not been 
systematically studied in complex human genetic studies. CNVs are very 
prominent for their role in DNDs. These variants also helped to identify previously 
unrecognized syndromes (Ballif et al. 2007; Ballif et al. 2008). For example, three 
independent groups characterized a microdeletion syndrome at 17q21.31 (Shaw-
Smith et al. 2006; Sharp et al. 2006; Koolen et al. 2006). On chromosome 15, 
three novel syndromes associated with mental retardation have been confirmed 
at 15q13.3, 15q24, and 15q26.2 (Poot et al. 2007; Sharp et al. 2007; Sharp et al. 
2008). Collectively, these reports strongly suggest the importance of CNVs in the 
etiology of DNDs. For common complex diseases, the initial major analysis by the 
WTCCC on CNV association lead to major scepticism (WTCCC 201 0) and SNP-
based GWAS remained the primary tool to identify variants susceptible to 
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complex diseases. Although GWAS is a prominent approach to identify disease 
susceptibility SNPs, they can explain only a fraction of the missing heritability for 
any given complex disease. Hence, investigating the role of CNVs as potential 
variants to fill the void with respect to the missing heritability represents a logical 
step forward. In the last few years, numerous reports (see Chapter 1.5, Table 
1.1) have showed CNV associations (i.e. beta-defensin DEFB gene CNV with 
Psoriasis, FCGR3B and CCL3L 1 gene CNV with SLE, CCL3L 1 CNV and 
LCE3C_LCE3B-deletion with RA, CNV at locus 5q33.1 with Crohn etc.) with 
common complex diseases (McKinney et al. 2008; Hollox et al. 2008;Willcocks et 
al. 2008; Mamtani et al. 2008; Brest et al. 2011 ). The identification of CNVs in 
complex diseases is a major improvement considering the missing heritability 
problem associated with SNP-based GWAS. 
Recent advances in the detection of causal variants have been made 
through technological developments that can pinpoint CNV breakpoints with 
higher precision and accuracy. The refinement of microarrays and high 
throughput re-sequencing technologies has enhanced the detection capacity to 
identify CNVs that are below 1 kb in length. Multiple large scale population-based 
analyses on CNVs have produced higher resolution data and smaller variants 
have been discovered, along with increased precision to identify breakpoints 
(McCarroll et al. 2008; Kidd et al. 2008; Korbel 2007; Sudmant et al. 201 0; 
Conrad et al. 201 0). The work presented in this thesis provides a technique to 
narrow the target regions in the genome for better detection of CNVs and to 
analyze their susceptibility to complex diseases. I have used high throughput re-
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sequencing technology in combination with a custom-design microarray for the 
detection of CNVs within rearrangement hotspot regions and investigated their 
susceptibility in two complex diseases. 
The accurate detection of genomic aberrations is essential in measuring 
the effect of gene dosage on a given phenotype. The major detection methods, 
limitations within the hybridization-based methods include the inability to ensure 
(see chapter 1.3) exact copy numbers (especially CNV with higher copy number), 
duplication orientation, the identity of CNV locus within the genome and genome 
coverage. However, high throughput sequencing is rapidly improving the 
investigation of human and population genomics. This technology sheds light on 
these problems by sequencing the entire genome in parallel. Using such large 
amounts of data, it is possible to achieve higher precision in the detection of 
genomic variants. 
High throughput sequencing technologies typically produce shorter 
sequences with higher error rates from relatively short insert libraries. The major 
technological platform for high throughput sequencing includes Roche 454, 
lllumina, and SOLiD. Each platform produces reads with varying lengths and an 
array of softwares are available to map the reads. Most mapping tools are 
developed to produce information with respect to the reference genome by 
applying various alignment algorithms. This is due to the lack of technological 
development to produce genome assembly without the reference genome, also 
known as de novo assembly. Most de novo assembly methods for short reads 
are primarily based on computational approaches known as de Bruijin graph and 
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Eulerian path which are not efficient to assemble complex regions of the genome 
(Chaisson et al. 2009; Simpson et al. 2009; Li et al. 2009; Mills et al. 2011 ; 
Gnerre et al. 2011 ; Hajirasouliha et al. 2010). For example, a recent analysis 
showed de novo assemblies were 16.2% shorter than the reference genome and 
that 420.2 MBp pairs of common repeats and 99.1% of validated duplicated 
sequences were missing from the genome (Aikan et al. 2011 ). The de novo 
assembly also showed that over 2,377 coding exons were completely missing 
from the reference genome. Hence, these methods lack the maturity to apply de 
novo approach for genome assembly with high precision. 
The limitations mentioned above for each molecular and computational 
method underscores the importance to adapt a new approach in the detection of 
"rearrangement hotspots" that are vulnerable to produce CNVs and SDs. It is also 
imperative to characterize these complex regions within the context of sequence 
homology to better understand the underlying mechanisms in the origin of CNVs 
and SDs. To achieve the three objectives specified in chapter 1.6, this thesis is 
organized in two major parts - first, the detection of complex genomic regions 
(i.e. , "rearrangement hotspots" - see chapter 2) and secondly, the analysis of 
these regions in complex diseases to detect novel CNV variants (see chapters 
3,4 and 5). 
In chapter 2 of this thesis, I applied novel algorithm techniques to identify 
SDs and gene CNVs using high throughput sequencing technology and 
subsequently validated them by using molecular experiments. One of the primary 
objectives of my thesis was to detect and characterize rearrangement hotspots. 
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In chapter 2, I applied algorithmic techniques that analyze mapped short reads 
(using reference specific or de novo assembly) to detect SO regions and gene 
CNVs. One of the findings arising from this work was the characterization of 
rearrangement hotspots within SDs that are prone to produce CNVs. We have 
processed short read data that was sequenced using reversible terminator 
chemistry on an lllumina Genome Analyzer. A novel hierarchical approach was 
applied to the NA18507 human genome (i.e., an Yoruban male) where, 1.5 billion 
short reads (18x coverage) were processed with 55.78% (i.e., -839 million short 
reads) mapped to the repeat masked human reference genome with the 
mrsFAST aligner, which returned all possible mapping locations of a read, which 
is a key requirement to accurately predicting the absolute copy number of 
duplicated sequences (Aikan et al. 2009). After applying median-based GC 
correction to reduce the known bias and associated amplification artefacts with 
next generation sequencing technology towards GC-rich and GC-poor regions 
(Yoon et al. 2009), a mean + 2 S.D. (standard deviation) was applied to the read 
depth as a threshold for each overlapping window of 100 bp across the human 
genome in order to assess the breakpoints associated with SD units. 
One limitation of mrsFAST includes the inability to generate a consensus 
genome from short reads. Hence, after the duplicated breakpoints were 
identified, the short reads were reprocessed and the NA 18507 genome was 
assembled using MAQ by mapping the short reads against the reference (hg 18) 
human genome. Once the consensus sequence was obtained using MAQ, low 
copy sequences with <90% sequence identity were removed through filtering. 
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The primary reason for applying MAO assembly was to obtain all consensus 
sequences for the breakpoints obtained by read depth-based analysis. When the 
consensus sequences were obtained for those high read depth breakpoints, a 
new variant of semi-global algorithm, end space free pair wise alignment coupled 
with seed anq extend technique was implemented to accurately pinpoint duplicon 
breakpoints (or homologues). The consensus sequences were analyzed to detect 
rearrangement hotspots by investigating each 100 bp window for possible 
duplicons with >90% sequence identity. It is noteworthy that both mapping tools 
applied in this thesis were unable to return information regarding the orientation 
of the duplicated loci; therefore analysis excluded detection of inversions. 
One of the highlights of this study (presented in chapter 2) was the 
inference of all possible homologues (i.e., intra or inter chromosomal) for each 
SDs that leads to the characterization of complex genomic regions (see chapter 
2). While intra- and inter-chromosomal recombination events cannot be 
determined by asserting copy number estimation from read depth approaches, an 
integrating alignment algorithm was described. Also in chapter 2, we determined 
the breakpoint information required to characterize the complexity of a region in 
cases of excessive tandem duplication or where duplications within a duplication 
occurs within a chromosome or between chromosomes. Using 409 million 
pairwise alignments, the identification of 1963 complex SO units or 
'rearrangement hotspots' in the human genome showed an increase in copy 
number gain (i .e ., increase of 62% in copy number gains within hotspots). Further 
analysis showed that 25% of these 'rearrangement hotspots' (i.e., 489/1963) 
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overlapped with 166 unique genes (Fig. 2b) of which 77% were contained within 
82 genes which were previously shown to have an increased copy number gain 
by using microarray analysis (Chid et al. 2009). Twenty five of these genes are 
highly variable in copy number within three populations indicating a population-
specific frequency of the underlying events in the origin of CNVs (McCarroll et al. 
2008) which , in turn, implies an increase in frequency of genomic rearrangement 
events within hotspot regions. 
Chapter 2 also highlighted that genic regions were enriched with intra-
chromosomal recombination, whereas agenic regions evolved through both inter-
and intra-chromosomal recombination. Such intra-chromosomal recombination 
within genic SO units may represent conserved genomic organizations subject to 
gene conversion and concerted evolution (Shevell et al. 2003; VanderWeele et 
al. 2004; Dawson 2010). Extreme variation , attributed in part, to SDs has been 
reported in at least 20% of the copy number variable gene families in three 
human populations (McCarroll et al. 2008). We have produced a genome-wide 
high resolution map of 'rearrangement hotspots' which likely serve as templates 
primarily for NAHR mechanism. The characterization of pathogenic reg ions by 
our approach (i.e. 16p11-p12, 22q11.21 etc.) and subsequent validation with 
FISH experiment helps understand the possibility of intra/inter chromosomal 
NAHR as a disease mechanism within those regions. A collection of 24 
previously identified genomic disorders predominantly mediated by de novo 
NAHR events are catalogued in the DECIPHER database (Figure 2.3). Analysis 
of the detected hotspot regions revealed that 20% of the hotspots were located at 
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the end/start of those 24 pathogenic deletions/duplications breakpoints (see 
chapter 2) . This finding indicates a higher rate of NAHR that produces de novo 
aberrations within the detected genome-wide rearrangement hotspot regions. 
One of the limitations of our approach was the exclusion of inversions and 
insertions into the identification of "rearrangement hotspots". The method 
employed a read map algorithm, mrsFAST, which was unable to return 
information regarding the orientation of duplicated loci. Hence, the hotspot 
regions which are located within inversions are beyond the scope of the proposed 
work. The work described in chapter 2 indicates that NAHR represents an 
underlying mechanism for the creation of hotspots within the SO regions. Hence, 
this thesis largely excluded hotspot regions that are vulnerable to genomic 
aberrations through mechanisms other than NAHR (i.e. NHEJ, MMBIR, FoSTeS). 
Although the aforementioned limitations require further improvement, the overall 
strength outweighs the limitations and weaknesses. The genome-wide 
characterization of 'rearrangement hotspots' will enhance the clinical applicability 
of high resolution genome analysis to uncover uncharacterized genomic 
disorders. 
In order to identify these complex regions, applying high throughput 
sequencing with high coverage will allow the detection of CNVs in a 
comprehensive manner. A similar approach described in chapter 2 can be 
applied with high detection accuracy for CNV breakpoints. Although the method 
showed promising results in a personal genome, it is impractical to apply high 
throughput sequencing in large cohorts due to the extreme computational burden 
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and high cost associated with this new technology (Aikan et al. 2011 ). That these 
limitations associated with CNV detection using high throughput sequencing are 
tangible is evidenced by fact that the most comprehensive CNV profile published 
to date using high throughput sequencing analyzed only 159 individuals 
(Sudmant et · al. 201 0). The next commonly applied approach towards CNV 
detection is the use of microarray-based platforms. The most comprehensive 
CNV catalogue using aCGH was published using 20 genomic tilling arrays 
consisting of 42 million probes (Conrad et al. 2010). Similar to high throughput 
sequencing, the cost and time associated with processing and analyzing 20 
microarrays per individual is not realistic for large disease cohorts as indicated by 
the inclusion of only 40 individuals in the study conducted by Conrad et al. 
A more practical approach is to design a custom microarray to capture the 
aberrations within the detected hotpot regions (see chapter 2). There are two 
primary technologies that can be used - SNP-based microarray or array 
comparative genomic hybridization (aCGH). In contrast with SNP-based 
microarray, aCGH is primarily used for clinical characterization of CNVs. Modern 
molecular cytogenetics has begun to characterize CNVs responsible for mental 
retardation , autism spectrum disorder, and developmental delay, identify causal 
genes for known genetic conditions, and define new genomic syndromes on the 
basis of common genomic aberrations. Shaffer et al. 2008, reported on a series 
of 8789 clinical cases of children with a variety of developmental problems who 
were tested with aCGH (Shaffer et al. 2005). The results of that study indicated 
that 6.9% of children with abnormal results of microarray-based CGH exhibited 
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clinically relevant abnormalities, 1.2% exhibited a polymorphism, and 3.9% 
manifested changes of unclear clinical significance. 
Microarray-based cytogenetics is currently considered to be the first line 
test for patients with mental retardation, autism spectrum disorder, or 
developmental delay (Miller et al. 201 0). It is crucial to select an optimum 
platform with highest sensitivity and accuracy. CGH arrays generally show better 
signal-to-noise ratios compared to SNP-based arrays, probably as a 
consequence of non-uniform probe distribution on the former platform (Pinto et al. 
2011 ). The number of probes required to detect a single-copy alteration varies 
between platforms, with Agilent Technologies offering the highest per-probe 
performance (Coe et al. 2007; Pinto et al. 2011 ). Moreover, Agilent's in silica 
probe performance score is a meaningful metric for prioritizing probes for 
inclusion in microarrays. Although alterations can, theoretically, be detected with 
a single probe using the Agilent platform, a more conservative detection limit of 
three to five probes is advised (Pinto et al. 2011 ). There are also examples of 
studies where the analysis was a combination of array CGH and SNP-based 
platforms to offer higher confidence in CNV detection (Redan et al. 2006; 
McCarroll et al. 2008; Winchester et al. 2009). These studies also implicated the 
need for a better single detection technique that will provide higher precision in 
CNV detection. We chose Agilent technology and designed a custom microarray 
which consisting of 2 million probes with an average spacing of 280bp for the 
hotspot regions (see chapter 3 method section). For algorithmic prediction, it has 
been shown that platform-specific algorithms perform best in comparison with 
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platform-independent algorithms (Pinto et al. 2011 ). We used an Agilent platform-
specific algorithm (i.e., aberration detection module 2 - ADM-2) to detect CNVs 
from the custom microarray. 
The detected hotspots show convincing evidence that these regions are 
highly variable and are often found to be associated with disease. Such complex 
regions often are the harbour ground for de novo or atypical aberrations that are 
frequent in patients with neuropsychiatric disease. The application of the custom 
microarray described in chapter 3, revealed the detection of novel atypical 
microduplications within the 2q21.1-21.2 locus for Tourette syndrome. TS is a 
common complex neuropsychiatric disease and the genetic basis for this disease 
remains unknown. TS is characterized by involuntary motor and vocal tics. Other 
conditions (i.e. , ADHD, OCD) are often found to be manifesting with TS and the 
exact cause for such co-morbidity is unknown. The findings in chapter 3 highlight 
the impact of CNVs with respect to human health and genomic susceptibility to 
Tourette syndrome. The analysis detected co-occurrences of two atypical 
microduplication blocks that segregated in a multiplex family. 
The co-morbidity is very complex issue for the genetic analysis 1n any 
neuropsychiatric disease. The co-morbidity of diseases within Family A showed 
variability within the affected members. In-depth phenotypic analysis showed 
three siblings within the family with various features of TS. The oldest siblings 
demonstrated extreme phenotypic morbidity of TS. The mother and the 
grandfather also exhibited high functioning TS (Table 3.1 ). Five of the six affected 
members within Family A showed segregation of two microduplication blocks. 
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The custom microarray analysis revealed the presence of a partial duplication of 
the larger block on the fourth sibling. The large microduplication that segregated 
within the family is rare within the ethnically-matched control population. This 
indicates thatthe 2q21.1-21.2 locus is possibly linked with the TS etiology in this 
particular family. 
The larger microduplication that segregated within the affected individuals 
of Family A contains the C2orf27A gene. There is no report with respect to the 
function of the C2orf27 A gene which complicates to hypothesize the exact role of 
this gene in TS pathogenesis. We have analyzed a well characterized TS cohort 
which consisted of a multi-generational pedigree, two trios and additional 
unrelated individuals with a history of TS. Although we have determined the 
frequency of the larger microduplication block within a large control population, 
due to the lack of a larger TS sample set, it was impossible to determine the true 
frequency within TS patients. The rare frequency of this microduplication within 
the control population is indicative of a possible link between the 2q21.1-21 .2 
locus and TS pathogenesis. Until a large TS cohort is analyzed, it is not possible 
to determine the actual frequencies of these microduplications among TS 
individuals. 
Family,..specific CNVs are often associated with numerous 
neuropsychiatric diseases. These variants have the property of manifesting within 
affected members of a family and are extremely rare or absent within the control 
and other affected pedigree (Sato et al. 2012). Although the analysis identified 
the presence of the larger duplication block in an unrelated TS sample, it was 
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absent within the additional two trios and nine other unrelated TS samples. 
Previously reported neuropsychiatric disease studies using aCGH have showed 
the absence of these two microduplications (Cooper et al. 2011 ). However, it is 
premature to state that this locus is TS-specific until a more comprehensive study 
has been completed. 
In previous reports, several regions showed complex genotype-phenotype 
correlation where a locus consisted of multiple microduplications/microdeletions 
reported to be associated with several neuropsychiatric diseases (see Figure 2.5) 
(Antonacci et al. 201 0; Ensenauer et al. 2003; Shaw-Smith et al. 2006). The 
exact cause for such complex relationships between genomic variants and 
neuropsychiatric diseases remains unclear. This complexity is also apparent with 
the identified locus 2q21 .1-21.2 being a part of a broader 9MB locus 2q14.3-
2q21.3. This 9MB locus was previously implicated in a study where linkage 
analysis on a multi-generational pedigree with the history of Dystonia showed the 
high LOD score within this region (Norgren et al. 2011 ). In a more recent study, 
multiple patients with developmental delay (DD)/intellectual disability (ID), ADHD, 
epilepsy were reported to have recurrent microduplications and microdeletions 
within 2q21 .1-21.2 (Dharmadhikari et al. 2012). Our findings of microduplications 
at 2q21.1 -21 .2 within a family with a history of TS (and ADHD/OCD) adds to the 
growing list of genomic variants within that 9MB region. Screening for CNVs 
within this region (2q14.3-2q21.3) on a large cohort with TS and related 
conditions is warranted. 
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We have detected novel microduplications in one of our complex diseases 
using the custom microarray. The second disease of interest in this thesis is a 
common complex autoimmune disease, specifically Ankylosing Spondylitis (AS). 
Common complex diseases have been investigated extensively with SNP-based 
microarrays for the last decade through numerous genome-wide association 
studies. The National Human Genome Research Institute (NHGRI) published a 
catalogue of more than 237 GWAS studies on common complex diseases that 
produced a huge amount of SNP-based microarray data (Hindorffa et al. 2009). 
Until very recently, the development of microarrays showed promising results and 
became the ultimate experimental workhorse for CNV discovery and genotyping. 
SNP-based microarrays have proved popular in CNV-detection studies, 
historically as complements to array CGH platforms for fine-mapping regions and 
currently in the large-scale discovery of CNVs in a broad variety of populations 
(ltsara et al. 2009; McCarroll et al. 2008; Cooper et al. 2008; Jakobsson et al. 
2008; Gusev et al. 2009). Early SNP-based microarrays demonstrated poor 
coverage of CNV regions and were specifically designed for SNP-based genome 
wide association studies. CNV detection reusing GWAS data is becoming routine 
through the development of algorithms that can analyze SNP probe intensities. 
In chapter 4, CNV association analysis was performed using SNP probe 
intensities for rheumatoid arthritis (RA), which is an inflammatory polyarthritis 
involving many different pathways including aberrations in the innate and the 
adaptive immune system (Firestein 2003). RA can affect the articular structures 
particularly small joints of the hand and feet (and also extra articular structures 
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such as rheumatoid nodules) (Isenberg 2004). The WTCCC performed 
association analysis on a large cohort from a homogenous British population. In 
that study, the Affymetrix 500K platform was used to identify RA susceptible loci. 
The use of SNP-based microarrays were demonstrated to be useful in detecting 
CNVs where there is enough SNP-specific probe coverage to compute 
hybridization intensities for a CNV call. This suggests that SNP-based 
microarrays suffer from the lack of a back bone covering the genome with 
uniform probe spacing. Regions dense with SNP probes will have high coverage 
which creates the problem of insufficient probe coverage to make a CNV call for 
genomic loci with low SNP probe density. Probe coverage is strongly correlated 
with CNV detection resolution and therefore detecting small CNVs with SNP-
based microarrays is problematic and often introduces higher false positives. 
Hence, for complex disease CNV association studies, one of the major limitations 
includes uniform distribution of probes to form a consistent backbone for genome 
wide coverage. Our analysis also failed to replicate and validate findings due to 
the absence of a rheumatoid arthritis cohort. To overcome the limitation of 
inadequate genome coverage, recent arrays (such as the Affymetrix 6.0 SNP and 
Ilium ina 1M platforms) incorporate better SNP selection criteria along with custom 
selection of probes specific to CNV detection in complex regions of the genome 
and non-polymorphic copy-number probes (McCarroll et al. 2008; Cooper et al. 
2008; Winchester et al. 2009). 
The association analysis of the detected CNVs in chapter 4 was performed 
in two distinct CNV groups with a population frequency of < 5% - CNV that are < 
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1 MBp; and large CNV that are > 1 MBp. The primary goal of this study was to 
identify rare CNV variants that are susceptible to RA. The analysis model 
introduced two CNV groups of varying length. The association for <1 MBp 
reached significance within the cohort for the following gene CNVs - IRF1, 
TNFAIP3, TNIP1 , LCP2, 82M, PRKCH, PREX1, ALOX5AP, LITAF and SRGN. 
Among these genes, TNFAIP3 and TNIP1 are implicated in autoimmune 
pathways and are also associated with RA in GWAS studies. The other two 
important genes were ALOX5AP and L/TAF; both inflammatory mediator genes. 
The non-genic CNVs that reached significance included deletions located on 
chromosome 7p21.3, with the nearest gene (located approximately 50 kb away 
from the deletion) being thrombospondin type-1 domain-containing protein 7 A 
(THSD7A) . The association of the second group of CNVs with >1MB length 
includes 16p11 .2 which has frequently been previously associated with 
neurodevelopment disorders. 
A recently validated CNV for rheumatoid arthritis was the deletion of the 
Late Cornified Envelope (LCE) 38 and 3C genes (LCE3C_LCE38-del) (Lu et al. 
2011; Judith et al. 2012). Another non-HLA CNV found to be associated with RA 
is the FCGR38 gene copy number variant that is reported to be associated with 
susceptibility to RA. The presence of inversions/genomic gaps does not 
necessarily provide the true picture for CNV associations. In the case of the 
chemokine ligand 3-like 1 (CCL3L 1) gene copy number association (McKinney, C. 
2008), there exists contradicting evidence due to the fact that within this region a 
large inversion is also present. We were unable to replicate previously implicated 
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CNVs in RA pathogenesis - LCE3C_LCE38-del and FCGR38 which is primarily 
due to poor coverage of the region. The validation and replication was not 
performed due to the lack of an additional RA cohort. 
As we have discussed the pros and cons of using SNP-based microarrays 
from existing GWAS data, it is clear that for comprehensive detection of CNVs, a 
uniform and targeted array will provide higher accuracy. To overcome these 
limitations and to achieve higher detection precision, the custom hotspot 
microarray have been created to detect CNVs within the Ankylosing Spondylitis 
(AS) cohort in chapter 5. We analyzed a unique multi-generation family with a 
high incidence of AS and back pain. The custom microarray analysis revealed 
that 56 CNVs that overlap or consist of a gene are enriched in at least three 
affected members and are absent within the unaffected family members. Among 
these 56 genes, ten CNVs segregated with all the affected members of the 
family. After scrutinizing all ten CNVs based on potential function , further analysis 
was performed on the association of the UGT2817 gene in large AS cohorts. The 
primary reason for investigating this gene was the functional relevance with a 
bone-related condition (i.e., osteoporosis) . The affected individuals were all HLA-
827 positive and they all carried two copies of the gene that was validated using 
QF-PCR. 
The UGT2817 gene appears to be highly stratified within multiple 
populations however the reason for stratification is not yet known . It is often 
suspected that stratified genes are correlated with diseases and consequently 
hard to replicate into other populations. The association of this gene was 
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conducted in two geographically distant Canadian Caucasian populations from 
Newfoundland and Alberta . The association showed a trend of significance (p < 
0.05) in the Newfoundland population but replication failed in the Alberta 
population. In the global population, this gene is highly stratified, where deletion 
is much more prevalent within Asian populations, and rare in African populations. 
Although the cause of such varying selection pressure of these types of genes in 
different populations is unknown, they are often thought to be good candidates 
for disease susceptibility. One hypothesis stated that stratified genes are a more 
general risk factor with particular manifestations sensitive to genetic modifiers or 
environmental effects (ltsara et al. 2009). This requires more investigation to 
elucidate the cause that underlies the stratification. 
Functionally, the UGT2B17 gene has been demonstrated to be relevant in 
two different diseases, osteoporosis and prostate cancer. Although, there are 
conflicting reports on UGT2B17 association, this gene is highly expressed in the 
prostate. The association reported with osteoporosis is much more relevant to the 
AS study presented in chapter 5. UGT2B17 encodes a key enzyme responsible 
for glucuronidation of androgens and their metabolites in humans. For estrogen, 
androgen is 9 major source, and both have direct effects for stimulating bone 
formation. This is relevant with the osteoporosis association and UG T2B 17 
because the gene product influences serum androgen or estrogen 
concentrations. The authors hypothesised that UGT2B17 gene dosage through 
CNV is strongly linked with androgen or estrogen concentrations. AS is a disease 
characterized by bone overgrowth, whereas osteoporosis is the loss of bone 
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density that causes the diseases. Although the primary effect on bone for these 
two diseases (AS and OP) appears to be in opposite directions, it has been 
acknowledged that a significant portion of AS patients develop osteoporosis 
(Magrey and Khan 201 0). This correlation supports the role of UGT2B17 gene 
dosage in the regulation of bone density within AS patients. 
A comprehensive map of CNVs is presently not available and it will take 
an unprecedented amount of data and work to unfold the true content of 
structural variants in the human genome. The methods described in this thesis 
needs further validation , especially the characterization of rearrangement 
hotspots within multiple complex diseases that requires large scale investigation. 
This thesis did not attempt to capture all structural variants, and excluded new 
insertions relative to the reference genome and inversions. The method of 
detection of insertions and inversions is still in the developmental phase. More 
research is required to improve the detection resolution and to elucidate their role 
in disease pathogenesis. The analyses of CNVs in complex diseases are not 
mature enough because determining a technique to make an absolute copy 
number call is not yet straight forward. Hence, the effect of gene dosage within 
disease pathogenesis is still not clear. High throughput technology holds the 
promise to overcome these complexities in the near future. 
For the identification of novel variants and to better understand the role of 
these hotspots, additional complex diseases need to be investigated. In the case 
of Tourette syndrome, in-depth evaluation of the 2q14.3-2q21 .3 critical region 
within large multiplex families and well defined case-control TS cohort is 
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warranted . Functional analysis on the C2orf27A gene is required to unravel the 
potential molecular correlation of C2orf27A gene in Tourette syndrome. Due to 
multiple co-morbidities in this family, it is also of interest to assess genes specific 
to the various phenotypes (such as OCD and ADHD) . Finally, a large well-
phenotyped cohort of TS patients will allow us to assess the generalizability of 
our findings and allow subset analysis on CNV association that will eventually 
lead to more direct genotype-phenotype correlations. 
Regarding Ankylosing Spondylitis, the copy number of the UGT2817 gene 
warrants analysis in additional datasets within the SPARCC (Spondylitis 
Research Consortium of Canada) or NASC (North American Spondylitis 
Consortium) cohorts that have already been collected and in additional large 
multiplex families. The remaining nine CNVs (chapter 5, supplementary 1) that 
segregated within the large multiplex family should also be assessed in multiplex 
AS families and in a large AS cohort (similar to what is being proposed for the 
UGT2B17 analysis). 
Family-specific association with CNVs (atypical or rare) are very common 
in developmental neurocognitive disorders (Dharmadhikari et al. 2012; Cooper et 
al. 2011 ; Cook et al. 2008). This property of CNV segregation has yet to be 
systematically assessed for common complex diseases (i .e. RA, AS, SLE, 
Crohns, etc.).. The primary two diseases (TS - chapter 3; AS - chapter 5) 
investigated in this thesis used multiplex families as a starting point in the 
detection of novel CNV variants. The present strategy being employed for gene 
identification in common complex diseases involve recruitment of a large number 
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of unrelated case-control samples for GWAS (WTCCC 2007; WTCCC 2010). 
However, this approach overlooks the informative multiplex families that are 
important to assess rare highly penetrant variants. As a result, we feel that the 
optimal approach for gene identification is to combine the interrogation of 
multigenerational pedigrees along with large population-based cohorts. This 
hypothesis of family-specific causal variants for common complex diseases 
requires strong validation through extensive research. As high throughput 
sequencing technology is becoming available as a cost effective approach, 
genomic research will shed light on family-specific segregation of causal genomic 
variants. 
The effort being put into genomic discovery is expanding exponentially, 
especially with respect to structural variations. The results described in this thesis 
will prove increasingly important for the elucidation of complex regions and their 
underlying mechanism into the etiology of complex diseases. The future direction 
of this research should focus predominantly on the characterization of these 
hotspot regions in human complex diseases. Improvement in high throughput 
sequencing technology will provide an edge over all other existing technologies to 
better understand the origin and mechanism of these hotspot regions in disease 
pathogenesis. We have explored these complex genomic regions specifying 
primarily as a hotbed for the NAHR mechanism. A comprehensive analysis will 
shed light on the contribution of other proposed mechanisms (i.e. NHEJ, MMBIR, 
FoSTeS, etc.). Another important factor is the environmental effect on genotype-
phenotype correlation that is beyond the scope of this thesis. For future research, 
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along with genomic variants, analyzing environmental covariates will increase the 
possibility to identify the apparent missing heritability of complex diseases. 
In this thesis, an attempt was made to characterize complex genomic 
regions through computational and molecular approaches; subsequent analyses 
also investigated the role of such regions in complex diseases. The primary 
contributions of this thesis include: 1) the development of computational 
algorithms to characterize complex regions; 2) custom design microarray 
targeting those detected hotspot regions; and 3) the application of custom design 
microarray in two complex diseases. The application of the custom microarray 
detected a novel locus for Tourette syndrome and a candidate CNV for AS and 
represent a major contribution to this thesis. There are three major contributions 
arising from this thesis. First, a computational technique using high throughput 
sequencing was developed that is able to decipher complex regions (specifically, 
the relationship between SDs) that alleviate all previous microarray-based 
approaches. • Secondly, the detection and characterization of rearrangement 
hotspots to better elucidate the underlying mechanism for pathogenic CNV 
variants was performed. Thirdly, molecular experiments targeting these regions 
were effectively utilized to detect novel variants, as was demonstrated in two 
disease cohorts. 
Although it is ideal to analyze the entire spectrum of mutation variants, 
CNV was the primary variant type that was investigated in chapter 3, 4 and 5. For 
future research, a complete genome sequence analysis for 'Family A' (analyzed 
in chapter 3) , using high throughput sequencing technology, with at least 40x 
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coverage, will be undertaken. This will allow us to detect and analyze all 
spectrums of genomic mutations (i.e. SNP, CNV etc) . Similar sequencing 
analysis will be applied to the AS multiplex family described in chapter 5, with the 
anticipation of detecting a rare familial AS susceptibility locus. 
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Supplementary Figure 51.1 Length and GC distribution of segmental 
duplication (SO) units detected by computational prediction. a) The mean size 
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was 822 bp after exclusion of common repeat elements from duplicated loci. 
b) Interestingly, the majority (i.e. , approximately >80%) of these loci were 
located within the 30th to 70th G+C percentile. 
Chr 1 3 Chr 14 ChriS Chr 1 6 
Chr17 ChrlB Chr19 Chr20 
Chr21 Chr22 ChrX ChrY 
Supplementary Figure 51.2 Read depth distribution of the complete human 
genome segmented between duplicated (right Y-axis - red line) and non-
duplicated regions (leftY-axis - blue line). The distribution illustrates a distinctive 
distribution pattern between duplicated and non-duplicated regions with an 
approximate 7% error rate. These discrepancies are largely attributed to micro-
deletion polymorphisms that are located within the SO units as previously 
reported . 
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Supplementary Figure 51.1 Population comparison of detected SD units. a) 
The bar chart illustrates the comparison between detected duplicated regions 
which are common between 18x and 43x coverage of the NA 18507 human 
genome. The SD regions detected using low coverage short read data in three 
different populations (i.e., 57 Yoruba, 48 European and 54 Asian individuals) 
illustrate a concordance of 82.95%, 83.03% and 83.19%, respectively. b) The 
first bar (NA 18507 18X) represents a comparison between this study and Conrad 
et al. 201 Ob study while the second bar (NA 18507 43X) represents a comparison 
between studies by Sudmant eta/. 2010 and Conrad eta/. 2010. 
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Supplementary Figure 51.2 Concordance of autosomal SO unit in three 
populations are depicted in color-coded histograms. More than 90% of the 
concordant SO units are common within these three populations. Note that the 
average read depth for most of the individuals varies from 1.5 to ?x. The Asian 
population is associated with a higher error rate which is attributed to the lowest 
coverage. 
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Supplementary Figure 51.3 Breakpoint comparison (i.e., >50% overlap) of 
highly variable genes detected by Alkan et a/. 2009, illustrates that 79% of these 
genes are within our detected segmental duplication (SO) breakpoints. 
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Supplementary Figure 51.4 Criteria for inter- and intra-chromosomal 
rearrangements. In this scenario, two mechanistic evolutionary forces are 
imposed (intra-chromosomal rearrangements including tandem duplications, and 
inter-chromosomal rearrangements) together to illustrate the criteria for 
rearrangements. 
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Supplementary Figure 51.5 Inter- and intra-chromosomal rearrangement 
distribution for the NA 18507 genome depicting the landscape of human genic 
and agenic region rearrangements with a 99% confidence interval. a) Intra-
chromosomal rearrangement enrichment and b) low inter-chromosomal 
rearrangement was observed within genic regions as compared with agenic 
regions. For Y chromosome the analysis shows no inter chromosomal 
rearrangement within the genic duplicated region (excluding DUX family region 
from the analysis). Mean duplicons that define pericentromeric duplications with 
c) intra-chromosomal and d) inter-chromosomal rearrangements. e) The mean 
duplicon within the telomeric region with intra-chromosomal rearrangement 
depicts chromosome 13q34 and Yq12 as an outlier with extensive intra-
chromosomal rearrangement. f) Illustrates that inter-chromosomal rearrangement 
is dominant within the telomeric region of NA 18507 human genome. 
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Supplementary Table 51.1 Rearrangement analysis of SO units within genic, 
subtelomeric and pericentromeric regions of the human genome. 
Chromosome Genic I Non-Genic Subtelomeric Pericentromeric 
Intra pT Inter pT Intra pT Inter pT Intra pT Inter pT 
1.0X10_, 0 .995 0.999 1.0X10_, 0 .841 
2 1.0X10_, 1.0X10_, 0.479 3 .5X10-4 
3 0.843 0 .996 1.0X 10-<> 0 .939 0. 93 0 .999 
4 1.0 X 10-<> 0.407 0.974 9.5 X 10'3 4.8 X 10-2 0.999 
5 1.0 X 10-<> 4 .5 X 10-2 1.0X10_, 1.0 X 10'5 
6 1.0 X 10-<> 0 .526 3.3 X 10-4 0 .695 0.234 0.405 
7 1.0 X 10-<> 0.992 1.0 X 10-<> 1.0 X 10-<> 
8 8.0 X 10-<> 0 .996 0.999 3 .3 X 10'2 0.986 
9 0.261 0 .106 5 .9 X 10'5 0.649 0.869 
10 1.0 X 10_, 0.999 0.766 1.0 X 10-<> 1.0X10_, 
11 3.2X10-3 0.418 1.0X 10-<> 1.0X 10_, 
12 0 .166 0 .827 1.0 X 10-<> 0 .770 0.985 0 .999 
13 0 .997 0 .908 1.0 X 10-<> 1.9X10-2 
14 0.784 9 .9 X 10-4 1.0 X 10-<> 0 .990 0.955 
15 1.3 X 10-5 0.997 0.779 0 .652 1.0X10_, 
16 1.0 X 10-<> 1.0 X 10-<> 1.0 X 10-<> 
17 6.3 X 10'2 ' 0.951 0.965 0 .123 1.0X10_, 
18 3.2 X 10-4 0.999 2.9 X 10-2 0 .865 0 .999 8.4X 10-2 
19 0.999 0 .999 8 .0X10-3 0.998 0 .999 
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20 
21 
22 
X 
y 
0.999 0.714 9.2 X 10-2 5.6 X 10-5 0.832 0.999 
0.999 6.5 X 10-2 0.933 0.995 
0.865 9.0 X 10-6 0.998 1.4 X 10-3 1.0 X10-6 
1.0X10-6 0 .999 0.913 1.0X 10-6 0.997 1.6 X 10-2 
1.0 X 10-6 0.999 8.6X10-3 
Note: The SO units that overlap with a reference gene was analyzed for each 
chromosome based on the captured inter- and intra-chromosomal 
rearrangements against the rest of the human genome. The inter and inter-
chromosomal rearrangement of the segmental duplications with in 
subtelomeric and pericentromeric regions were also analyzed against the rest 
of the duplicated regions in the human genome. 
¥ - The table shows a series of 1-tail analysis of genomic rearrangements 
using 1 million permutations of mean differences to obtain empirical P-values. 
*Chromosme Y contained only two genes (i .e., RBMY1A1 and RBMY1F) 
which revealed intra-chromosomal rearrangements, whereas the OUX4 gene 
was associated with inter-chromosomal rearrangement. Thus, we have 
excluded chromosome Y from permutation test. 
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Supplementary Figure 51.6 Rearrangement within PAR (pseudohomologous 
region). a) The pseudohomologous region of the sex chromosomes contain a 90 
kbp duplication between chromosomes X andY where extensive inter- and intra-
chromosomal tandem duplications were observed. b) A 90 kbp region within 
Yq12 locus illustrating extreme tandem duplication with a duplicon of 100 bp in 
length. 
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Supplementary Figure 51.9 Localization of the NPIP and NPIPL3 gene 
derivatives. The alignment of the read depth plot is approximated in the 
chromosome contig . Multiple copies of the NPIP gene is located within close 
proximity of the NPIPL3 gene derivatives. Our analysis revealed the localization 
for the NPIP gene is within chromosome 16, whereas the NPIPL3 derivatives are 
localized in both chromosomes 16 and 18, which has been confirmed by FISH. 
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Supplementary Table S1.2 Summary of FISH analysis. 
Numb Chromos Probes used Chromos Signal 
er of orne in orne Summary 
cells modal hybridization hybridizat 
count number ion of (approxima 
ed (Probe label probes ted) 
in brackets) 
10 46 G248P8712C Chr 1 of Signals 
10 both observed at 
(Spectrum Ora homologs three 
10 cells nge) localizations 
with 46 on both chr 
chromoso 1 homologs: 
mes 1) at band 
1p36: >one 
signal per 
homolog; 
10 46 G248P8661F Chr16 Signals 
9 and 18 of observed at 
(SpectrumOra both three 
10 cells nge) homologs localizations 
with 46 on both chr 
chromoso 16 and chr 
17 46 G248P80054 Chr 1, 5, Signals 
G1 20, and 22 observed at 
(Spectrum 0 ra of both six 
17 cells nge) homologs localizations 
with 46 on both chr 
chromoso 1, chr 5, chr 
mes 6, chr 20, 
and chr 22 
homologs: 
1) at band 
1p13:one 
signal per 
homolog; 
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2) at band 
5p13: >one 
signals per 
homolog; 
3) at band 
6p: >one to 
two signals 
per 
homolog; 
4) at band 
5q21 : one 
signal per 
homolog. 
Chr 22 of 5) at band 
both 20p11.2-
: homologs one signal 
RP11-111312 per 
(SpectrumGre homolog; 
en) 
6) at band 
22q11 .2-
-four to five 
signals per 
homolog. 
Two signals 
present, 
one on each 
homolog of 
chr 22 at 
band 
22q13. 
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Supplementary Figure 51.10 The localization of the DUX gene family illustrating 
copies at the base pair level in chromosomes 3, 4, 10, Y and within the novel de 
novo assembly sequences. The DUX4 gene has been previously reported to 
possess the most number of copies within the human genome, however the 
location of this gene family remains incompletely characterized. We have 
revealed the position of each copy within the human genome, indicating the 
presence of the DUX gene family on chromosome 3. 
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Supplementary Figure 51.11 End space free alignment algorithm. The DP 
matrix populates according to the cost function and only trace back occurs from 
the maximum position of the matrix to 0. The gap is minimized by introducing a 
high penalty rate (i.e., -2 or -3) . 
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Supplementary Figure 51.12 The 'seed and extend' mechanism to detect 
optimal seeds with a 1 00 bp window of alignment. The seeds with <90% 
sequence identity was ignored for extend step. The extend step is a recursive 
procedure which does not stop until it crosses the predetermined threshold of 
90%. If there are multiple overlapping seeds, only the seeds with maximum 
expansion were kept. 
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Supplementary Table S1.3 Short reads map statistics. Short reads were 
mapped using mrsFAST with an average read length of 36 bp in the NA18507 
human genome with approximately 56% being mapped against the repeat 
masked reference genome. 
Summary Statistics 
Genome NA 18507 (Hapmap Yoruba sample) 
Platform lllumina Genome Analyzer 
Number of Short Reads 1,504,002,272 
Total Mapped Short Reads 839,039,591 
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Please find the attached CD. 
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Supplementary Figure 53.1: Criteria to consider CNVR breakpoints where 
multiple CNVs that overlap with each other in a region. The first case indicates 
where CNV1 is contained within CNV, the second and third cases show the 
overlap between boundaries. The fourth case shows where a CNV is contained 
within a larger CNV. The CNVR start point is defined with the start point of the left 
most CNV and end point is defined as the end point of the right most CNV. 
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Supplementary Figure 53.2 Histogram of copy number signals 
plotted for controls and rheumatoid arthritis samples. 
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Supplement~ry Figure 53.3: LRR Spread histograms of RA samples for the 11 
selected genic regions. 
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Supplementary Figure 53.4: Plot of all identified CNVs. Blue lines represent 
copy number duplications and red lines represent deletions. CNVs in orange are 
from WTCCC controls and CNVs from RA cases are in green. 
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Supplementary Figure 53.5: CNVs detected by comparative 
intensity analysis. The y-axis is the log R ratios of probes from the 
11 loci with the greatest significant difference in signal intensity for 
duplications and deletions. 
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SUPPLEMENTARY 4 CHAPTER 5 
Supplementary Table 54.1. A list of gene CNVs that segregates at with six AS 
affected individuals within the family. 
Chr Start End Length #of Status Gene(s) 
(bp) Probes 
4 69518934 69530196 11262 40 gain UGT2815 
9 84533087 84558449 25362 56 gain FLJ4395~ FLJ43859, FLJ44082 
10 48747724 49389683 641959 1857 gain PTPN208, PTPN20A, 
FRMP02L 1, FRMPD2L2, 
BMS1 P5, BMS1 P1, FAM258, 
FAM25C, FAM25G, 
LOC399753, FRMP02 
14 36327173 36329122 1949 7 loss BRMS1 L 
17 43589332 43597242 7910 27 loss LRRC37A4 
2 3440855 3441900 1045 6 loss TTC15 
5 677193 852102 174909 592 loss TPPP, ZDHHC11 
5 69534796 69559366 24570 86 gain LOC653391 
13 77871860 77874499 2639 10 gain MYCBP2 
SUPPLEMENTARY 5 CHAPTER 5 
Please find the attached CD. 
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